var title_f14_44_15040="Scaphoid shift test 2";
var content_f14_44_15040=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F80834&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F80834&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Scaphoid shift test: Step 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 445px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Next, place your other thumb on the volar side of the scaphoid tubercle. The tubercle is located proximal to the thenar eminence near the wrist crease. Use the hand grasping the metacarpals to repeatedly move the wrist, alternating between ulnar and radial deviation, while lightly palpating with the opposite thumb for the tubercle of the scaphoid. Try to feel if the tubercle protrudes volarly during radial deviation and recedes with ulnar deviation. This preliminary movement helps position you to perform the actual test.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin deWeber, MD, FAAFP, FACSM.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15040=[""].join("\n");
var outline_f14_44_15040=null;
var title_f14_44_15041="Inlet VSD 4 chamber 2D and color";
var content_f14_44_15041=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1196px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/58066/Inlet_VSD_4_chamb_2D_movie.mp4?title=Inlet+VSD+4+chamber+2D+and+color\" style=\"width:496px;height:400px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 580px\">",
"   <div class=\"ttl\">",
"    Inlet VSD 4 chamber 2D and color",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 560px; height: 440px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In these paired apical images (inverted), the atrioventricular valves can be seen to move in the same plane. In both panels, there are abnormal mitral valve attachments to the trabecular portion of the intraventricular septum in addition to the more normal septal attachments of the tricuspid valve. In the right hand panel, color flow mapping demonstrates the left-to-right flow across the large septal defect.",
"    <div class=\"footnotes\">",
"     RA: right atrium; LA: left atrium; TV: tricuspid valve; MV: mitral valve; RV: right ventricle; LV: left ventricle; IVS: intraventricular septum; arrow: VSD.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15041=[""].join("\n");
var outline_f14_44_15041=null;
var title_f14_44_15042="Drug interactions with immunosuppressants";
var content_f14_44_15042=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F81998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F81998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major drug interactions with immunosuppressants: Cyclosporine, tacrolimus, sirolimus, or everolimus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"20%\">",
"     </colgroup>",
"     <colgroup width=\"40%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td colspan=\"4\">",
"        Immunosuppressants are subject to numerous drug interactions, particularly with drugs or foods that inhibit or induce CYP 450 3A4 and/or P-gp. Drug therapy should be managed by transplant specialists with expertise in therapeutic drug monitoring, and doses should be adjusted based upon measurement of immunosuppressant concentrations, particularly whenever drug therapy is altered. The following is NOT a complete list of all possible interactions.*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <p>",
"         <strong>",
"          &uarr; INCREASED immunosuppressant concentration:",
"         </strong>",
"         Clinical effects may include infection, renal failure, cardiotoxicity, or other serious or life-threatening toxicity.",
"        </p>",
"        <p>",
"         <strong>",
"          &darr; DECREASED immunosuppressant concentration:",
"         </strong>",
"         Clinical effects may include risk of transplant organ rejection.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Interacting class",
"       </td>",
"       <td class=\"subtitle1\">",
"        Interacting agents",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect(s)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Management suggestions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Anticonvulsants",
"        </strong>",
"        (also see benzodiazepines below)",
"       </td>",
"       <td>",
"        Carbamazepine, fosphenytoin, oxcarbazepine, pentobarbital, phenobarbital, phenytoin, primidone",
"       </td>",
"       <td>",
"        &darr;&darr; immunosuppressant concentration",
"       </td>",
"       <td>",
"        Closely monitor immunosuppressant serum concentrations. Significant immunosuppressant dose increases may be needed. Avoid concomitant treatment with everolimus if possible. Effect of CYP3A4 induction may occur over weeks.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist_other_start\" colspan=\"4\">",
"        <strong>",
"         Antidiabetic",
"        </strong>",
"        (see hypoglycemic below)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist_other_start\" colspan=\"4\">",
"        <strong>",
"         Antimicrobials",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aminoglycosides",
"       </td>",
"       <td>",
"        Amikacin, gentamicin, kanamycin, neomycin, streptomycin, tobramycin",
"       </td>",
"       <td>",
"        Elevated risk of nephrotoxicity with cyclosporine or tacrolimus",
"       </td>",
"       <td>",
"        Consider substituting a non-interacting antibiotic. If aminoglycosides are used with calcineurin inhibitors, closely monitor renal function and serum concentrations of aminoglycoside and calcineurin inhibitor.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Antifungals",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Clotrimazole (oral)",
"        <sup>",
"         &yen;",
"        </sup>",
"        , fluconazole",
"        <sup>",
"         &yen;",
"        </sup>",
"        , itraconazole, ketoconazole (oral), posaconazole, voriconazole",
"       </td>",
"       <td>",
"        <p>",
"         &uarr;&uarr; immunosuppressant concentration",
"        </p>",
"        <p>",
"         Additive QTc prolongation due to fluconazole or voriconazole with tacrolimus",
"        </p>",
"       </td>",
"       <td rowspan=\"2\">",
"        <p>",
"         Closely monitor immunosuppressant concentrations to determine necessary dose adjustment. Everolimus prescribing information (US) recommends avoiding concurrent use with strong CYP3A4 inhibitors (such as itraconazole, ketoconazole, posaconazole and voriconazole).",
"        </p>",
"        <p>",
"         The following empiric initial dose adjustments may be considered: decrease tacrolimus dose by 66 percent if initiating posaconazole or voriconazole, or by 40 percent if initiating fluconazole &ge;200 mg/day; or decrease cyclosporine dose by 50 percent if initiating voriconazole or 25 percent if initiating posaconazole or fluconazole &ge;200 mg/day; or decrease sirolimus dose by 50 to 90 percent if initiating any azole antifungal.",
"         <sup>",
"          &Delta;[1]",
"         </sup>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amphotericin",
"       </td>",
"       <td>",
"        Increased risk of nephrotoxicity with cyclosporine or tacrolimus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Antimalarials",
"       </td>",
"       <td>",
"        Halofantrine",
"        <sup>",
"         &bull;",
"        </sup>",
"        , lumefantrine, mefloquine, quinine, quinidine",
"       </td>",
"       <td>",
"        <p>",
"         &uarr; immunosuppressant concentration with mefloquine, quinine or quinidine",
"        </p>",
"        <p>",
"         Additive QTc prolongation due to tacrolimus with anti-malarials",
"        </p>",
"       </td>",
"       <td>",
"        Monitor immunosuppressant concentrations to determine dose alteration if concurrent treatment with mefloquine, quinine, or quinidine is necessary. Monitor for QTc prolongation if antimalarial treatment must be initiated in a patient receiving tacrolimus. Avoid lumefantrine with tacrolimus.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Antimycobacterial",
"       </td>",
"       <td>",
"        Rifabutin, rifampin, rifapentine",
"       </td>",
"       <td>",
"        &darr;&darr; immunosuppressant concentration",
"       </td>",
"       <td>",
"        Closely monitor immunosuppressant serum concentrations and allograft function. Significant immunosuppressant dose increases may be needed, particularly with rifampin.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        HIV and hepatitis C virus (HCV) antiretrovirals",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        Amprenavir",
"        <sup>",
"         &bull;",
"        </sup>",
"        , atazanavir, boceprevir, cobicistat containing co-formulations, darunavir, delavirdine, fosamprenavir",
"        <sup>",
"         ������",
"        </sup>",
"        , indinavir, lopinavir-ritonavir, nelfinavir, ritonavir, saquinavir, telaprevir, tipranavir",
"        <sup>",
"         ������",
"        </sup>",
"       </td>",
"       <td>",
"        <p>",
"         &uarr;&uarr; immunosuppressant concentration",
"        </p>",
"        <p>",
"         Cyclosporine may increase protease inhibitor concentrations",
"        </p>",
"       </td>",
"       <td>",
"        Closely monitor immunosuppressant serum concentrations and for signs of toxicity (eg, nephrotoxicity). Significant immunosuppressant dose reductions may be needed. Avoid concomitant treatment with everolimus if possible. If used with cyclosporine, monitor protease inhibitor(s) for toxicity and serum concentrations where available. Early consultation with HIV/HCV infectious diseases specialist is recommended.",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Efavirenz",
"        <sup>",
"         ������",
"        </sup>",
"        , etravirine, nevirapine, tipranavir",
"        <sup>",
"         ������",
"        </sup>",
"       </td>",
"       <td>",
"        &darr;&darr; immunosuppressant concentration",
"       </td>",
"       <td>",
"        Closely monitor immunosuppressant serum concentrations and allograft function.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Macrolide antibiotics",
"       </td>",
"       <td>",
"        Clarithromycin, erythromycin, telithromycin (ketolide)",
"       </td>",
"       <td>",
"        &uarr;&uarr; immunosuppressant concentration",
"       </td>",
"       <td>",
"        Consider substituting a non-interacting antibiotic. Azithromycin and spiramycin",
"        <sup>",
"         &bull;",
"        </sup>",
"        are less likely to interact.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Other anti-infectives",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"       <td>",
"        Chloramphenicol, levofloxacin (with tacrolimus or cyclosporine), metronidazole, norfloxacin (with cyclosporine), quinupristin-dalfoprisitin, tetracycline, tigecycline",
"       </td>",
"       <td>",
"        &uarr; immunosuppressant concentration",
"       </td>",
"       <td>",
"        Monitor immunosuppressant concentrations during concurrent therapy to determine whether dose alteration is needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nafcillin",
"       </td>",
"       <td>",
"        &darr;&darr; immunosuppressant concentration",
"       </td>",
"       <td>",
"        Consider substituting a non-interacting antibiotic such as oxacillin or flucloxacillin. If concurrent therapy is required, monitor immunosuppressant to determine whether dose alteration is needed.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        <strong>",
"         Antineoplastic",
"        </strong>",
"       </td>",
"       <td>",
"        Bicalutamide",
"        <sup>",
"         &yen;",
"        </sup>",
"        , nilotinib, sunitinib, tamoxifen, vandetanib, vemurafenib",
"       </td>",
"       <td>",
"        &uarr; immunosuppressant concentration",
"       </td>",
"       <td>",
"        Monitor immunosuppressant concentrations during concurrent therapy to determine whether dose alteration is needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antineoplastic agents that are dependent upon&nbsp;CYP3A4 and/or P-gp (eg, doxorubicin, vinblastine)",
"       </td>",
"       <td>",
"        Cyclosporine, and to a lesser degree tacrolimus, may increase concentrations and toxicity of antineoplastic agents that are major substrates of CYP3A4 and/or P-gp. Immunosuppressant concentrations may be altered by doxorubicin",
"        <sup>",
"         ������",
"        </sup>",
"        or vinblastine",
"        <sup>",
"         ������",
"        </sup>",
"        .",
"       </td>",
"       <td>",
"        Monitor antineoplastic for exaggerated toxicity. Monitor immunosuppressant concentrations during concurrent therapy to determine whether dose alteration is needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Crizotinib",
"       </td>",
"       <td>",
"        <p>",
"         &uarr; cyclosporine and tacrolimus",
"        </p>",
"        <p>",
"         Increased QT prolongation with tacrolimus",
"        </p>",
"       </td>",
"       <td>",
"        Monitor immunosuppressant concentrations during concurrent therapy to determine whether dose alteration is needed. Avoid crizotinib with tacrolimus or monitor for QTc prolongation.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Benzodiazepines",
"        </strong>",
"        (also see hypnotics below)",
"       </td>",
"       <td>",
"        Alprazolam, clonazepam, clorazepate, diazepam, flurazepam, midazolam, triazolam",
"       </td>",
"       <td>",
"        Moderate increase in benzodiazepine concentration with cyclosporine",
"       </td>",
"       <td>",
"        Monitor benzodiazepine effect to determine whether dose alteration needed.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist_other_start\" colspan=\"4\">",
"        <strong>",
"         Cardiovascular",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Angiotensin converting enzyme (ACE) inhibitors",
"       </td>",
"       <td>",
"        Benazepril, captopril, cilazapril, enalapril, enalaprilat, fosinopril, lisinopril, moexipril, perindopril, quinapril, ramipril, trandolapril",
"       </td>",
"       <td>",
"        Increased risk of angioedema with sirolimus or everolimus; case reports of nephrotoxicity with cyclosporine",
"       </td>",
"       <td>",
"        Monitor for toxicity.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Antiarrhythmics",
"       </td>",
"       <td>",
"        Amiodarone, dronedarone, lidocaine",
"        <sup>",
"         &yen;",
"        </sup>",
"        (systemic), quinidine",
"       </td>",
"       <td>",
"        <p>",
"         &uarr; immunosuppressant concentration",
"        </p>",
"        <p>",
"         Additive QTc prolongation with tacrolimus",
"        </p>",
"       </td>",
"       <td>",
"        Monitor immunosuppressant serum concentrations and signs of toxicity (eg, nephrotoxicity and cardiotoxicity). Significant immunosuppressant dose reductions may be needed. According to US prescribing information, use of dronedarone with cyclosporine or tacrolimus is contraindicated. Avoid QTc prolonging antiarrhythmics with tacrolimus or closely monitor for QTc prolongation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anticoagulants, newer oral",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        Apixaban, dabigatran, rivaroxaban",
"       </td>",
"       <td>",
"        Increased newer oral anticoagulant effect with cyclosporine or tacrolimus",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"       <td>",
"        <p>",
"         If concomitant use is required, administer apixaban, dabigatran, or rivaroxaban two hours before cyclosporine or tacrolimus to minimize effect. Monitor for signs of excessive anticoagulation. Avoid newer oral anticoagulants in patients receiving cyclosporine or tacrolimus with renal insufficiency (CrCl &lt;50 mL/minute).",
"         <sup>",
"          &sect;",
"         </sup>",
"        </p>",
"        <p>",
"         Significant alteration of warfarin's anticoagulant effect has not been associated with these immunosuppressants.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Calcium channel blockers (CCB)",
"       </td>",
"       <td>",
"        Diltiazem, nicardipine, verapamil",
"       </td>",
"       <td>",
"        &uarr;&uarr; immunosuppressant concentrations",
"       </td>",
"       <td>",
"        Monitor immunosuppressant serum concentrations and signs of toxicity.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amlodipine, felodipine, nifedipine, nimodipine, nisoldipine",
"       </td>",
"       <td>",
"        Increased dihydropyridine CCB concentration with cyclosporine",
"       </td>",
"       <td>",
"        Monitor for exaggerated dihydropyridine CCB effects including hypotension and bradycardia.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        HMG-CoA reductase inhibitors(\"statins\") (also see ezetimibe below)",
"        <sup>",
"         ������",
"        </sup>",
"       </td>",
"       <td>",
"        Atorvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, simvastatin",
"       </td>",
"       <td>",
"        Increased statin concentrations and risk of statin toxicity including myotoxicity with cyclosporine",
"       </td>",
"       <td>",
"        Fluvastatin or pravastatin appears to have a lower risk of interaction with cyclosporine and may be preferred. Avoid simvastatin and pitavastatin (contraindicated in US prescribing information with cyclosporine). Limit lovastatin to 20 mg per day, atorvastatin to 10 mg per day, or rosuvastatin to 5 mg per day with cyclosporine. Monitor for signs of myotoxicity.",
"        <sup>",
"         ������",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atorvastatin",
"       </td>",
"       <td>",
"        &uarr; immunosuppressant concentration",
"       </td>",
"       <td>",
"        Potential interaction specific to atorvastatin due to its inhibition of P-gp.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Potassium-sparing diuretics",
"       </td>",
"       <td>",
"        Amiloride, triamterene, spironolactone",
"       </td>",
"       <td>",
"        Increased risk of hyperkalemia with cyclosporine and to a lesser degree tacrolimus; effect more pronounced with renal insufficiency",
"       </td>",
"       <td>",
"        In general, potassium sparing diuretics are avoided with cyclosporine.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Other cardiovascular",
"       </td>",
"       <td>",
"        Carvedilol, dipyridamole, propranolol, ranolazine, reserpine",
"       </td>",
"       <td>",
"        <p>",
"         &uarr; immunosuppressant concentration",
"        </p>",
"        <p>",
"         Additive QTc prolongation if ranolazine used with tacrolimus",
"        </p>",
"       </td>",
"       <td>",
"        Concentrations of tacrolimus and sirolimus are less likely to be altered due to these interactions than everolimus or cyclosporine. Monitor immunosuppressant concentrations during concurrent therapy to determine whether dose alteration is needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ezetimibe",
"        <sup>",
"         ������",
"        </sup>",
"       </td>",
"       <td>",
"        &uarr; ezetimibe concentration",
"       </td>",
"       <td>",
"        Increased concentrations of ezetimibe and possible alteration of cyclosporine level. 5 mg ezetimibe daily may suffice for LDL lowering effect in combination with cyclosporine.",
"        <sup>",
"         ������",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Dietary",
"        </strong>",
"       </td>",
"       <td>",
"        Grapefruit juice",
"       </td>",
"       <td>",
"        &uarr; immunosuppressant concentration",
"       </td>",
"       <td>",
"        Avoid grapefruit juice and grapefruit with immunosuppressants.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        <strong>",
"         Gastrointestinal",
"        </strong>",
"       </td>",
"       <td>",
"        Aprepitant",
"        <sup>",
"         &yen;",
"        </sup>",
"        , cimetidine",
"        <sup>",
"         &yen;",
"        </sup>",
"        , fosaprepitant",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"       <td>",
"        &uarr; immunosuppressant concentration",
"       </td>",
"       <td rowspan=\"2\">",
"        Monitor immunosuppressant concentrations during concurrent therapy to determine whether dose alteration is needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metoclopramide",
"       </td>",
"       <td>",
"        &uarr; immunosuppressant concentration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Octreotide",
"       </td>",
"       <td>",
"        <p>",
"         &darr; cyclosporine (orally administered)",
"        </p>",
"        <p>",
"         Additive QTc prolongation with tacrolimus",
"        </p>",
"       </td>",
"       <td>",
"        Cyclosporine microemulsion may be less likely to interact with octreotide.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Orlistat",
"       </td>",
"       <td>",
"        &darr;&darr; cyclosporine",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Omeprazole, lansoprazole",
"       </td>",
"       <td>",
"        &uarr; tacrolimus",
"       </td>",
"       <td>",
"        Pantoprazole and rabeprazole are less likely to interact with tacrolimus.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist_other_start\" colspan=\"4\">",
"        <strong>",
"         Glucocorticoids and anti-gout",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Glucocorticoids, systemic (also see immunosuppressants below)",
"       </td>",
"       <td>",
"        Methylprednisolone, dexamethasone, prednisone, prednisolone",
"       </td>",
"       <td>",
"        <p>",
"         &uarr; or &darr; cyclosporine",
"        </p>",
"        <p>",
"         &darr; everolimus",
"        </p>",
"        <p>",
"         &uarr; methylprednisolone, prednisone, or prednisolone concentration",
"        </p>",
"       </td>",
"       <td>",
"        Variable effects are described. If possible, avoid dexamethasone with everolimus. Monitor immunosuppressant concentrations closely.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Anti-gout",
"       </td>",
"       <td>",
"        Allopurinol",
"       </td>",
"       <td>",
"        &uarr;&uarr; cyclosporine",
"       </td>",
"       <td>",
"        Closely monitor cyclosporine concentration to determine need for dose alteration.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Colchicine",
"       </td>",
"       <td>",
"        <p>",
"         &uarr; colchicine toxicity with cyclosporine or tacrolimus. Toxic effects more pronounced with renal and/or hepatic insufficiency.",
"        </p>",
"        <p>",
"         &uarr; cyclosporine",
"        </p>",
"       </td>",
"       <td>",
"        Monitor colchicine toxicity and consider colchicine dose reduction with cyclosporine or tacrolimus if co-administration is unavoidable. For patients with normal renal and hepatic function, the following colchicine dose reductions are suggested: Acute gout: 0.6 mg once followed by 0.3 mg one hour later. Do not repeat before 72 hours. Gout prophylaxis: reduce dose by 50 percent; double interval. Familial Mediterranean fever: maximum daily dose 0.6 mg. Avoid colchicine with cyclosporine or tacrolimus in patients with renal and/or hepatic insufficiency.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         Herbs",
"        </strong>",
"       </td>",
"       <td>",
"        St. Johns wort",
"       </td>",
"       <td>",
"        &darr;&darr; immunosuppressant concentration",
"       </td>",
"       <td>",
"        Avoid St. Johns wort with immunosuppressants.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Schisandra",
"       </td>",
"       <td>",
"        &uarr; tacrolimus",
"       </td>",
"       <td>",
"        Avoid Schisandra with immunosuppressants.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         Hormones",
"        </strong>",
"       </td>",
"       <td>",
"        Estrogen preparations",
"       </td>",
"       <td>",
"        &uarr; cyclosporine",
"       </td>",
"       <td>",
"        Estrogenic hormones may increase cyclosporine concentrations and risk of toxicities including renal, hepatic, and central nervous system (seizures). Monitor cyclosporine concentrations and effects closely when estrogens are started or discontinued.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Testosterone preparations (including danazol, methyltestosterone, testosterone)",
"       </td>",
"       <td>",
"        <p>",
"         &uarr; cyclosporine",
"        </p>",
"        <p>",
"         &uarr; tacrolimus",
"        </p>",
"       </td>",
"       <td>",
"        Androgenic hormones may increase cyclosporine concentrations and risk toxicity. Avoid use with cyclosporine if possible. Similar effect is associated with tacrolimus in a case report.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Hypnotic",
"        </strong>",
"        (also see benzodiazepines above)",
"       </td>",
"       <td>",
"        Eszopiclone, zolpidem",
"       </td>",
"       <td>",
"        Moderate increase in hypnotic concentration with cyclosporine",
"       </td>",
"       <td>",
"        Monitor hypnotic effect to determine whether dose alteration is needed.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         Hypoglycemic",
"        </strong>",
"       </td>",
"       <td>",
"        Insulins, nateglinide, repaglinide, saxagliptin, sitagliptin",
"       </td>",
"       <td>",
"        If used with cyclosporine",
"        <sup>",
"         &yen;",
"        </sup>",
"        or tacrolimus, potential loss of glycemic control or worsening of hyperglycemia",
"       </td>",
"       <td>",
"        Monitor glycemic control with calcineurin inhibitors.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulfonylureas including gliclazide, glimepiride, glipizide, glyburide",
"       </td>",
"       <td>",
"        <p>",
"         &uarr; cyclosporine",
"        </p>",
"        <p>",
"         &darr; sulfonylurea effect with cyclosporine",
"        </p>",
"       </td>",
"       <td>",
"        Monitor cyclosporine concentrations closely. Monitor glycemic control with cyclosporine.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist_other_start\" colspan=\"4\">",
"        <strong>",
"         Immunosuppressant",
"        </strong>",
"        (also see glucocorticoids above)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        Cyclosporine",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Increased risk of serious renal, hematologic, and other toxicities in combination with tacrolimus",
"         </strong>",
"         and to lesser degree sirolimus",
"        </p>",
"        <p>",
"         &darr;&darr; mycophenolate",
"        </p>",
"        <p>",
"         &uarr;&uarr; everolimus",
"        </p>",
"        <p>",
"         &uarr;&uarr; sirolimus (with cyclosporine microemulsion)",
"        </p>",
"       </td>",
"       <td>",
"        Tacrolimus and cyclosporine should",
"        <strong>",
"         not",
"        </strong>",
"        be co-administered. Alteration of mycophenolate dosing is usually required when cyclosporine is initiated, stopped, or added. When used with everolimus, reduction of cyclosporine dose and target concentration is generally necessary. Risk of serious hematologic abnormalities is increased when cyclosporine is used with sirolimus. It is suggested that oral doses of sirolimus be administered four hours after cyclosporine doses.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tacrolimus",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Increased risk of serious renal, hematologic, or other toxicities with sirolimus or cyclosporine",
"         </strong>",
"         (see above)",
"        </p>",
"        <p>",
"         &uarr; everolimus",
"        </p>",
"       </td>",
"       <td>",
"        Avoid concomitant use of tacrolimus and sirolimus; serious toxicities have been reported. Tacrolimus and cyclosporine should",
"        <strong>",
"         not",
"        </strong>",
"        be co-administered; see information above. If everolimus is used with tacrolimus, closely monitor immunosuppressant concentrations to determine whether dose alteration is required.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Nonsteroidal antiinflammatory drugs (NSAIDs)",
"        </strong>",
"       </td>",
"       <td>",
"        Examples include celecoxib, ibuprofen, naproxen, others",
"       </td>",
"       <td>",
"        If used with cyclosporine or tacrolimus, increased risk of nephrotoxicity and hypertension",
"       </td>",
"       <td>",
"        In general, avoid NSAIDs with cyclosporine or tacrolimus. If concomitant use is required, monitor renal function and blood pressure.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         Psychiatry",
"        </strong>",
"       </td>",
"       <td>",
"        Desipramine",
"        <sup>",
"         &yen;",
"        </sup>",
"        , haloperidol",
"        <sup>",
"         &yen;",
"        </sup>",
"        , fluoxetine",
"        <sup>",
"         &yen;",
"        </sup>",
"        , fluvoxamine",
"        <sup>",
"         &yen;",
"        </sup>",
"        , sertraline",
"        <sup>",
"         &yen;",
"        </sup>",
"        , nefazodone",
"        <sup>",
"         ������",
"        </sup>",
"        , trazodone",
"        <sup>",
"         &yen;",
"        </sup>",
"        ; (also see \"herb\", \"benzodiazepines\")",
"       </td>",
"       <td>",
"        <p>",
"         &uarr; immunosuppressant concentration",
"        </p>",
"        <p>",
"         (exception: variable effect of nefazodone including increased and decreased immunosuppressant concentration)",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Avoid use of nefazodone with immunosuppressants",
"         <sup>",
"          ������",
"         </sup>",
"         . Nefazodone has been rarely associated with hepatoxicity and liver failure in non-transplant population.",
"        </p>",
"        <p>",
"         Monitor immunosuppressant if used with other interacting agents.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pimozide",
"       </td>",
"       <td>",
"        Elevated pimozide level and/or increased QTc prolongation with cyclosporine, tacrolimus, or sirolimus",
"       </td>",
"       <td>",
"        Avoid use of pimozide with cyclosporine, sirolimus, or tacrolimus due to increased risk of cardiotoxicity.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Other",
"        </strong>",
"       </td>",
"       <td>",
"        Bosentan",
"       </td>",
"       <td>",
"        &darr;&darr; immunosuppressant concentration",
"       </td>",
"       <td rowspan=\"4\">",
"        Monitor immunosuppressant concentrations during concurrent therapy to determine whether dose alteration is needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cinacalcet",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"       <td>",
"        &darr; tacrolimus or cyclosporine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Conivaptan",
"       </td>",
"       <td>",
"        &uarr; immunosuppressant concentration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sevelamer",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"       <td>",
"        <p>",
"         &darr; tacrolimus",
"        </p>",
"        <p>",
"         &darr;&darr; cyclosporine",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Interaction data and recommendations refer to systemic drug forms of cyclosporine, tacrolimus, sirolimus, or everolimus as immunosuppressant agents.",
"    <div class=\"footnotes\">",
"     CYP3A4: cytochrome P450 3A4; P-gp: P-glycoprotein efflux membrane transporters; HCV: hepatitis C virus; NSAID: nonsteroidal antiinflammatory drug; CCB: calcium channel blocker; ACEI: angiotensin converting enzyme inhibitor.",
"     <br>",
"      * For additional information see Lexi-Interact&trade; drug interactions&nbsp;program included with UpToDate. Also refer to UpToDate topic review&nbsp;of pharmacology and side effects of cyclosporine and tacrolimus (sections on drug interactions).",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       Not available in US.",
"       <br>",
"        &Delta; For additional information, refer to the UpToDate topic review on pharmacology of azole antifungal agents (section on selected clinical effects).",
"        <br>",
"         <font class=\"lozenge\">",
"          &loz;",
"         </font>",
"         For additional information, refer to the UpToDate topic review on solid organ transplantation in HIV-infected individuals (section on pharmacological aspects after transplantation).",
"         <br>",
"          &sect; For additional information, refer to the UpToDate review on anticoagulants other than heparin and warfarin (sections on novel oral anticoagulant interactions).",
"          <br>",
"           &yen; Moderate metabolic inhibitor(s). Interaction effect may be moderate.",
"           <br>",
"            &Dagger; Complex effects may increase or decrease serum concentration of immunosuppressants highly dependent upon CYP3A4 and/or P-gp for elimination.",
"            <br>",
"             &dagger; For additional information refer to the UpToDate topic review on nonimmunologic complications of liver transplantation (section on hyperlipidemias).",
"            </br>",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     <br>",
"      Lexi-Interact. Copyright &copy; 1978-2013 Lexicomp, Inc. All Rights Reserved.",
"      <br>",
"       Additional data:",
"       <br>",
"        <ol>",
"         <li>",
"          Dodds-Ahsley E. Management of drug and food interactions with azole antifungals in transplant recipients; Pharmacotherapy 2010; 30(8):842.",
"         </li>",
"         <li>",
"          Kuypers D, Immunotherapy in elderly transplant recipients: A guide to clinically significant drug interactions. Drugs Aging 2009; 26(9):715.",
"         </li>",
"        </ol>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15042=[""].join("\n");
var outline_f14_44_15042=null;
var title_f14_44_15043="H pylori photomicrograph";
var content_f14_44_15043=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F74689&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F74689&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Helicobacter pylori",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 258px; height: 260px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <em>",
"     Helicobacter pylori",
"    </em>",
"    (",
"    <em>",
"     H. pylori",
"    </em>",
"    )&nbsp;is a spiral shaped Gram negative bacterium measuring approximately 3.5 microns in length and 0.5 microns in width.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of the American Gastroenterological Association&copy;. This slide cannot be downloaded but may be purchased as part of a set from the AGA through Milner-Fenwick, Inc. at 1-800- 432-8433.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15043=[""].join("\n");
var outline_f14_44_15043=null;
var title_f14_44_15044="38 yo MS brain MRI";
var content_f14_44_15044=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F52184&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F52184&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 539px\">",
"   <div class=\"ttl\">",
"    38 year-old woman with multiple sclerosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 519px; height: 313px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAE5AgcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5p1bUb4apeAXlz/rn/wCWrf3j71V/tK+/5/bn/v63+NGrf8hW9/67P/6Ea6j4UeBn8f8Aid9MbUE0yzgtpLu6vXj8xYI0A5K7lzlio6jrntQBy/8AaV9/z+3P/f1v8aP7Svv+f25/7+t/jV3xfoNx4X8Uapod6d09hcPAXAwHAPDAehGCPrWPQBb/ALSvv+f25/7+t/jR/aV9/wA/tz/39b/GqlFAFv8AtK+/5/bn/v63+NH9pX3/AD+3P/f1v8aqUUAW/wC0r7/n8uf+/rf40f2lff8AP7c/9/W/xqpRQBb/ALSvv+f25/7+t/jR/aV9/wA/tz/39b/GoIYZJnCRKWY9hXR6d4UuZlDTEKeuwdaAMP8AtK+/5/bn/v63+NA1G/PS8uv+/rf4131n4EZiohikllxkrtzxXSab8MXuVU20Mhz0UpzmgDx/7fqGM/a7rHr5jf40C/1AsFF3dbj281v8a93/AOFUXUZJWyaVIxyvTP0q4/wivFjM0GntIxGRgfdFAHgRl1YKSbi7AH/TVv8AGozeakOtzd/9/G/xr6RtfhVcx20T3Fsz+YQHRVyRXSw/AyGRlAj8uF8csORQB8inUb4HBvLnP/XVv8aP7Svv+f25/wC/rf419R+Nv2aUMP2jRrsmXHzKR1NeOeL/AIN+KPDdqLmS0aeA9WjGcUAef/2lff8AP7c/9/W/xo/tK+/5/bn/AL+t/jUE8MsEhSaNkcdQwxUdAFv+0r7/AJ/bn/v63+NL/aN8f+Xy5/7+t/jVOloAtf2lff8AP5c/9/W/xo/tK+/5/bn/AL+t/jVUc9enegigC1/aV9/z+3P/AH9b/Gj+0r7/AJ/bn/v63+NVaSgC3/aV9/z+3P8A39b/ABo/tK+/5/bn/v63+NVKKALf9pX3/P7c/wDf1v8AGj+0r7/n9uf+/rf41UooAt/2lff8/tz/AN/W/wAaP7Svv+f25/7+t/jVSvQPhb8PofG1l4gu7nU7qyi0iKKRktdPN5LLvYrhUDqeMe/6UAcV/aV9/wA/tz/39b/Gj+0r7/n9uf8Av63+NdF8TvB6+B/FLaOuopqAEEU4k8kwugddwWSMklHAIJUnuK5KgC3/AGlff8/tz/39b/Gj+0r7/n9uf+/rf41UooAt/wBpX3/P7c/9/W/xo/tK+/5/bn/v63+NVKKALf8AaV9/z+3P/f1v8aP7Svv+f25/7+t/jVSigC3/AGlff8/tz/39b/Gj+0r7/n9uf+/rf41b8P8Ah3VvEN2LfR7Ge6kJwfLUkL9T2r3Pwb+zibvTE1DxTr9tY27gkLburnjrz0zQB4ENRvycC8uif+urf41ahOszLmOW9I/66N/jXofiTS/D2kX1zZ+H4zeQwybY7xhzJ65HatGTxFGNLtrKSxthdHgTL1UelAHn2n6J4o1C4WCzW+llboqyMTWpfeB/GdlgXXnpKePKNwd/5ZzXqXgTxFJ4I1rTtcv3D6fPujnhiAYr6EV23xU8RaNDosHiHREEmsau6XEEsp+a22e1AHzWPDfihrn7NHLO90BloEnYyJ/vL1FV7jSNegkWM3xeRm2lEuSSp9CO1ehaF8QdW03Wta1i1tLf+3tSjMcl+TzGT/EF6VJq3jPR75op49Bt7e/jQfaLlW5nk7uR6mgDiNY8HeMtHigkv1uUWddyYuCcj86w5rfXobU3Dve+QDguJGIH6175oVkfH6Q6faahsnC8yTNjy89h611GifCS60TUP7H1nUoLi0u428pC2Du9aAPko6jfjreXQ/7at/jR/aV9/wA/tz/39b/GvpOH4e+HdC1ltG8XaYs9zcy7YJhJs2R/36p+OP2cohI0ngvW7a6kYbls5pFDn/d9aAPnj+0r7/n9uf8Av63+NH9pX3/P7c/9/W/xq94k8M6x4avXtdasJ7WVTj51IB+hrGoAt/2lff8AP7c/9/W/xo/tK+/5/bn/AL+t/jVSigC3/aV9/wA/tz/39b/Gj+0r7/n9uf8Av63+NVKKALf9pX3/AD+3P/f1v8aP7Svv+f25/wC/rf41UooAt/2lff8AP7c/9/W/xo/tK+/5/bn/AL+t/jVSigDtPhhf3j+OdMV7u4ZT5vBkJH+qf3oqt8Lf+R70z/tr/wCinooA5/Vv+Qre/wDXZ/8A0I12Pw/+IbeCfD2u2Vjo9nd32qmJHuL0LNEkKEkxmErhtxPJJ7DjiuO1b/kK3v8A12f/ANCNVKAOv+KHjMePPEcWuS6cljfPaRQ3hSTetxMi7TKBtG0EBRt5xjqa5CilFABigY79KfwEPNR0ALRnikqSKJpGwv4n0oAYoLcCrlnp890wWFCTnGewq/pWkm8Ybj5UX8TnuPava/hf8KNV8VpHJDG1hoy8efIvzSfQd6AOA8MeF9RuJvI0W1+1XX8cgXIWvp/wT8INL0qxtrvXZ/tNy6hto6Z9K0Nd1fwV8GPDBtw0Yu5UKqi4aWU46n0r5+8YftCavf8AkwaHAtrawg7S/LE+tAH09eXXhjw9avJ5dukijDZx8lcbqnxi8OaTFIdPiiuL5VwOgVQe5r441fxRrOryO99fzyFzlhuOCaxzI5zl2OeuTQB9ZeLfjXoz+HYLawkxqBG7zE6BvSq+l/H9bWC1RjCGRQJy3O6vlKigD7BX9pTSYpHXyF8teV2ryaqz/tLWZvJTFHutnUbVYcoa+VbeS2Fq8ciZkPO6q0Wzd84yO1AH2In7RGm6hHbT2ySx3EQImhP3ZB7V32h/FPwr4ptltnuEhkljOYZhjn0Br4w0fw7b3mlvOdSS2lAyEzkmqSWmqW7FLS6WQ9RzyKAPqrxB8MfCnje1n/s0RwXik7sHDD3968B+IfwV8ReFd1xBA15YZ4kjGTioNL8b6vpawx6hNNBPDzFcoT83s3rXufws+Mkd7B9j8RYuUc/LIQDg+hFAHyBIjxsVkVlYdQRg00HBr7a8a/Cfwl8RrGW+8PtFaanyxEZADH3Havk3x34I1jwZqT2uq20iLn5ZMcEfWgDl80uCV96QHB4ooAKdtJOKRCAwJ6CgtyccA0AIQQaSnhuMdc0ygAopyEA5bn2pKAEr0D4W/EGHwTZeILS50y6vYtXiijZ7XUDZyxbGLZVwjHnPt+tef0UAdl8UPG7eOtZsrv7D9igsrOOyhR7hriVkQk7pJWALtljyRXG0UUAFFFFABRRVixs5r2dYoELMf0oAjhiknkWOFGd26KoyTXrvwu+F9hqVkdb8Y3rWemRSbfs6D94/+Aqr8OtKi07VLWYwsdsoW6unQlIE7mu/+OvivRtUl02z8L3Ecun2qbZJIBgSH+tAFvxB45svC2r6XbfDq1gttIsyXnQcG8JGCsh64rzvUPEOp3IMKFls4ZHlitVJ8uIucnFYkTW09wpZ3RD15rYu76CzsxDZbWVurMMmgDGhu5bmfZhYg/LKnc1Z1HTYrMK4nDSNyQ3aqsbL9rRd67m6bRV3VCwYJInzY+81AEmjLDJfRpqF5iw6uQenpiotWuJJtRRXlZrfOIyx6LWRb4dzE5CpnrU0xeQlQcxp0agDtH022trS2e5tHNnJy8sY+bHtWNrOn6Tbyn+z5GlhbkBvvD61PpuoX99bpZhmEKDABq3e6M0ESyNGN/tQBy9vdT2Mwa0uZoGBBDocYI6V2mnfES+t7+0vNQu5tUv4HDq9wc4A7CsaKwjnYtcKI1Hes7UNOCzb7cBgOhWgD2zU9Sj+L7rJaz2un6/bQnyrZm5mHXaPevOIl1PSNfee7aSy1S0YAncfkI7D61xVtcTW1xIbeRre8x+7uAcNGfUGvWvEkzfECRNX8PqbiPTrKKPUVbh1KjmT3zQB6k2v2XxC8KWcer6Zp4uHYRzQXvEhHTcnueteOfGT4AXHh+NtX8Ls0+mty1vIfnjJ7e4ruPEcN5D4A0LxHoSxG3iIaeaVPnUg8cdcZr0698WaNe6R4c07xJqttbanqapIIgpIl9h6ZoA/PmaJ4ZGjlUq6nBB7Uyvrj4v+B9F8SeOf+Efj04aPdm23Wd2ifJPJ6NjjFfMnjDwrqvhLV5dO1m2eGZDgMR8rj1BoAwqKKKACiiigAooooA6v4W/8j3pn/bX/ANFPRR8Lf+R70z/tr/6KeigDn9W/5Ct7/wBdn/8AQjVSrerf8hW9/wCuz/8AoRqpQAUvSnkABOOvOaYxyTQAlFFPRCwJHbtQAiozdATXT6RpK7Ea53CJmHyqOW9qd4a0wJ5c9zGXdj+6h7sa+pfhB8NLfStMHinxsscflAzxW8gwsKj+JvegCt8JPgzay6fFrPi+Dy4siW3tCduxeuX/AMKn+KHx00nw9Z3GmeHDG00GYkSPAGR346AVx3xq+Mt7fadLaaSzW0N3mOCJeH2f329M9hXi2iaVplrp02q+I5meU/6m2U5Ln1NAGVrNzrPia8l1PUJJJmYkl5G4Ue2axZY9jlAdzD+7yK7q20nU/FAQogstNX7qjjIrqdI8IaZp4Vni81+hZu9AHlVjo99d4MFu2BzuIrpNM8BXd6D9ouUhPXkV6DKkNs6+RGqYONo71LNcqIl+TMx4AFAHm+s+ArmwgaSC6juWAzsQc1z1ppLzTrC7ESseEA5r222vUicooUMPvE1wt6tva/ETMWPKZN30NAGnZfD+xWzj+0NmVxk+1Vrr4eWsQZRKxzyrCus+1xGNUMm4N1I7VHFehXaGZjx0PtQB5nqfg/V9NlDW+ZIuoZTisvOqWE4lkjkJU5zivYZ5zOVtg/yt3FEem2b7kIJOMHPOaAOE0rxBpWqQtaa7DtB6OO1Sz+F7q1j/ALU8J3Bu4FyXRDkr+FM8Q+ES1zKbNAe+VrF019b8NXX2jTZ3ikHVR0P1HegDt/AnxD1DRr1ZTuhv0b72eCPQivo/RNe0H4qaImneJ7WGO8fKxvxtkP8Asn19q+L5NVXULqWS+GyaVizOnHNdB4d8RXvhllhkd5dMlIdXB+aNuzKfWgDo/jT8GtR8DzyX9irXOkM33gMmP6+1eP190/C/x7Y+O9IPh3xOIpp5YsRzNjbcp/RhXzd8ffhhL4A8QmW03SaTdEvE2Puf7JoA8npaSlBwcigA6Gg9qDnPPWl4KjjkUANoqRwAOgphBGPegBKKKKACiiigAooq5pNjJqN7Hbx8bjyfQUASaNpc+q3awwKdvV3xnaPWvX9P07TtJ07SrDTNMeTUZ5dsl3u3NJnphOwFdb8G/hrNdxXsssE+mvGn+gtOu0XTn1z2rtvBHhqy+G9nrWueNb6yl1tCJEjt23vAp6BR70ASfE/VbHwF8MYdFdbeTXtQjHmokYy4/iY+nFfNYvI2jCW1phFHCgVvfEbxZc+LPEVzqkkIiaU4WPdkIo6Yo00RWmnxsqpJO46DnFAGEifaWXfCQ3cYxV4iG2tyfL3D37VZeK9ubj93FsXvxU1xYSzmKAKcE8kCgBng+yt7q/aafCqM7Qax/E8066pKWwYlOAB6V12u6BceHtJiuZA0aSD5T0ripm8xWJYOW7mgCrGYnbI4J6ip0VijbDwTwKrfZTEwfJB/nVgSiGVPL+bd1oA6XTrtre0VRGBJ6irM93cShfP3L6ZrCYPbXVvKlx5hZhmP0Fet2/h6x8R6XFLFJ5dwi8qKAOOvhZtpCiZikpHWub0ryftbI82EQ5GT1rtvF1gulaWbeeDzDjAf0ry2KNfM+ZmXntQBueJYrSWUNaEbiOcetUdFv9T0W48+yne3buVOFbH94dx9avRw2zwqwkxjqfWrFrbJqJMQ5iA5NAHufw1+Juk+JdEm0bxd5EV/Ivl/KoWK644YDopFdv4M8MXPhe8BvJbbVdCMbXCXU0amS2bPCof7uK+QrzTRZO0tlIWVTXpXwx+JPipPEWk6bFdLqVpNiz/s+4baig/xA9yKAPp7W9XtJbHz7OzTUH2bgeBhfZuxrzz4vReGfEvhewTxLZSwfaiY4byJN/2dh03EdqzPD15rkXjm8FveWb+D4rpoLyGaQKkDY52nua7+bUNOu9N1nTvKtLfS4kCxSXDbUdm+vbPSgD4R+IHgvUfBmsG0vkL28g329yo+SZOxBrlq+w7PwkniRNV8F+K73zr1UMunIoytsO2G9DXy5438J6n4O12fS9XhMc0Z+Vuzj1FAHP0UUUAFFFFAHV/C3/ke9M/7a/8Aop6KPhb/AMj3pn/bX/0U9FAHP6t/yFb3/rs//oRqqATVrVv+Qre/9dn/APQjVUEjpQArZHBPSkBxQaSgArY0S1Sdy0rAImMk1mRQtJMkaj5mOBXsHwX8Cr4s8WQaVIpNjFie7Yeg7Z96APY/gN8KYPLs/FmtXC3Idd0FqV+SIDox965D9o74tPfak+gaQ2NOtnw20/69x6/7Irv/ANoz4iweA/D9r4c0EpFdzR4KR8eXHjAHtmvjqK982+kvL3dPOxLBT3NAFqRp55DJcF5dRuGGwnnYK7TRfBwl8qfUZWYJg7T3q54J8ORC2Gsamd1xP/qo8cIK6OWRlG3cNg+7igC67rHEI4lVI1H3VrJvbvM2EclcYI9KbPcsM7eD3J71m3Mojy7EHd1oAteYFDOW+YDoe9QRXTH51xuHC5rKluZJGwGGw9OKvtGY7XIwGPTNAEy7SsjZJc/eIrm9ZtRa+ILWZAWaReprqdOy6AxjgfezWT4yCwz2ZOGdTnjrQBYu3MEKzsAQuNwFLdyNLDFcxHcCOMdaWWNr7T/3RQMBnaT1FM0iJpbUoVZduQCaAH2twpbzYycgYINXrO82zAq/LDnPaufffb3DIScA9PWnW1yTI247QO2KAOvhnVsFsH1xTZbe2nyzojj0x2rAF2UZVLfMRkD2q7FcbI/OmbEZGFUdTQBz/jPwZAtq19pjYPVo65fRb9FR9O1NAYTwpbqpr0+O6aaP512ROMYauc8c+GoZdOjv7Pasynaw/vUAc9b6hqHhTUY0jkkWIESxMDyvuK+o/DusWHxm+GE2m6xJGmqW4wjt1Jxwfxr5Mtb55mFpqA3MBtV36rXS/DbxNeeEPEy3ELCW0kISdCeCuetAHNeMfDV/4W1qfT9SgeJ0Y7SRww9RWFX214v0jwz8VNBhikdYbjZi2v152vj7jV8g+MfDWoeFNduNL1SIpLExAbHDjsQe4oAxKcjBc5GT2plKKADcck+tJTiMDJpKAEooooAKKKKAJIInnlWOJSzscACvY/hR4SnivvtFx9nijQfNNP8AdQ1N8DPh/JqQn1TUYGWFrd2t5CuVBA5JrZtLi81Cyg0SJWvFkuPLikgjIBb0c/40AeleKPFwuJfDVzo0s9vLJO1laXV6MWayqvL47+1eG63f3N9qF3FPP9r1R52W5vmPzS89B/sjtXefFHxPead4GsvCOq6Gmn6pbS+ZyQ6mPsykdCa8ksZ4rQiSRiWP50AXNV05rSEIjF3Iyag8PSNbXqec/BPeu/8ADHh221/TZbp7j98o4XNctfaC9vfFbgMgDcEjFAHUfbLdWU7sKRzWr4VgbU9S4iCwIchiOtWfCfhux1fTWRnBdRwa6jTbWPQrd4pQpOMAigDhvi3qkuoCLTmZTDB2FebrpZmULHnA7jtXf6/DZW9/NdzziTeSduelZNzr9i+ntHaW6+Z03AYoA5i4sdtk+C7unf0rPsMiQRbNzNxu9KvNfXEccsLyokUv3gRk1VjgnihNwinyQfvUAWzpslncqUcyS+lbnhzXdS0rUVdtwGcFe1c9FqsiTLLC4L/7QrsfCq2+rzb72VIyOoPegD0TW7FvEfhhriEDztu4ivE73TWDSROCkinmvpDwrqGjWtg9tvLOFxivHfiBC0+qSyW6hVBPQYyKAPOCHjkWMNwTivW/DEulaX4Une5hzdSLgEiuF0jRPt+pwCUeVlh1PWu8+Kr2uiaRp1ramN5SOQooA81vNWDSzRJFsRz3osY7iyaO+spXjmjbckqfejb1FQ2en3es3ieRCWJPIA6VuXtpLo86WqDztww6jtQB0PhT4hXWneJYZrvT49Qsb3EV7YKufPb/AJ6KD/y0J616XpNzJqHxOsNC8YabIkdwPPhg2/udnWNXH95a+d763kS7BtHaOZW3JtPKn2Ne+/D74inWv7P0/wAZXdldTXQ2JFbp5c9l5YyGkc9d2O1AG78RZ9P8LeOri5H2h9Q1AIUFv1iRRj8K5/4jRWXxT8ONax6bc/27arutbhVB8wDsxr034aS+GvFkuu6xaWkgvrqUw3UdxIJCoUYG3+6COeKwdQ0PR/AfjTRUsbmZDe3G1YmfIA/woA+HLu3ltLmW3uEKSxMUdT1BHWoa+ov2q/hl/pR8U+H7RfL25vVixgH+9gV8u0AFFFFAHV/C3/ke9M/7a/8Aop6KPhb/AMj3pn/bX/0U9FAHP6t/yFb3/rs//oRqrVrVv+Qre/8AXZ//AEI1UoAKcqk8gdKTBxmr+kWpu5ii5wOWx3FAGz4R0lru4iCxs9xO2yFB3Jr650rSD8K/hgBYxKdcu8SXU5/5ZDqST6AcfjXH/s1eBYjG3i7VISqxExWNvIMc/wB6uc/aV+KZvWk8LaLMDGGzfTofvt/cB9BQB4t491668WeML3UJ5nuJJpNqE+g4Fdz4P8J6fp9rFcX0f2i8cbhn7qVw/wAPdO+3+IIywBjiBds16fJJJauZNpkV/wCD2oAvTyrBCI4toi/u+lZlxvaEz23zKlJezCSMSJxkcqeorMa8kWNlXCg9RQBFc3xwA5JJ9Kp+a0kwLrkZ7U2WMysUz3zuqZgIpVZFzlcUAPKLvDdOeK0XhN0Ihz8nbtWba/vZMScjNbMRfBVFPHGPT3oA0NNhCOI2HI4+tRW1jBPdXF1cIJpI22gN0AqS2jKMASWPYiq+nPJDfXVpMGw3zKx70ASy2VtFIJYoic+h4FR3h8gI8YGxuDjtRNPNaqGHz246r3qneajDPB8gw5ONvpQBS1QCWVWjA3Gsm4Dox2/Me5q7PMwcoBubHUVCEPmHYpII79qAGxSbm/eZAHIPf6VuHyJkhkGTOg49BWdFaHdwCxapxA9umWyq+negDRE0UWHlcs7DhfWqOqxzXdozThkt8Y2A9PerKBMRlkBGPvelPMu9vLlZQO/oaAPPtX0hvsIeMFpYhuLdytZkVzv8sjBzww6Yr1uztYbmIxTAHBwMDqDXk3iPTm0fW7i1lBChsrj0PSgD0v4TePpPCmpNFdxfaNKmYLPbN2H95fevZfi14HtvHvhE3+lSpNNBH51nIOWZcZKGvlOyJcIMnkd+te+/AD4hLpl+nh/XceRMf3EhPAb0oA+ap4ngmeKVSsiEqynqCKZ29695/ah+HX9ha0niTS4x/ZuondIqDiOT/A14LQA4Y2nP3qQ0DrSnB56e1ADaKKKACux+FXg2Txx4vtdKWVYYCd80rHG1R1/GuPVSzBVGSTgV9OfAbw7pWg67oseuQzQahcKZkeQbY344GaAPTrvxd4W+HHhbUrPRLFhPaMsPkTAp5xIwWBPavNvEXivWPDFtDe6TFpeiHUojJ9jtXFwJs/8ALYt/Aw9K9H8ZXOnXWsa7rGu2mnaj4d06L7OP4381hwMDtXy3feVLM7QwLbozErEjEiMZ6DPagB4SfVZ57vU7uWUnLM8rlifxNZMwImJtkLqOOlXjPshMOwlTUul3wtpVDQDAPOR1oA3/AIc391p2pjBZUc8qa7T4hanDd2scUSAXHsK5jTtTs3vYXEQRge1WvFNwz3STxKCTwBQB2nw82ppBhgQfayPmYmk1v7Tpwlmnm8xTnIJ6U/4dWyTKHkcLOw7GsH4x3H9nzLFIZCG6470Aef6rf21xczMxZgTx6CsaS5kbCxEBM+lOlZZkzCQFPUd6aiI7LHGpaU8AUARXVuSglLZI6Zra0q+jurBbe4+XnAPanHT44IRHe585hkKO1ZiSQQ3BiKttzyfSgDV1fw/cWEAuQnmQNyGXtWLBcMk6PGzLg9jXXaFrctmklrcbbizlGBv5IrQ0nRNKkaW6fCIOdpoA7zSbVP8AhF4L+x2zXO35lB5rlvEU1w9q0l3beUT7Vf8AB9jqUFz9vtd404nG1umK2vEgh1PO5g2B92gDya1Z5JEcSsCp+XjFaF5aNqN1Cl3Lk+pOeKXUVFmzxmHDduKx4HlecPM7IqntQB6fZTaP4U00smx5GXBNeZa3rxeeZ7I4Z8jJ54rXvLG41yxJ07DLGOdx5rlINNdrhopVZZAcUAUrX7Y9yjRg7yeGPSrF9a3llcl7hWjmYffHf8a15gdPgCTqTjkDFO1LULnWLKNJIVKxjCso5H1oA9M+HGp6d4ek8JX3hi0kMrAwa3O7sI1ZjxuJ4J9K6v4y215rHiC31jTbG6Szsn8qabafm77h6D3ryL4W+JLbw9dX2m+KJJH8OXMLySQom8+cB8jgeor6c+HesxeNPhfIukSzTDynto57wYaQ4wC2KAPOfAM1vpcuvahr1895FqkK20NpNJmM8+p4Br5y+Lfg258H+KJIniVbK5/fWzRvvUqewPtXsH/CTQaF4f1bwvrmlW15fQyMkTpk7X7lal1O1s/iT8MrrS7OyWDVNBj821wctIuMsKAPmKinOpR2VhhgcEU2gDq/hb/yPemf9tf/AEU9FHwt/wCR70z/ALa/+inooA5/Vv8AkK3v/XZ//QjVSrerf8hW9/67P/6EaqUAOXrg5xXqHwg8IT+I/FlrpVsSjcT3MmMhYx2rznS41e7BcZVBuI9a+uPgzYWvw9+FOpeMNWQJeXimRd3Up/Co+tADvj145tvB/h2DSdGPlXjDy440ONi4wWP1r4+uZJJriSSVi8jsSx65Jrc8XeILzxPrt5q1+7PPO5ZVJ4RewFZ/h62+2a1aQEZDSDNAHq/gLRYtL0VZJD/pU/zsfQelXbmUSSMd+0g/Lirt+wgAggIAUAE+lY0pEbEs2VH60AMmvERnLISx4wayLicKwCgjPJNNu2eeRiCQUPHvTTG8gVSMY5+tAE9uAI2ZlBJ5/CgMCCw7jgelPEBWHLPx6DtSQqTJsK8dj60AQwy+WwK4Oe3pXT6VPDJu8xx5hTAArmJoSk+0xkAcE1OkhUgFdhXgY7j1oA6iyffcCOM8D+dYPi3VpoLxbGzX/S3Iyx6itXRri0gt3cEyTDJ+lcnrN5NN4nivZIPMV+AV7AUAdjBuW0VJlBJTD/X1rmbkpAzuq7ucbq1b/UbeeEm1EgLcc+tYEkcgAJJC+9AD7NgwkDnA65qywDIhz7AetaWiaBczaZNfSxFbePue9U7op5yIo5XnPrQBNBK0UOSQo/hqtJISxZ3Zh1NXBGFtxK6gru6U4W6bzjAHWgCksmIldCxiJxtNTSeXKgwfm6cVKEV8YUADjmpkii80MVXHQHtQBPYZjhBHyuvB96xPiNpP27SFv4wDc2/EnqVreXaAQBlW6n0qLV7uBdLu4SQd0RH6UAeQadfeSwSUAx9M9xWulxOI43gI8yNtyEnmuaI+Y46ZrZt2KooGduBigD64+HmqWfxX+E15ol6Q19HEYzv6qw6EV8ea9pdxour3Wn3alZoJChH0NeofBPxo/g3x7ZO4H2G9YRTbjgDPet/9rbwjHpPie11yyybXU13EjoGoA8BHBo5B96SnBuvbNADaKKKAOy+F2h/2t4hFzKYltNPH2mYy/dYDov419Gaxrmo+NtGtpNP02Ca5tiQWtxxCg6fpXivgawntvCdxMHVIpmzIO7DsK9b0PXrjwf4TN/HYok1whTTrvcNhbHzB074oA47xhq8Oi6DLpuipdo2pMJNVEzZQyL08sdq5DRLS3u0d7mYJIRwKfrWo3GryuoxI24tI3bJ5OKltNFlmtBNbPuCDLYoAzr2ymtpD5bB1zwaguHeSELtxJ616j4I0rSNTspE1J/JkHG5jTpfAul/ajLHfqyKeBQB514T0+5vdWjhKOWz17V2Ot2c8OpR26LvKDJxWzc6bLaxb9NKllGMqvNc/ZTXkeql53JY9Q1AHV+HLhftcaQ5jkXrXQ+MtPh1jSybi38x0XhwOa42wkS0vg0rYMjV6pOLeTw7/AKNOhlK9DQB86S6XHFOypFjnGMVq2fhu6RFvIbUlV5LEcCu8TwheXlpPNlFlPK1JPpHiW18KS2NtameeUkeYD0FAHkmsagPtbyBNzrxWPcW0kkJl3BnkOQq9RWprega1p8ixXtnIjk5JxV3QfCupXDhhFIQ3TigBPDPhi+1yeO0s9zSt79K9Y0r4aLYILK/u8zEZbJ6VH8MvBOr6ZrAvGdoY/UivWLvTrS3kM1wzPK45YnNAHlrXMmiSHTI5PMtl4B9K47UrhrfVi4dihPQV6T4uTSNOge5eZA56KTzXBaCtv4h1qKCRSsZb72O1ADLmJbpRPNHuTHpWDdaMt1PuZjHET0FezeP9O0vQ9ASO0dNxHOa8oGoabNaPE0+2UdPrQBRj0u50udfsM0hibsDWhNZMZFeW3YE/xAVhWvie50yZ1IWSMdCRmrM3xAuljBMSSL2+WgCeXSLuaUl4S8PuK5641KSxuXt47YxpnByK2H8fahd2bwmBVz90gYrDublztuLuRZHJ5XFAGfexSJcpOo3r1x2I9DX0t+z7rHiDxAk9/N9gsdJtYPsVrbWy7I2l/vMO5r53v5Gmt/NhjIQDmtr4da/qumapbpp+tf2XpiSCW5LR+YPrt7mgD3Dx94SfW9S/4Sm1ksLOG1/c3gljwd4OGcGsaO1sPAvjbTdasblb7QbiExzC3OTucc59qXx/HBrNxqMPiXU7mztobRbu1MQKR3ob1Xpn2rgNF02/8QRXGnaFbySRonmLGZMYwM5oA4D42eG20DxveTQW7xaZfOZ7QsPvIfT8a8+r6Q+ItxD4z+DMEt40ceu6FKIQO8qd8V830AdX8Lf+R70z/tr/AOinoo+Fv/I96Z/21/8ART0UAc/q3/IVvf8Ars//AKEaq1a1b/kK3n/XZ/8A0I1BEu+ZVHGTigDu/hD4afxP4v07TliLQyzDzj/sDk/yr1L9qzxdF9utvBmjMEtdPjVZlQ8ZA6fhW/8Asv6dHofhPxN4su40UW0brBI/TCrk/mcCvmjXb6fWdZutTu5Wkmu52kd2PXJoAzwcwlMYx371u+ElWz8S6XI2GRz196x7vagQJy571taeojuraeRQFgIP1NAHqt6GZnypO9uKxbpNrlWbjp9K0/trGISooIcAgselZV5cW6TsZrhFZvx5oAZ5cULDfhj020ojVy2AcdqF8nbvUh267h3q9C0bttyQepFAFWOFYQ2VyDwD1qq7eUwkDdDWvFMguUhOG8w4XFUNTt1jlZGPGaAOg0ptHudA1W/1h3CWyjATqxribe6tNQ8yTTnJHQI5+bFbmj2v2nSNQtpjhJcAAd65XUPB99prfatPYiVDuC+1AGrFm3cxKrDf1p5hcyB0AKqcYFUPDuux32oRWmqAxTsdpOO9dPPZw6deNBcTAMx5PYCgDIKANuBLIp4UdzTb+6g0i2M16u+bGYoPf3rU1+W28LWUVxKolvJ8m3Ttj+8a890+2vPE+pvLcOzNuyx7AegoA6PwP4l1S/1W7huZXezljbfEPur6VcBZpGKrgdBmtXTdIh0vebdBllwMdzXeeGvhi+raO15dTtBcycxxAdBQBwsGJo9hUBivfpVSSOdHDRkHbxtPetbU9HutI1OXTbpSJkPyk/xCqYysjk8MnQEUAU4fOBzIiq3cE07yJnYZkCgcAVYnjjDByGMjDJB/pQZxgbkwwHNAD7exuvm/0lQp6J61kapomoEPJFIPlHzr6rWzDdF3z90Ada0bW6RIyjEOGH3jQB4VfRG1vJYxkYPetQANbwMOFYYwKteP7D7JrJkVgySjIIpgVf8AhGlZABk4Dd80AQONwEZbr90jqDX0xKw+J37MLO48zU9HG3ceWzH1/NcV8uIfLjDlSWU5Jz0NfRP7JGqpJrfiTwxdZ+y39v56IenTa2PwI/KgD5kIwSD1FJXT/Erw/L4Y8b6vpcqkCGdghx1XPBrme9ABVjTrZru9hgTq7AVXPU10fgu233r3BBPlj5QO5oA9r0WGwexsrWz01A6RiKRmbG5/7wFYnxK0TVfDaWOmarcoZBmaOKN8hVbpXXeC7C/8W3OmtZ2ZaztJQLma3HIxzisb46ajF4k1iLWbOGSC3hH2P96MOxQ4PFAHnNuTb2zjdgv1NSWWvz6YpjhY7W4IrOvG3IoVjmoE5GWUbfegDp4tc8y3K7zHnriuk0XUILex3TTbs9ya4O2jjMRxhvY1ETMxKRsdg7HpQB6pZeNLSNxbxhQDxuNN1OSGW6ScMoY88d68ukgkSMF9irnOa2dOvy0kCFmkwRQB7jpnhq31fRxequ2ZFzzXF3erHS53SUsEBxuzXa6feXS6XDHbOoMibdqmuU8W+HItP0C5utRuP9JLZWM0Adb4H1/QNSdI9S1ZoJWOFHbNeoSRtbRJ9ndLi3I+WRDu/OviNghk3RSMoB7GvQ/h98UL7wvdRwTM01g3DRuaAPoi8tbGdvN1NI5PQECp9In0u2kO2zTyuwxWLb63oXiK1S9gu443YZMbtjFVLiOS6lVbW+gSIerUAdld6kJ5NllEEB4AArnvHOq2/hbSmmv5Ue6lHyJnNYnirxlaeDtKGyWO7vSOCpyBXz54s8W33iWeSa7lJHUAngfSgCHxLrcmsao0807H5s7c8V6p8LFhvNLluY1US25x7mvCbKHfJkgnNe1fDKWCw0yZZJFill4UE0AYvxZ1a9v7lUi3iKPgj1ry9J3imzIp29xX0B4j0QXemOIGjln+8WFeIay5W9eGSEB1+X5RQBCjxXGQ7FUqNkjVikD7hVWNG84o2VVvWtBdInjAZJEZD/dPNAEEkpjAREDE981LF5Xlbp87x2pEtgshDtyKhmcbipG6gC/Nq7PpzWkVuoVz/re4p3gvUzo/iSwvSnmx2sokaMLuMg9AO9VbO1lmGGUrFTI5/sGoQ3FqCssDh0YdVYd6APtDTdSh8aabpP8Aanht3S4lYlbmLb5EePlb/wCtXiUlze+B/iJePaaXcJbt5kaQwoXwh4yfaul8K+PfEUHwmS+XV01bWIbwy3mXDPBbFuNw7Vq/F5ruC00rxl4fvZ4ftMSpcBfusuKAOK+G/hrTfECaz9oaaKyhhklnjjG59xycAdzXzh4l0/8As3Wrq3RJUiDFoxKhVth6ZB6Gvofw41/plvP4h068W2uAfMZc4Rz6fjXnXxxMuuS6d4qYKPtyGOYL0WVeooA5T4W/8j3pn/bX/wBFPRR8Lf8Ake9M/wC2v/op6KAOf1b/AJCt7/12f/0I1LosJnuwoBJPCgDqTxUWrf8AIVvP+uz/APoRr0D4JaG+t+NdGtI1VszCWQf7KnJoA9u+Lsp8Bfs5aToMbeVeajtjkA4JH3n/AFxXy2In/wBHjKgkgKPavff2ytT83xvoOlq26K1tBIyZ4DMx/oBXg0szIJJiBuB4HpQAy4tz/a0UMX75wQOBWwLF7m5WC3YybTliOn0pnhi1kltdT1aRzGttGdjerHtXV/DUW507aSHuZGLsT1AoAlt7RooUjmLyEDCgHpV+HRLcsHljDFxz3xWpdFYtwjRcjkD2qGFjMcx9e5zQBUfRo0jxAxXHUGsS8hvbSN5BKGhJx710s9zCS0SuHfHzEGsvV4Li4tDHHHlyOAPSgA0Jd4N2yjeowgHNFzI89wSwJz972q/pkC6do624OXxuYnrmq2AUaQnbjigBdMmMKEAhlLYIHUV0EBFwBvYlR0OK5NZBHcKVUqn8R9a2dPu96iNWITOVxQByHxI0ZrNxqdt+7IYZI9ag8VX7yx6XI5ZpJIFJ9/eu+8TW8Gp+Fbi1MuZickkdMV5t4miC6TpE2W2xKYdx6NzQBN4suW1PVrSAtvMVsqdenHauz8M6ZBp2kxlYx/tMOua5+bTIneK9fEcqwIQM8twK7JAkenxOMgFQTzQAsbRpcwKX+VnHNfQOkXcNhYqZJESPYAGJ68dq+Z9UnJXaDtHByOoq1DrupXUMcMtzJJEn3RQB2nxp1C0n1XTZbSQG5KkOV9K40yAQGWTBB4Bx3rMvZZJJt8j7nZsAnqBV+6BFqhhzIB1AHH1oAZDE2TNdsGbPygfwiqN5I09x90BgeMdxUk0xaXG1sYwcdDTZdsf+qUbh97PagCeJGaLeMBegzVK0Z7y7mFv/AKmPhiOmannV5lWJS2w8nHarVkkVpF5UXyk849aAOW8WaJPJpskrMXaL51PtXLaLPG+m3VrIDvUeZGc969p8qO4haOVBtdCCD9K8OuIFtdflhQ/IkhH4UASwIskGWyfM+8PSu5+DOs/8I98T/DV6W/dNL9jkbOBhuBn8SK4hUa3nmgc4Q/vEPrTTMYbRZIiVkSVZRjqCO9AHt37ZGifZfGNjqkaYju4ACwHBI4r53r6+/aDtn8VfB3w9rcYDKtusxYckEqK+QaACvUvAGmBPCc98sLSzGYKMH7oPevL40MkiovViAK9s0S3g8MWEJ1O0klLRgkLJgAe9AH0Oun39r4J8PN4EjVlWVJLpbYhS5/i3eteS/tHajcx+K4NLaO2EaQLMUiXBDN13e9bfwr8UasdCvZ9ElTT9K02RrmRbgbhdg/8ALJSehrxLXdQfWNTu7u4mkaS5maQiRssgJzjPoKAMt/mZw6ENSqESLGCzUktvIJQIpM5/iqZbSdCMAyOfSgCkrtGxC5A96lErADk4PpVz7JczYSSMRg1NLp0Vko81zuPYigCng43DLL33cimNemNQIFwe5FTeYp3iI5UdQaZCAxO7AQckYoA9S+D8lxdXaNPJI6A8ZrsvizNZgxx6nEwjZcKwFYPwfW5KCYqvkxnIXGMiu4+IN5aeJtDfFr+8gHGB6UAfN2paYIi7WzExHlTWKHdmUSDcFPB9K6O+FwzMv3Iwcbao3dsiKHibd6gDpQBHb3MxfMFw8Y6YBq7D4j1GD9wk8uDwCWrOsVBmC7wgPtSTxMJCsnGTkN60AWL68uJk8q5kdyTu3E1WtbZ7kbsYRTSy8tskB46GoYZ2jYJuIQHOB3oA27KzMxB3qgB6etXtSuHtlUQykFOmDVWzneW5jKRbIlHJzReWrkSTA7lbpzQBq6R4mmiiw9ywZhjk1T0rwl4i8Xa4y6FYTXm5vmmHyxpnuzHisW2jFxMkJjPJxkV9H+E/Fut+APDFs+oRQXukqOIwBHKg9iOD+NAHiXif4f6l4f8AEb6RfJcXMyIjtNbwO0eWGSoOO1bGkrLoG2OTR7y7Ddzauf6V13jH9obW312T/hEDbf2UY0K/arf51fHzA/Q1X8MfHPxzql+IpjpxjzglbegC1beB4fEVuL17Ce0B52+UQfyxWdqvgW10pkdbC7mx6Qsf6V7Bq3xD1XT9A+2tHCXVctlCBXmE/wC0B4jnkf7CLAKv96ImgDhvEw+yoGk066t4Om9oWRfzIrkL5LcDzrWQPu6j0rtfHXxe8S+K9JbStUSzNmZFkPlxbWyvTmvOkWS7dtsbKe+BQB3/AIO8RWWiG3tdOtSbrWv9E1RpBmPyR93b6HPevosR2+ifBJ11+1lmt4o2Hl9WCk/Ka+Y/AGu3XhjVmxpcOqWV6vlXVtIo3Mg7qx+6RX1H4Bntb7Qbi7m1hdU8MXxWKztHiy1uR96Nm74PFAHh7QC/8NtbeG3E0UJ8yZXPK1P8Vrnw/wCLPhDa/wBmgWup6QQ0kIG0Nxhjjv8AWq3xMgh8K+ObxtMt5rEEgLHyECnr7GofCV9oEmka3ZXFs95f6rE0Cso/1ZxkYFAHj/wt/wCR70z/ALa/+inoqX4bxGD4iWMJBBR5l59o3ooA5rVv+Qref9d3/wDQjX0X+yZYRzeOZ5/LINtacNjpnFfPV0u/X51xnNy3/oRr66/ZF0zZputak7glpREBjoBzQB4R+0TqTap8ZPEEhO5bSUW4yemwbf6V53flgEj6s3Jx3rb8aXT6h4v8RX8uGE97IWOe+41gsDLeQquccY9qAOpEUp0vTtCt+JLxg0mO31r0Kw0ez8P20MEKneBhpf7xrj/h+Y7jxibmQlo7aIru98V213OW3hhlFJKk96AGfIwkXO5u/wBKzIrj7NOVODExwPWpleQswVTuH61Hb2fnXDEgYAyQe1ACy2Nutx9oUlASM4rXjURwb0YPuGA46Vl2l1b3srQwMRsO11YcmrMEElqxUHbCTwjUAQ3BbzBv5AFQ3DLIAY/u+lNvmX7TtywXHIzSIygcEFQOKAILtNi5HVjRp/mRyqqsMk4yOwpt6RuXLEbhmpbKNQwaV8E9NtAE/i+STT/B+1CftF7NsU98CuXS0e9+GpeQO09vd4wfSuk8aCS9On26jAyFA7rnvV2Wyt9JsDo8czPG7CQuw5LUAcn4/km03U7CCJcB7KMhj2JArq/D94mo+FonQb723OyZfb1rK8TW39uQK0Sl5LaL5jjkgUngCaCCCXzCYvtPyEnoDQA65Je4cbfvDBNTW7suFi+UAcGp9RtxHLhQRIOD6H3qrbHcWVjtK8gn+KgCJhls8kk9T2rX0+YpD5W4MWHIHas4xkMX65PI9KktGWO5ZwwAxgD3oA0buEBFAwPYVmXaqX3cLjirGpAvEzRufNAyp7VXsZo9RsVY4LR/LKncH1oABe7ICVUbwMEVBa7mn8yRjgDOaSaIxyeXxz/F60IACUzk4yRQBoT6jKGWK0jM0pHJ9BXm3i+wuLDVxc3EYEcx3DH6ivSdO2JKPLHzY5b2qHxjZx6joE8QXc8fzxnHOaAPN75kuYLae2/g+VgaQLJLHInlAoyHB9xWbFuFnKNxDK33a1NFlld4wzAq5xz60AfVfwuaPxV+zHJYsxaSzjlhcHkjaSQPyIr46u4vIuZYj95HK19d/sjyLd+B/FFgzbrhLpiUHTBQY/UGvmT4j2Lad4z1OBk2fvScfWgDF0dFfU7YOMqJASPYGvZZpNR8VXEsGnaawtBjAiG5lUDqfavKvBcCXHiC3SQZUAnH4V9jfs+6VbP4c1W/RQ9581uRH1246H3oA4bVdAk1H4R2FjpAjT+w7tr2/G7aGjx2Pc+1eM37W19dobNSqO2c+1fRfxVsJbfwP9m8PXkemaTas0t+Zmw12x6wj1NfN10RFNHLCu1T8wUfwj0oA3X01Y0SKE545Jq5BDFagJM5Mh4AArFXVJJbpZImQeqmvQvCmlaVq4NxqF0kcyjhVPegDBi0pI83FxdRqw5VCeTUF3cx6nIsc0CjZwHFY/i+NotbljiZ2QNhSehFZZlu0QqJj9AaANLXNLgt5Fe2myCMtiqOmo884hhTe7naBTY7e6lhyzkrmuv+Hvh6+vdXimtIxtiOST0oA663vb/wxpcUc9sUZ04OK6n4U6kmpxXcF1tLkHg+9ZfxEuri7jisbxEBUYDJWb8I3tdM1OWGaYmdzjDGgDkviFo8lvrF3HaFlUMSABxXM2++30+VZYzvYYzX0T8Q9ATUYHe02JLtySOpr501S3ntrmWOV5GQHBX1oAyVJkbcnDjp71YnzgCRg0g/hFQuQk6JEMAcmp7lSsyyBMepoArG58xwGBCqME02JB9pUh/lY0+42NIIgCu4ZyavaXbbyjbQY84NAHRW1nbLZhnnQuRgAHmur8HfD2fUQbmWfFv12+tcc2mGXVIILcBEZhya+jtA8PzaZpaPaylwE6evFAHjF6dF0nxRBa+TxG43Eium+MviGzl8LW0enIGyAD7CuO8f2sn/AAkjXkkOCH+YVu3uj2/iDw0kthIHkQcxn1oA8hso0u7jyydgPU16b4Iu9K8PMDOyS47V55NBJZ30kMkRjkXggipNCEb6wEvJCIyaAPoDWtYHirw/LZaeiorLjJ44r591WxOlXjwhwWU84r2yD7EmgyLps21gnWvEb1prnVXjxvmL4HvQBFY28lzex/aAVjY/nXbRxxWziKK2WEEYLY5YV0+heEbLTtFS/wBZcrMq7hu6CuJ1jWUn1UzQvviQ4AHpQBg6tO8N68ds7Lg/Svpf9m7VLLULO9s7CSWNYNvn6W6fubVv70bdW3dTXy3rl39svjKihPYV7N8FtbsrKxntPD9tqlz4r1UAXLRL+5twp4OaAPSvjtollea9ol94hnMOhQgpIUGW3E8VwMVr4d0r4reGYvC6rcWLzB5ZDztyK9M1+NfG3gXU7PXtM1G2bSpBmQgDzyozvT/ZrzO91Dw5d6FYXfhtfseoWjhZC/BYD+KgDyC0s/sHx4vLYDAjvLnA+qOf60U3TpjcfG+SUymYvPMTJ/e/ctRQBxRGfEVycfdmkP8A48a+zv2Yh9k+HN9cyDA8xpD7gL/9avjNBnxJcgttBmk5/E19hfBh5bD4Jazd6cDNdpDMyQtzkhT2oA+Q9W2zXdxLxsmu5HA9s1DoKq+oSSEDCg4BqvdXLHcHh2kszkehJqTSZvs9tcybcsMY+tAHcfDQlbjUbjYGVmwqiuwnIzuYYB6+xrE8D6O2m6dDdZO+Ub3X1zW1c4EJkBxnqvXFAFZMk8MSvf1qQQvE5mdWweAMVmzw70UiWSNzzuFVJ7q+09821212cf6phQBq3Tw2kgvZEUYIDMoxWhcSR3ShYmDSYDKc9q5C71+G5t5bW6jeOVhl48cA1Y0IzB0jyfnH7s+3pQBoTIxuP3gB2+lEYRpNrJhs5yOlTTqVmCYwR1qGQ4V2XhR3oAp3AWW9JyMr2q1bldvyfez0NU1QSMWQAlj1FWo1wzKOSOhPrQBLFIyarFdsN7pzzyOK0L5o9T1B5pMBgm8AVQVNyuQwUKMUltKu9Sp2kKQfcUAVPDty8cUs0pKv5pG3sVpotUWe6CLiOY7lUdvpTNP/ANVdwsT9/cpPpVx42REMb4JGAD2oAezvLaIshI2DarHqagiQq5WTkqMg06RJGyVOW6EdqfZwTzl1hhkmx95lHAoAdkNHuVizN2HSoljPneSqDLHr6VYj+VgFjKgcbT1pikC5UnkZyAPWgCywFtEyXB3DHQdQapaVAtqsssaKJJT1J61Y1W4WFN7DLsOnrVPTRJIxaddidQCaAJ5LZiCzptPXJNZ8m1ZiV5YdSKuXMzXUhRCXVeMiqxR1JUrtPqaAL9lIFZAq8Yrbi2Sv+9i3Jjn6GufsCfNZRzx96ujtblIQTOABt5HrQB494x0xdG8SXtoDmGT50PseRWfo8kSRuJ2KgMMEdq2fiXd/bfEYmCbU8tVX6CsRbYx3nlup2yLuGKAPb/2Ydan0bxvcaZoyPeSX+PNRuFRF/jz7ZrH/AGrdOFl8RWlWNUE0YJ29zWn+y3cJB8aFRWCmbT5EIPc/KcD8q0v2vLNv7WhuChGHI3Hv9KAPDvA5x4igGcFgVB9Ca+2vBL6r4N8D2vkaG9+0n76WSAhcr6n1NfE/gVpE8QRPCMyKjEDGc19naJ8QtQEeg6dp+iXL2724S5nlQqsT/U9qAOB+PN7dv4Y0vTddeKe6urw38Rgj8sRQnorDu3vXkGmywQJK1xbNcq2Qu3+Gut+N/jK88W628F1pzWC2DGFc/wDLbB+8D6VxVjf/AGWyMZUbj0JoAzbqF45zNBEwXOcY6V13gHT5ta1qIbmRAPmA4roPDkVlquiuZGjSdR0IHNTeEb3+yb+4SAKJSCAcUAdT450XRW0cW8cai9Uffzg14jq9lHZS4lJD+oPWrfi7VdSn1a5NzM6ODwB0xWMC0zIHkLlvWgC7pshZcb9o7Zr1j4S+JLeztbuC6jPmDOHXvXlDafe7ViWDcT909K7XwBpF7BLIt5GQjDtzQBH4q1h73V5mgmbGeMnpSfDoSv4pjmmYNtbknvWT4mszBeziM7MHOa9C+CfhZ9ZuBfahOsVtGeAOrUAe13+hw3WnLcmTBK9Aa+bPidpWo6dqjOLJo7Vj8spHDV9L61NZ2triGUskQ9a8F+J3ie98Xyx2FqF+wWh3dMEn60AeNXfmSXQyNvriuoi0W4uNG+0ZBC8D3rGnh8u+JmfaucEYr1fw3FYw6bELqUGIjOM0AeQXcUsDJ5ifL0OetMtCwEiKzDHzDBrrfiHBZG732rYhPAA71ysMbb4wAQpOM0Ad34HsJtRltJmmBl3cg+1fTGjz/ZLOFHIZiAMV8x6dK9ld2ItyUJYYYdK+pNA09k0eCW/ALsgINAHjHx28M3wb+07Vgsb/AHgKxPglaR2t5K1/eAow4j3d69F+KeL+wktmlOAOADXhvhLbpniNV3Ps3fMoOc0AXvi29sPFEn2SPA7kd64rzLeSNm5E69MV7j4+8H2msaWmpaeRFcIuWVjjcK8U1HTltAzO4BBwVFAHo3wy1rTns3t9YG1SME5rpdM0Pw7DqZvbMrJg5AbmvB4bhuBD8q+ua9U8HxQvpwM9zjjrmgDU+KOujUrAafCAij+7Xj1wn2aIxo2H9xXo14+kJdy+YxmI6EGsxtPXVblTZ2wbBoA5LRtP2Rz3WoRtIm35ADjmuo8AaveeH9RhutLkMFzczLCRnqrHBzS+KNNn020UTR7cjgZrihPciZWKspU5XHqOlAH2wdL8WXslxp8Wo2EeijETB498skbD5uR0PNfOvjmz0PwrrVzp+hw3LxRTeTI7tuwa9P8A2cilx4N16R9cuZ9Tv5tsqtktasVwMZ6+tRfEn4Z3GheF7a90ktqF9byeZdSSDl/VzQB886Zp40r42GyV94ikkw3rmBj/AFoqHQbqW++Mi3NymyaSWUsuc4PktRQByOAfEdyD086T/wBCNfa/7NKAeBZRKAYyT97075r4pAz4iusLuImkOP8AgRr7a/Z1Qy/DCZXTCuXG4dfu0AfFvittmt6yqBTH9sdRjsNxqt4ajNxqUULH91nc3HpUnixII9c1BbWZpYjcOQWHJ5pNB8yCVJYjkyZUigD0U67dQo1tYxCQnhfpUTz+JMljbx4HYVoeGbSOCwFxgl3/AIjyRWjIxIDcnPvQBgH+1pEUTosf071JaWV3KThVyDye9acjiJc7WPc1NYvE65iYZPUUAc3Lpxh1iNLraySHk4/SuoltYQU8tRGydMVT1tDdoYkGyVRkN70zS70SwiO5by7lBgn+8KAJb2Q5TfwxOC1VZx5hKhdgXqOxp92u6VGBJRj1NL5bsQ5bPOCR3oAqRx7ZjI42qvZakiAFy+G3bucVIw+bYOWzTFVFmYOfn25P+FAAzYLqBlTycUahm30yWdFCrGAC56nNNtBvk3YfYOgxVLxDeGc/ZIw/lnhsjAJoAi0243MIzhmf5jWxbIJo5Fb7wOQB1FcskMm5AgKyRY4HeujsrsJIJkA+cbX56UASNCyjcrEBj8wx0Ner/DbTre48P+ZG6ho3LSkD73tXntzBus1mgIfd1962vhj4qOmGazuof3CkliOuKAJPiHpsVtdpd24wJScHGAa4lygkGxRuTkn1ru/iBrMesyWsdpgW0WTnFcTcoFnQquB1b3oAi1ZV2oxUBcZOTTVIkRATjdyPpS3yxTQLCckM2d39KkgeOIHeAzgYVR2oAcY/LwsZ8s46AVVkEjSBZFZ/Qip2kfcMuFboaR52jBRRlhznPWgBkUzW/wDq4i0ueFPSrcFsZJPNuGJcnOwHp7VlrNKX3EEL6jtW1ZRkr5sjnIGQRQByPxS0poba0vIhmAnb05X2rk/PWUaey5M20oxr0T4lXaHwotv8xcyBs4rzSNEGkRT78PHLjAoA9R/Zwngi+MultKzeeQ8aKO52nP6V6h+2fbn7Bpk3Ytjj+teO/B6aG0+JugTh9twLhRH77uCP1r3r9sSMN4SsnEW4h8k0AfL/AMKnVPHukb45JFMygqgySCRX3h4z1Wa00rUTpqWk0NhaNNPFu+YkDhCB0BFfHv7LggHxdsZLrZ5UVvNIdwzjC/zr6VTUtLmbxg0/k2mo6nbSyW0EnDTwqpG/H1oA8C+JXjQ+MU0rUZ7GCyY2oURRHKqM+tcRFB9rAjRsehqTSIftjxW0/wByPgAelWry3SzvAsKMoFAGhpzx6XFmeQhh6HrTZdeiNwGIZD2YVm6hZSTurIzPnqAaz5rGfGwbifQ0AdTNFHfx+e8omPv1rCkCvcbYdoCnt2qvHNJZwY+ZWqfUZ4HtkkiQxynqV70AWpdVvbeWNJHLRr0zXr/wz12HUNJuEjhZ7mJehFeFtgwrmYtIfXtXqfwWvo7C+khmdQJRyaAOa8Tfa73Vrl3iVQWwVPFe1/CbSGXQ438zyx3UGuB+IOmpqPiKO00qVVklYZxXtHhHQ5/DehxQXeJNyj5h2oAb4l1LSNIsHF45ywwT2rwy9tjHLNcWkqi1mcsGB7Gun+L+qAn7CFDO/SuZ8CC2S0mtNUlBXqqt2oA5jUbSEzq8jFhntUd5fGJVhQMCvI+ldXcQ2f2s+SodQelct4qhjdmlWQIRwADQBBrMMl3YwzwozJ/EewNUtMDK2JyPLz+NdJ4V1KS00Ga1mt0lhk+6zDOD61kx6YUmZpXwGOcUAdzBBZar4cWKzUrcwnIduDmvRfh94wuZrOPR9Vm82eH5Qc84rzXQdJkli3WdyAR/CT1rpND0M6XqSXl1IFlY5JzQB7FqGhaZqNuDInzkZJryC50Sy0Tx7HItsJEfjGK9a0rVbHULUwxXCeeBgc1zU+gyJq8t3dSh1A+UntQB498YfEE39pLFps7QxqMFFOBXnEcrTy+bcP5jDtmvUfGuhwz3M0wXeoJLGvM9VuLeN/KtYtvqaAJtKOnrPKbuMOxGVWp7bVfL81AGjjzgKKwwjCRCVI3cBq6iz0lLa08+4ZXY8gHrQA/Qmtmv8zRt5Z6u1a84vbGdp9Lk/d542c5rOvdbtriwSza2WFh/GowTVZ77bCLa0nZHAzgntQBp69qn2+wX+1JSLhelc1DdRSsFYcJ+tV727SSXE53Mo6+pqjDIXRsDGO4oA9r+A2qX0HiGS28OQ29xqMzhpYrh9iLAD8zDHVh6V9EfEi4ZPDN+FkliSOIySFFzuXutfHvws8R3PhrxKdasDbhraJvtAn6PF/EF/wBr0r6Z8MeIW8ULfxi2vUi1ayN1aR3fICnjFAHyH4bdJPjAjw/6tpZSv08pqKm0a0ksfjU9rKAJIridWC9AfKeigDkEcp4juyOvmyY/76NfZ37Ld4bjwbPbSsN0b8r9R1r4slbb4huOcf6Q4/8AHjX1X+ypq0Fsuo6Y+Wvbhg8bAZAAHQ0AeBfHvSItE+KeuWdtEsVuJt8ar2B5/rXM2TvBpUEqD/lvjOOtemftYaXLp/xSlmlJf7VAku/GATjBry6C4LWmn2/8InyR+IoA9ptwtvp0arwCgYD04qpI4dQBIFHU5qy8paPCKMFRtz9KyLxhuxs2+vtQAl1dTE7ETcMcn1qtEw8xGVjG3ce9MlkLEIm5m9qkhspZVIuGC7j/AA9cUAWZbxtn71CxU43iqb7WmSVNxL8ACtE6csaYikkdccg9RQlnHbL5gclh0PpQAqoyW22ckkHK1PGrBshgTjJ9KYkpfATEmOcmpfOihieSUARDlx7+lABBGkp8wjZHnBJ6k+1Ur57WO6ZwNoH3Qx61Wk16KJ31C6+aQfLbWgHA9zXGahqdxcXJM5/fyHdt9PagDtDqdxLtS0aNST/CM1M9lPclmvmG7rgDGak8NWdtpmmxPKA2oXA8zLdEonuHkmPmSAhjg4oApxQQK5YSBJBwCakmssj94MoR99O9QxMpLLgcNzmrcEhXcAxAznB7UAZeh6pNayT6eckjJQE9qS61Z4HF9YgkodsqZ7d+KsavpL6hGZtPwmoQfOFBx5grkLp3uC1xaq0Mw+WaMnjIoA9L0+8g1K1jubP5on4Yf3T6GkvFzwqHKmuR8CXIGum3dmWGePDKp43etdld/wCtPOCg24x1oAyb2BtiyCQD1HtVa2WZgSxRVzwO5FXJSyglgMNwAfWqwTMgVzgZwSKAHjdN9wDbnBqytkq8uSF/vE4xUqQqHUW449aqXlp5k3l3ssrhugQ4FAFi2hjdvLgmjbPbNaEMUsWY2AG3tXNXGkQ7C1vJLC46YPNQ2mv3WlziDUFaePpuHJAoA6LxlaQzeFL8z4JiQNH9a8dtWH9kXS8bg6mvQ/FniOO78P3KW4crIAvzDGK4C2eP+wLiPyx5vmgh++PSgD0D4Q6VPqnxO8LC3jVwsyyuc9AvJP6V9C/tYXMH/CHPA+RMMFT2NeSfst2qal8S7VFRh9gt2nZgeM4xj9a7P9rnUz9jW2yMbto+tAHlv7K1u118WIkiKLN9huDEzjKq+3gkdxntXunxz1Q6F4BtNL1S6srrxjPH80kEPllos/OV/ur7V4P+yzLcRfGDTzaxCVzDKpUnHykDJr1z9ox7e4s9UuNZsZI9XtrpbbTLlVOGgYZbJ6daAPnuy1EW2PLQluxp91cTzSeZk7m7Zqzb2EU/lRu3l4+8ar3LJHMyRglF4BxQBVNzNAch2B+tWor55QCz4Y96mtJrcqTPFuHvT4L7T45MNa5T1oAqTQ3Eu7ALrjr6UyOYBBG65bpXaaLfaX9nlRIwfMGMHtXIXsHlXcjIGBByARQBI9i+1ZFG5j/CK7TwNplwb5J5gY0XrWDYTWslqGMm25XqvrXXeCL/AH3JtHYN5pwMdqAPRLHwpa6lrVveWsxEikEnNejXepNpUaRXzb4gMZNZmhaLHpFqkiyZLc9aseKmsv7MknnmBKoaAPHvHBsdR8XiczhYSuAc9Kx1tLJnkFtJ5rjuBWC0ButWmmvbh1hZ8x4Hatezlh0+Ym0DTZ74oAoXkd7AjiPgN3HWuX1RQYWWUsZRyRmvQYZopGlndlDgEiMnvXmusmV712aTBLZFAF7wnM0s3lPL5cecYbpWxq0Yt5/L8wMD0YVyMUsjvGp+Tn5iK7Vm0z+zEcMzTAc5oAZp4nsJUkFyck564rV8aalqSWME8UhMO3lgc1xM8j3MpKSkIOwq5HfTyWLWZJZT0zQBo6BqVyHjuYruQODnAJr6M+GGoTeILULeW8ku3gtjivlrQXeyvAkgJOegFfWXw38SLZ+HIY2gYIBwoXFAHKfHTRLq0iht9IsJplnUs5gjLbeehxXz5daNqlq7EaNqLn/r1c/0r6e+KPxSvtBht5dGRURkPmedFu2tnj9K8m/4X541llbyriwWNT1NqOf1oA4yDTp3sI3m0jUjcqeFFq+P5VDPa6s5YnS9TBIxj7K+B+ldpH8evHk115UM+ntnoBaD/Gr0/wAaviDaor3Eungdx9lH+NAHlEumawshk/snUFjQbi8lu4AHqcioFvRcE+fEAw/iXjNeqa18YfGutaTPao9k9rcxmKVRb4bBGDg15tbeHNSkjzFCzDHp0oAxZpg9wSF+QcVtWFkF0ua6C788ba2/D3hpJWf7YoUqMkGszWbyGC8a2hOI04O2gCPRJk0vUtOvHiWa1SZZJYiPvAHkV9t6drVn5ulTm0SG1voVFrMABtJ5EeB0r4UiuYiXDBiP4V9TX1v8NPHXhjWNH0WePU1Se3jWxe0lwNkmOuD/ADoA+Y7uGeD9ojUY7pdsy3txuH/bN8fpRVrX42h/aW1ZHlMpF5P857/uWNFAHlGpMV1m6I6i4c/+PGvcv2fNXOn+PLGNCE+0HbIe2K8L1U41a8P/AE3f/wBCNel/Ce/K+LdFyqBZZFVmP8PNAHrH7bOjM8Hh/WkHyLvtnIH/AAIf1r5n8KrHJ4gsVnGYzIOK+sv2zPMj8BaKqq7Qm5IZh0B2jGfrzXx5aytBcRyxkhkYEYoA+g70JldoAj9R2rGuIYkclZS3PQ1f0G5TU9Et7nkZXnPc1FcWcbAneM+goAzWaPlvuAcHb3p0RRF3oxJ75qGf7PbsRJIcdcds0+3uoHAMZyenPrQBYFzIhKx8AjvVfe24b3yT2HSpyhMZxlmI7dqqRpjPYH86ALESbFRi3fBAp2uIqackIbdubJwOakjQFkZQTtq08UU0RV3MZ7kCgDmJoYoIJJpERwq8KfvE+1RaTorB49T1SMLM3+qhPXHvXUQ22nwZmji825BxukPA/Cqt35skxkGWJ/iPb6UAVrqVmYbgN3b2qGNJJpOQAgblqenl+eWlUkHjFXIgiYWPG3rzQBgXDvBfrGw3GR8Jt/nW3LaTBXyVLYHPtWbq9o58VaRNCflkJ47ZrYnuBbzYZSEOQR1oAqQyGGdZjuAAwCKo6pp8V1N58CFXPzOoH3q0BNGyOBhg3T2qe0jIDfMdw+6R2oAwNCsYv7QRkDpIpJ5GK66TAYBmO/vkUzc0Tjei+YPm3AUk0u+RXY539DQBBdxIUBHzMTnOelZ+dspPoe9WbnaZGQMRzwapTEhj655oAtJMQSfuqvUDvVp32qUaNpYjyCvVTWZGC38WMjj3pVknjIUMVx196AL1xDciASQqCCe/amWtmmS1wASxyXI/Sollndggb5RzWlZQ+c2JH+XsKAKXjK1s18E3rCFY8MuxsdTXk9gwaJYjxufFei/Fy/aLSbCwU4DnzGx3xXmtrsjMby7sctgUAfVf7G2jxmPxBrm35t4tVbtwMn+Yrzz9qPVvtfiSO3D5KElgDxmve/2ZdHOi/Bu3nbIe+aS6wR2PA/QCvlH433z3vjm7LKqhWOAPrQBsfsvTi3+MGmEkAvFKi56ZK8V9J/tF3tlcfD9bC7ngfVXZZo4YzlmAPLAegr5C+E2tr4e8f6RqToZFil5UfxA8Yr6Y+K+v2+seC5JNS0yHTdedv+JfE4/fPa5+Zh7UAfO9tdx/aB5nbj2NNuZI3usKRj2ph8hThxx2qvdxpvV4j8vegCZ5IzlFFQSxhUJQkn37VEVZW3x804I75bJB/nQAWVy1tcpJjfg5xXYa5rtrqemwKlrHFIgwzKOTXMQSRhcSBRULqI33KxZT2HSgCYsqt5kacj1rf8Ia5FY6zbF4cF3C59DWAszEgKoINWLLTLy9v4haRs8oIIAFAH2NpGnyajpqSSSbE2gjmue8WDT4dMuI2mEkgBAGe9Z+mT6/a+FYIZ1dJNgXPtXI+MfEGn6Ppf2Zg02qvy3cLQBiTXFhZaU630ebpslfauS+3X5djaoVjPoKztR1mXUrkEjipINQltz5c2RGfu4oAmmEiBn3HzD96ufukuLiYgRl1zw1dNC6308cVurNIT8wHevT/DPw8aa3S5uVEUY52460AeKLp1xhGVWLjsRXSQWw/s7E8QRyK9/s/htp2owbkYRMOh9ayr/4avFL9nuSGjbhSKAPnLMdpcOwwWHYVKL0Sxo8YCt3BrofiB4UuPDWrPHPbsEbkNjgiuN80RNwAw7DvQB2vhh7WS7V3CtKvUHvXvvgrXknjW0ktVUAY4FfKMd2YJ1mg3Lg5NfR3wj8S2Gr6P5BTZqkIz/vj2oAg+PGq6fDpC2ccJM7nPI4r57Mck4XfmKMdMd69m+NOoLf+VCLYrIv3mxXjziQyENu+XoKAJrHUxp8ieVAoweWI5NdXJdTa9Zn90igDqKwrXRLrUmi/d7EJ5NdPq11ZaBpf2SLIn28n1oAy9IlXSG/01kaPPAB5rdn8XGAZt4USIjGSK8ze4SYNNI7NITwvpUbXk0igEsV9KAOrfV5rq7kaJuH6t2FY99pqRTArKHkc5OTSWEhliMa7U9qfYsVvM3Azt6ZoAz3tpVmKthQP4hX1l4L8AeCtSsdKeG0gW+axV5fLOHc/wB4/wCNfLF6ZLvUfLtx987VHbNerDxnb2mjabrXhSGe31/TSunzQTNlJfU49KAOK8SxrD+0zqsSfdS7lUfQQEUVj2uqPrfx0l1KUASXM8ruB0B8ls/rRQB53q3/ACFb3/rs/wD6Ea6Pwdfy20lvJGqF4JAVJrnNW/5Ct7/12f8A9CNS6LMYrsDdjdxz0oA++otOsvil8KRYasI3eeIYZTny5QPlYfSvgfxDpNzoOu3umXiFLi0laJgR3BxX1j+zN4mW2M2lTN+6mIK7jyrf4Vxn7Y3gk6f4htPFNnH/AKNfjyrggfdlUcH8R/I0Acd8NdWWbwvLakgS2z5HqQa3lQmH950Y5zXkfg+/fTdXt5ASsE/7qT0NeveUPK+QuU9+9AFKW2RzswCo61gzYtbnZCoyGyT2ro5YmUOc7RWW8MCTKxJODnnvQBfs7g+QG2gg8GqRkLTuYyCO4pkt353EY2p0IFQ+YFcIvDdTQBfSfaTs+U+hpzzhvlDZfHOKpFiQGJJycGoi5SZmHygHGfWgC9DKF6Au5P4U9pxysuRg8YpsTDy2I4J6CoWTzCS7hB6+9AEUzESEnBB6CpYraVGDkjb1xUJ3RShWUSDua2YikgDKMFRz70AUtQVC1g2TuWbhvSrF8qtIyDBGcZqh4tlkh0mCW2GCJxu9q1LeRLi3MxQLnGfrQBUjsEjJK8AdAad5nlSsEIFLdSgtknJxj2rOXLyEnJbsaAL897uDYPzDjNQC4YDaRnjIPpWerthwRna3buK07eESg71O7quPSgCm0u8Df64JFCpvfPYHA96nkRY1OFBz2NVC43AjOQfyoAmaJ45D8o5HT0puCANpZs9QatXzShUltofMBHzY61St9RhQ4lSTd/cK80AalqArKSPl6VdX/WgooAPAFY9p5txJvceVD/dPU1Nr98NK0ae8jwZB8qZ7E0AcP8QLz+0/Eq20TF0gURj696yLPP8Aa6Wkcau8pW3UHsWOP60aSjySTXkpJbk7j3Peuv8AgNoP/CUfFXSbWUAwxzfapDjPCc/zxQB9j6vat4U+Fdhp9rceU1tDFF5mOoA5r4Q8fXw1HxZqE6nKmQgGvtD9ofWjp3h8W6Djbux+FfCdzKZriWVvvOxJoAm0mXyNVs5s42TI2fowr67+Ocdnc+EtN8SyoV1MJHBZyg/KYWA3AjpmvjocHI619Htqmu+LfgVZWqpay6VYbTNdSSYmjdD8qKvcH1oA8wysdyXMW4elRM8DysWjIHpVq1nWUrHMhBfv6VZutHufMRIgrE8jJxQBkG3ZCXhPynsai8p34Lce1dI3hrWNmFiQ8dAagtPDF+05yoXHXmgDnZIGhb58kVaHltGA7YHsK77TfDun3kZhvZMSD+L0rc0/wPZoQsZE6HrjmgDzGztPNljS0Uu7EAV7x4L0u18KaYup6qqNcFchcVHb+ENJ0iMXSoWZPmx6VBf6gviFkhjOI4mxigDoH8YXd1Bcald2pTTIl+UeteC+JPEH23Ubu7lh5lb5R6CvY/Fa3U3hqOyslAij5bHevCL2Py72X7SPm6YxxQBSswxuCwGAe1XtKguL3Vo7dFMiuwXHWs6OcmcxwjdngA19I/AP4aC0iTxDrgwg+eJGHWgDs/Cnw00bQNBt5ruMPeyKGZiOR7V1dhJY3MZsrSIlgMc1qy3BuJhKse6BRgBulcZ498c6T4PTzkWP7a44VTQB0NppfkSOt5IYU/hxSxPbQ3R+0z+aR9wGvDLn46yyqzTRbmJ+QCtXwR8QrXWNQM1/sjZegJoA9J8eeHbbxpoU6Rwqt9Ep8vI618ZeIdJvdD1OaK5iZGRiuCtfbulajHen7TZMgK9getct8X/Bf/CRaUdS021R7tFJePHJoA+PExhluDtDcj2rrPhvqkuleILe6tCSsbYIPcVh6xZXNpcvFdQFJAcYI6Va8KxlNSXzWIxjFAHtfjfUUvIGu7W2WQgBmUiuOt7O38WRBtPs1tLtPvxnua0PEUs8OnR/Zd2ZByMVgeCl1aPxCFiVgG5JxigDfutCv9N00hAVm7CvPNStLyWaT7WrSzfSvddbuJYLMiRQ8uK8ya6nudRYeVl89MUAedXVnLaRbpU2ZPSkguDABug3ZHArsPFFm8rDzYiMcjiuRurjbIqeV8y8A4oAjK4cykmNjyFzSwyXczFUbr3xQYzJMpky3svNdBplpLMUFrAEUfelbgigDPstNuxOr5YuvzAdK6TQvCet2zXl3eWTLNbr/aRieTG6H+9VSe7uDqX2ZZMsPl3KOldzqXiK38RfCHVtWnZtN1XTB/ZqtG3y3S+je/tQB454EujffE+2uiNplkmfHpmN6KqfC7nx5pn/AG1/9FPRQBz+rf8AIVvf+uz/APoRqqpIYEHBFWtW/wCQre/9dn/9CNVKAPZ/gvrR0vxJp9ygEzykId3QGvrv4ieFbb4g+ALrSrr5WnjEsLj+CUDKn+n418AeEdSltLtY0bDA74/rX298D/HKeIvDkFtdkJew/IR64oA+CL6GawvZrR2IeCUqcf3gcZ/SvbvCGqrrXh63uAw86EeXKvoR0NV/2ovhsPB/igazYEHTNXkd1TH+qk6sv05yK8v8La3daBP9qtyXt3+SaPsaAPXryCS4BVSVOck1hXltJF95ia6S0vFudOt7qNS0Ey7lb+lZeqxzSzK20c9MUAYxO1cgY7D2qS3jV2JGc92p0kZjIDrg/wA6dJIIogq5A70APLB/u8YH3ariPD5yTntRCGdv3ecDqakyMtzjHSgCRCQzEEtxx7VIbZzbPu/1e3Jb0NFog3Mz8gUGXzYyFGNrdPUUAV7dJNiR3OMr0f1pSkkEgCk7WPrVjmQEyDhu3pSH50KkEEH5W9qAIPEm7/hHZCDljKqgelakQENvDHjClfmJ9apXik2BUjKbgefWrF43mL8wIJA+UdqAKUh82cBDlB1pWib5SvCg8CrMcIjt84Az0A6027A8kHG047dqAKqQ4Mhzg5q9YFkOVb5QetQyQZhU7+SOB3NNt5QCFOdw49sUAP1Ph8oMgnJasoqcs4yBWpdzB3Fvglz0+lVRA2Tt6A4NADreVwV/ebfQirscrStwiu69yKjRIzHuCHPQVpW8YIRSuMdGXrQAthZS3MyBVB3Hv2rhvihqUV3qMOk6ewdIT+8K9N9dL498SjRNJFnZuBfzj5iOqL/jXmnh20ae4e6uCRGoJLnuaALd0o07RGVVBL/JnPevoH9jDwwkr6p4lmjKvGPskLdjnBY/yr5qmkuNW1CO2gBYvIEjjHck198fCPw2nw9+F9tb3KiO52Ge4yf42HT+QoA8j/at1krbzWwfqQq+/rXyfXrP7QWvvq3iBImb7mWK+nPFeTUAFetfCWwvfE/hbWNDtdWttOSCRb2R7hiAEH3q8lru/gtr9v4e8eWM9/GJbKY+VMjDIZT6jvQBbnG27lSKSKZEciOWP7rj1Fa8mqSWsMTTw78dCK6H4qaPDZ6guradoV1omn3shEcU7AiU/wB9McKvtXGalNNcWyQ4xsoA1B4ydJBsRgB1FV73xJcy7ngYKD+dc1C6rKwk59TT5lQMpj5HqOlAGrFeX1xnZKy56nNdD4S8S6hpWoqBKJU6EMa5mG8/0YoyAY/iFVHmw2bcnee1AH03p00kti19dxq8Ui529a82sJkuPEl59jbyYEyxXpzWv8PNTvI/DyrqUnmADCis6a2itNQub0xsqSgjAoA7bwzcwX+l3MLMHlGQK811/wAC6lqGqNFZwPI7twFFdN4KEhuC9oRgnoTXqNhcvbTKWiKSkfeoA888DfBG2sbmK/8AF115SphhAp+Yn0Ne2nXbGGzEMcYjsYBhAO4FcnrM0UbefdXJlk6gM1cF4r8TPbRrIB+7B5QHrQBqfF34sahZ6etvodk8MR485lx+VfOt7qt/rF8JtTuGnduoJzXr/iHxlDrWhravpeBjhj2ryzUNFaI/aYQeTnaDQBLZWAbzHlQYjG5BVi18mFjdszIMcqnrUWlPHKJfOlZTsK496giEtwyxW8bOYznHrQB0WieMdZ0m9D2MsxjJ4Ruhr3r4f/ES5nAi1dRFMy5AbgNXjWg2U80f2xxAhi/5ZsOeKvy6/DqdwIbuPyZIxhXQ4xQB2Pj/AMPWfibUZJbNoYZ2OTngGsDQvh89jMJb4B1Q5ynes1b0sj4mcTR8qxPWt/whqWvaoSrY8lTjnvQBF4y1S1ijENvFtaMYyRXJaJqOp3M7SWwwF/iAq98QDcS3/wBkaEqzHBYcVs+HdJ+xaOsOeXHLd6AMSfxJdLfpaz/vWc4JHUVqy6hpujMs9xGDMRkDHWooPDSpqXmwMZZuuT2rifHEskd/ItxIGKcADtQB0tx4xstTvBDfWSxxnowFYmr3GlC6KxWysh7gVwW+QyBxIx9ia07K8ZwfPX5R3oA6PT7fR/MeWSYwkDgVn3Oqq5aCxlOwnG41nNA8pL28RkTv7UtqEfMUkYjCc5AoAsaZcyaNqB1OWI3BtT5yoRlXI7N7V2Hx48RRX3w18MRJpdppM+pu2oS29r91s8bq3Pg14RXxLfTanqu3+wtNBkdehkccgH2ryD42eI/+Ej8c3csLqbSD9zbogwsaDsB6UAZnwt/5HvTP+2v/AKKeij4W/wDI96Z/21/9FPRQBz+rf8hW9/67P/6EaqVc1X/kLXmf+ez/APoRqnQA+N2jkV0OGU5Br2r4ReN5tG1ywvnZfs7NtmUdzXidavh/UjY3GxxuikIBHofWgD73+KPhaz+KPw1mghwbnZ9os3HVZQOB+PSvgJN+nXlxaXkZUgmKRG4KkHFfX37PXjx1Emi6xPCsCAGCRmxnPY15t+1N8M7rTfElx4r0W1Muj32JLhohkQynqT7Hrn3oA4r4aa9HCsmg3sg2ud9tITxn0rtZ4/nJA5HDAdq+fo5GVlIYqV5BHUGvQvDHjIxeVBqrEE4HmnkMPegDsbq3DgZxurDv0dCy8/U9q6bdFdqHtmDL1DA8VQ1C2LJhuvrQBQgcWyKFyzOOuKiuhlVbB3NVrUAsSwDcMgbQKinYhgB0xQAts+FIyQDx9adbgpcTArkr0FVkZkyF7+tSx3DCFg4y+evrQBa3F1OP9cOo9qgEg8wqWOB2NQxzvGWZRkkYOaYZi/Djj6UAP1xQdKuPKmOeDgdBzVu3mQxoSd7CMbvrVW6Al0i8EbfwZKY7ZpY5StjbuAPnjHGKALcSRsvmF8Z7Z6UyYDy945D8Y61BboHjIYnPXaKYqt5OYz8o7UASPNHDNBIzA8bMGmTsY5M8bezetULZPtZL3HAjbgH1rQJMuFwMdh2oAr6tM8SW99EMtEQHA/iFasLPdQo4CrG4yAKq25RlNvcRb4ycGlRH0y6gjQM9lMdvPWOgDQsoD80Ry2DSazqEGg6e95dEbhxFGDyxq/IY7JJLi6kCRRLkN/eryHWb668Ua6ShJhDYQdlFAFKNbnxBrTzTbmLvuc/3RWp4mvIbWFdMsAdoHzEVb1O5ttCtTb2QzdOuHcd6679nz4WXHj3Xl1HUgw0W0kBlY/8ALVv7goA779k/4YLdbvFWvWatCD/oKyDqe74/lXr/AMbfFsOiaI8COodRufPTHYV13iDUrLwl4fVLWOOFIk2QxKMAAV8S/G3xzN4g1N7WOQmINl+epoA878QalJq2r3N5KcmRyR9KzqSlU4OcZoASpIJXgmSWI4dGDKfcUw9eKSgD6gi1TQvFHw3Lvqc0xtrf7Q+lhC7RXA4Mu/svt0rxYXLtI3zDaa1/gteQzXOoaJJrUmjSahF5aSgDy5v+mcpPRfemy6ZDbai9vcqu6OQxkocqccZU9xQBhSxFSzL37U35gmAhX8a6i502J50it3XY3qa3bX4fXl8imM4Trn1oA4KCNzEUU5z2rofB2gXOpX3l+X83biu90rwDaWbbr9x8vrXR6RZxWk2/TAARxkUAR+HtM/s0i1v0JJrU1yytZbNoiQqnpRrF8ba38ycf6QRwTXAX/ieaS7W3J3Mxxn0oA09N0a7t7vfp8jYU5GK6rVPFFxp2ilp0AnUYya1PA1rb29urXNwHlkGQK4/4zPFGRCG2K3JNAHnmr+KtX1DUEeOQuhPCg1pwx6hqckZmjBZf4N2a5PRpUtrh5I1Mu37oAzUc2o6jBqQubaZoX3ZxnrQB6T4r0Z4PDv2mYFGxwoGK8ytr6W3nSNpSPrzXqMfiu68TeF2067gCXKrhZMcNXld/p9xZ3ey9QqScBscGgC5e3SNKWiAAxywGMmr+ha7FY2kz7F8/HBxWLd2TQwb3b936VWi8uQBY/k460AXZdTu7mZ2EzorHJUGtnQoEvbpdxdSvUnvWDZTrFN5UgVn7Guz0uUWNt9odF3YyBQBuTQyFleKPakfBJHWuk8OPdSRM1k+1h3FeV6p4kvbtsJK8adCo712fw51W+QMI13JjnPWgCrrk122qSSajIPk7962dC1HzLffbSiVehXPNcV8Sprn+1fOHyA/eGaxdC1Q2FwtxA5RgcshPDUAe0TWmpS6bLcWMRjkweO5rwfxQz/2nIHZ/Pz+8B9a+n/h3rVv4k04ZdIpFGGUGvJ/jH4biTW2n0zBdvvgd6APLbSNGiAnb6GiVljk2BsrUE9tdQylZg6N2yOKnsrOWc4MRegC1p2qvbsYouEPWrZv1nl8tVAJ6nFQ2umxQOz3pESgcAVJ4f0y51/xFBp+kQSTzucogHX6+3qaAPafBqv4K+FHiDXdYkEUN5CyWduX/ANaGGA2PrXydK5llZ26scmvc/wBo/wAQSrZ+HPC11aW8Go6baAXnkMSiOf4VPpivCaAOr+Fv/I96Z/21/wDRT0UfC3/ke9M/7a/+inooAwNV/wCQre4/57P/AOhGqlWtW/5Ct7/12f8A9CNVQM0AJS0pBxk0lAHY+FdQjlkg+0GTfbsGIVsFwK+3vBPjDQfFvhaKzuhCiTReRJbS9GGMYr89bW5ktpkkibDKc16P4S8XSJOkkMginT5ipPBNAHR/GL4Da34Vur3U9ChN/oO4uvl8yQr1ww9B614xDKB+5nBMee/VTX3T8JvibHrtolnrUiCd/kXI4Psa4H9oL4DfbTN4j8E26+aQXubGMYDf7SD19qAPnHStV1LQWDwOZrPOSM5GP6V6bpWrWPiCz8y1lUTY+aJjhga8gs76XTzLa3MR252sjjBU96sxp+8+1aVMYpU5wpxQB6brMap5CsdrFtoB71HdRkKOM7ePrXI6Z4md7gLrPzMvRz2rsrPUYbtAAyuo53CgCjMjA9wB39aTaVUbskdRWrJHG6nA3Z5AqE/LHhkynrQBTVCznavzEdKlJk4UbCw7Y7VYhhYzpxw3ekmtZPPBUEAH0oAi+RobgrhcxHINQWZaTR7aSMg4G3pUPiqVdP06JeGuZScgHoKf4MkS8s2tpWCzJ9wE8UAaGmiW3ZrjAf5SNtVSHBJYYJOQBW3HbCEtnJkPygA9TUYsGQbmGW7rQBkw25cNldvfmr1vDEI12nBz3qRbW4MuHQgDuak1JLWwhEt5NHCuMjJ5NADhDCRliARWX4i17TtIsvLZhLO44Uc4rkde8Yby8WmA4PG8965yzsLvVpmlkY46l3oAva34k1DXyltkrAOBGv8AWtFJrfw/p6kBZLhxwPSqZlstEUeR+9ucYNa/w/8AA+vfETX1SxgzFu/eSuMJGtACfDfwVrHxD8UwxW8beTuDTTEfKiZ5r738P6Rpfg3w1BY2MaQWlumDgcs3cn3NZ3gDwbpXgHw+ttahA+0Gec8FzXl/xx+IlvpsL/Y7oxuEK+Vn757GgDh/jz8SJVM9okga5diFCn7i9hXzNLI0sjPISzMckmrWr6hNql/LdXDFnkOeTmqVABSnoKKD146UAJRRRQBb0m7FjqVtcvEkyRuGaNxlXGeQfava/iNDBPqVh4i0SzaPQb21jCkfcEoHzIv0rwmvWPhBeQeIo18J6pfNbSqzTaTPIcxQzY+bcvcEUAUvKM85nidlVRnAq3F4x1u0jFvDdYjXgYPNVtYt3sr5mhmDQyOyZxt3FTgnHYZq42mWccUEjNl2wTQBqxXur6rZq80s2P7w711/hC8NpGRPIdwHGTWUurWlrpawlkVcYwBzWJbaiqiYqGbPQ0AT+OPEVzdXhXeQi9NtVfDdql0pupycg8DvUfh7TjqutLHOCVdu/avQ9QtNM8FCOS6TzIH/AEoAk8KTImpxSvJlF6Kax/jPI+ozo4UiNRgYrrdAu/D2typ/ZrhZW5296zfibbCzhKXKExgZBAoA8d0snTI1Zio3HjNZ+ss0lz527I68Ut7JFMN6bsKeATUZlkeMZUBPegCa38QXkEYSFvu9K6SDW01qyjt7mNHmU5GRzXKXVssiLNARkdVFSaVK9vMJQyq6+tAFrXrqR5mt3jKbOwFZwSMKrBiGx0rZuLh76Y3aorsq4as6JuSwjB3nBOPu0AP0q1F5qUWMBQeSa0fFF7K9wttEwSJBjI71Ib22tLEJaQlpO7Vzc1z59yxlJznmgCa2nmUsSpkx0NejfDWC9mn89ZAF/u5rlof3lirQBBEo+Y9zU+layun3EUlrKwfdhlzxQB0PxPgmmmy8O0qPTrXmyyxjk/fXtXt+u6HP4i0xL2O4XKx7iPwrxTVY40u3WMYZThqAOi8J+KJ9JuNlsWUvxxXW2/iBZr8Sanzn+9Xm+maTM0f21HwimvToLS0u/CRmuI8sBgOOuaAF1Wx07XHEu+KJE5xXM6vq2mWwNnZBQ69XHeqclrDDpssiTyZ543VzMKR7WLcu3TPWgDW0+CPVbjZLMW54ya9x8FeHNO8N+ANZ1zUnuNNMO2S31GFgGbH8Kn0J4IryL4deFL/WtXE0Oj3OradbkG7trd/LdlPAwxo+POqWWkX6eEfDF1eDSLVQ80MtwZQJTyV/DpQB5v4u1258SeIr3Vb1y81xIWyfTtWNRRQB1fwt/wCR70z/ALa/+inoo+Fv/I96Z/21/wDRT0UAc/q3/IVvf+uz/wDoRqqDirWrf8hW9/67P/6EaqUALSUtBAxwaAEp8UjRMGjOGBzkUyigD0Pwj4pnt7mOWE7btBgr2YetfWHwf+JMer2iWOoyhpY1H7zPT2NfCEMrxSq6MVZTwa77wn4meCYGGT7PcEYY5wHFAH078bfgbp3jK3m1jw6kVprOC7BRhJ//AK9fG2s6RqnhrU5LTUreW1uYmwVYYzX1r8MviuYZYrLU5mlRiFyx+4K9L8UeFvCHxDtXh1CGGWZk+WVcB1z3BoA+B4L6wuji8i8t8YLDoasQvc2BR7C4WSMchD3HpXq/j39mzxFo7zT+HnXU7MZKqOJAPpXi+q6Pq+g3Hl6lZ3NnIOnmIRQB22meKrWZRHdg20x656VtwaxpklxDDHdoWYc5PFeVDU3cAXEUcw9xVNnDMSihO/FAHvEUUQZX3KdvK7WzVTxDdrbxRr5wiRW3sxPJ9q8Xjv7tBhLmUY44Y0S3FzdsvnzSOOmWOaANHxRqj3+rTOjsIx8o5qHQ9UmsryM+YfLJ556U2K2icZDbyODmr9vo8MqB3lVFPVe9AHRReMrZL0GZpJETgEVsL4703nMjAdc45+lcBeWmnwbkjmBPTOazvJjkYRwke7mgDvNT+Ix2smmwEt2eTt+FcTc3d9rd7uuZmldj3PAqWxtlhmV32uoyHB9K0tN0HVNTvWi0CymmdhkRohJxQBBHBa6XgsRNMwxz0FMS7urpxb2CHPQYHWvYPBn7OnibWVguNWZNPtpOXWXlx+Fe+eF/hb4L8A2qTzxrcTqf9bMAefYUAfO3wk+BeueK5ftmrxtYadu5klHzP9BX114e0XQfAWhx2tr5NrAoAaRsBpD6muW8SfFrSdIglSyjUlBw7kKgr5p+JHxivdWuHSC4M7DIU/wr9BQB6x8aPi7b20csNlNmNDiOMHlz6n2r5P8AEeuXmv6i93fSFmY8DPAFUr28nvrhprqVpJGOSWNV6AClpKUHrmgApKKKACiiigAqezuZbO7huLdyksTB1YdiKgooA+jPD2maR8QvBet6yrvP4xlKuIoosLbqg6KBx81cEt0VXy7mJ45UOCrDBH1FZXwj8c3XgfxH58c7x2V0hgudnUKeNw9x1r2Hx18NXg0O08TeF7ubxBp08fmXUz4MpY87sDt60AeUzy+dIQFOB71No+pyQT+XIAY84waie8hMZaIAkcEdwfSstyzTBgcZNAHvfw+srO83zoVWVeQK4X4t6xPNrAtXOVj4C9qqeBPEMmn37JIWCkcGsXxtfC71l5jk5oAu+A9SFj4itWyVYsMkHivoHx2lvqvhvA2tIU4PXtXy3YzbZRsJ3dQa9s+GGqDxBH9hvLjbNEOAT1oA8Z1KP7HNPAQQwJ6iqEIluBsV+R2r0L4qaJJY6xLK0RKfwuo61zng6xivNZgSZXwx9KAMKGWS1JV0OfSnGL7TJuXOfTNd34x8F6kmoebY22+Fuhx0rGh8IarbustzEVjPUrQBzqtcQM0MTHDfexVtXltY1SIh93XPaur1vRdMstKSeO58u9J5HrXGh181+WYdyKAH3EMgwS/J9KrRxqWJOQe/Fdv4U8JnWQtzLIUt05INVfF4sbWc21iASvBNAGHYB7eCUK2UbnGapW2x7r5iVJP5UkjTJ0ztFMtJClwWYEqRQB7Z4ZuRLor2qTlm8sjIPtXjeqW81tqFzFICdjnJr1/4PJatp0xuUCZOV3VxfxLt/sniKWSFP3EnOR0zQBzmnXDojKj/ALk9Vr0NdbtY/Bv2ZF+fHSvLIneCfeU3Iex6Vq6dftPeCNVwv6UARLNNuYSNiBjypp9n5SztJIB5SjPPQUmtyRvdCJFz7jpXX+GPA2oLqNpfeILN7Xw/bxi8u5Ln5Yp4P7i+pJ7UAekXlxa/Bjw5c6mNba7OtWQ+yadsAxIRy24dhmvku7uJLu6luJmLSSsXYk5ySa7H4teN38ceJ2u4ohb6dbqILOBeAkS8D8a4igAooooA6v4W/wDI96Z/21/9FPRR8Lf+R70z/tr/AOinooA5/Vv+Qre/9dn/APQjVSrerf8AIVvf+uz/APoRqpQAU4HHWm0UAPDLzlc03FJRQAU5WZWBUkEdDSUlAHR6P4kktiq3ILKP4h1r0nwz4+uRL5lpduGUYVd3K14nUkMskLh4nKsO4oA+1PAnxbu1TydaVZkYgLJnGK9MupfCviu0EGpW9pcq4+7MgJH41+f+meLL60O2VvNi9D2rqrH4iTDG66ljI6EHpQB9Kz/AjwZrgupYrMWq+YRF5b9q5vWv2YdHntzJpt3cwzD+A4INcVpPxnlht0gjvCAuOT1JrrNM+Mt7LIXS5XOB8pPGKAOXvP2X9WRd9vqKYz91l5rA1D9nbxPaRu6Osqrz8o5xXttj8ZJ9jC6RG5+VlPNbEPxjtfI/fRqJMfgaAPm9fgN4lMcbxq5aQZChTmpLD4GeJri2kkWOYOhwUYYzX0XcfGWx+zxtCqLIeDnkVGPjVpiZywLdxjvQB4ZpP7Pmv3joZ7Rogx+Yu2MV2Oj/ALM7HB1HUIoVVvmVRk7a6y++O9srnyvLEZXBy3I+lefan8e9l5K4mMi4K7FHWgD1nRPgb4G0rC3gN5Jt4818fjXTjUfCPgyALZRWkBUbcoBuI+tfJer/ABu1O8P7oMo9jg1xWr+PdV1FiXYKO3OSKAPq7xn8drGxt5UsQFYfdkY9fwr588W/GXVtVMkdu7LGTnJPWvLLu7nu5N9xIzt7moKAL2oare6g5a7uZJMnOC3FUaWgDPfFACUq4zz0oIx3zQDwaAA4zxSUUUALnP4UlFFABRRRQAUUUUAFe9fs2fFf/hGL8eHtdk3aNdthGfkRMf6V4LSg4OR1FAH3F8UfhRo3iLQ9Q13RNMkj1hIj9litmCxynsxA4ORXy7qGnNasIbhgs3QAKclh94fhXqn7P3x3Ojx2/h3xbKz2WQkF2xyYh6N7V9OT6B4b1a7sdSe0sp5IlYwOAuMOOT75oA+CraV4UEmcspxUt/iQK86kFxkGvS/il8PZIPHGo6folitnIytc2lu83F1EOXdfQg/w15bcyzSWnlyghk42suCvsRQBUiSRQ3lfNW34Q1dtE1uG5lZgmeSDVLT4j5BKct3qrcyFWYSDr2xQB7/c63pGu2IEkkb7h0brVvw54Z063U3kEatjnI7V85QSOFAjkdT2wa9X+G/ii5trWWzuWLoV4JNAHQ+MvH0FhE9nagNN0+lcn4e8Z3M0zR3CeZG3XNcL4n8yTWLqUtnc3A/Guh0rTobLR1vpJw2R90UAafi6w0y8ga4S4AkAzsNecwSKryBWwegzW5PdwXchCMQD71lLZs12VgTdjmgD0X4VNd33mWJZliYH5vStdPAVl/bUkd5dK5c+vNZPw9upbG0uC67ZQOgFc9d6xeR6407O+S+Qd3agC54p8CazYX0iWVnNcWhOVdBkYqDTfDTxtGb544YQfnD/AHq9k0nxzp8Hh8GaTzLjZjb6mvDvGOv3OpX8w8poYixIoA9B1S60iz0VW0m5zKo6KawV1O31XSWj1FFEo6Ma4e21UQ2hhcfN2NV3lYusjyEqf4QaAL2pQhGZYcNCP4qbo7JFBKzIfNPC471DLERCWVyEPOCa7n4R+CNW8W6vBMIWs9KtnDz3U67QAOcAHrmgDf8Ahj4As9S1azOvXcNrLNG11HbSjLSRL95vYfWuL+Nnjq2ujN4W8MXt3PoEFwZC08m7Ljjah/ue1dP8cPiBo2jajq2k+BQftV7hL6+3btoAwUi/ug98V88Hk5PWgBKKKKACiiigDq/hb/yPemf9tf8A0U9FHwt/5HvTP+2v/op6KAOf1b/kK3v/AF2f/wBCNVK+sLv/AI+pv99v51FQB8qUV9V0UAfKlFfVdFAHypRX1XRQB8qUV9V0UAfKlFfVdFAHyrUkc8sRzHI6n2NfU1FAHzEmq3yY23Mgx70jarfN1upf++q+nqKAPl/+0bzGPtMv/fVNa9uW6zyH8a+oqKAPldpHb7zsfqaZX1XRQB8qUV9V0UAfKlFfVdFAHyqTk0lfVdFAHypRX1XRQB8qUV9V0UAfKlFfVdFAHypRX1XRQB8qUV9V0UAfKlFfVdFAHypXY6B8Qtd0aCGGK6lkiidWVWkYYwen0r3qigDg9d+PZ17UdM1HV/CGm3F/pwxBN9okUjv2965Hxn8Ro/E2pT350Czsrqc7pGgkbDH1wa9qooA+dLfxNPbsDHBGPxNWbjxcZ49smnW5P97JzX0FRQB83proQ5WyjH/AzWla+NZ7bJisoQcYzuNe/UUAfOFz4hmnuDK8SZPUZNaVl41mtbJ7UWMDxt/eY8V77RQB80/2zIHZkiVcnPBNXYfFVzCyMkEYZe+TzX0TRQB4XB8Q7+GJ1S1gywwWyax5fE1xLP5rwoT6ZNfRlFAHz7B4xuIpUkFrEdvYscVb1jx0dTVN+k2sTqMbkY817vRQB803GsPM4JhRcdgadHrOzBNqjEerGvpSigDx/QfiXp+nadHb3vg7TNSlR94nnmcN9OO1XPiN8bNa8Y2NnZ29nBo1tbAjZZyMN/GMH2r1SigD5VZizFmJJPJJpK+q6KAPlSivquigD5Uor6rooA+f/hb/AMj3pn/bX/0U9FfSvhb/AJD1r/wL/wBBNFAH/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axial flair image (A) show two plaques in the internal capsule, one in the anterior limb and one in the posterior limb. Diffusion tensor fractional anisotropy map (B) shows asymmetric hypointensity (decreased anisotropy) in these regions (arrows), consistent with loss of axonal integrity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15044=[""].join("\n");
var outline_f14_44_15044=null;
var title_f14_44_15045="DIEP flap breast reconstruction";
var content_f14_44_15045=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F66615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F66615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 542px\">",
"   <div class=\"ttl\">",
"    DIEP flap breast reconstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 522px; height: 686px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The most commonly used perforator flap for breast reconstruction is the deep inferior epigastric perforator (DIEP) flap. The DIEP uses the lower abdominal island of skin and fat and spares the rectus abdominis muscle. Although the underlying muscle must be split to dissect out the perforating vessels, the muscle itself is not included in the transfer. The deep inferior epigastric artery and vein, which provide the vascular supply for the free flap, are anastomosed to local recipient vessels, using either the internal mammary or thoracodorsal arteries and veins.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15045=[""].join("\n");
var outline_f14_44_15045=null;
var title_f14_44_15046="Nabiximols: Drug information";
var content_f14_44_15046=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Nabiximols: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?13/26/13733?source=see_link\">",
"    see \"Nabiximols: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F596136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Sativex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F596139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Analgesic, Miscellaneous",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F608937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Spasticity or neuropathic pain associated with multiple sclerosis (MS), cancer pain:",
"     </b>",
"     Buccal spray:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Initial: One spray in the morning and one spray in the afternoon or evening (maximum initial dose: 2 sprays on first day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Titration and individualization: Dosage is self-titrated by the patient. After initiation of therapy, the dose may be increased each subsequent day by one spray as needed and tolerated. Usual dosage: 4-8 sprays daily. Most patients require &le;12 sprays daily. Experience is limited with dosage of &gt;12 sprays daily, though some patients may require and tolerate higher dosing. Sprays should be evenly distributed over the course of the day during initial titration.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F3062234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing. Use with caution and monitor closely.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F608938\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling (has not been studied in severe impairment); use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F608939\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling (has not been studied in severe impairment). Undergoes hepatic metabolism; use with caution as exposure may be increased.",
"    </p>",
"   </div>",
"   <div class=\"block dot drugH1Div\" id=\"F10839907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adjustment for Toxicity",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     If adverse reactions, including intoxication-type symptoms, are noted the dosage should be suspended until resolution of the symptoms; a dosage reduction or extension of the interval between doses may be used to avoid a recurrence of symptoms. Retitration may be required in the event of adverse reactions and/or worsening of symptoms.",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F5951003\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution, buccal [spray]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Sativex&reg;: Delta-9 tetrahydrocannabinol 27 mg/mL and cannabidiol 25 mg/mL (5.5 mL [delivers 48 metered sprays], 10 mL [delivers 90 metered sprays]) [100 microliters/spray; contains ethanol 50%, peppermint oil, and propylene glycol]",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11234346\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not available in U.S.",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F596134\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CDSA-II",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F608940\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     For buccal use only. Do not inhale, spray into nose, or apply spray to sore or inflamed mucosa.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Shake vial before use and remove protective cap; replace protective cap following use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Priming: Vial should be held in an upright position and primed into a tissue prior to the initial use by depression of the actuator 2-3 times until a fine spray appears. Priming should not be required for subsequent uses. Do not spray near children, pets, or an open flame.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Normal use: Hold vial in upright position and spray into mouth; spray should be directed below the tongue or on the inside of the cheeks, avoiding direction to the pharynx. Initiate therapy by administering 1 spray in the morning and 1 spray in the afternoon or evening (between 4 pm and bedtime) on day 1. With subsequent titration, allow at least 15 minutes between sprays; however, during initial titration, sprays should be evenly spaced throughout the day. The application site should be varied.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F596140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunctive treatment of neuropathic pain or spasticity in multiple sclerosis; adjunctive treatment of moderate-to-severe pain in advanced cancer",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F608919\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Central nervous system: Dizziness (12% to 25%), somnolence (8% to 15%), fatigue (13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Gastrointestinal: Nausea (10% to 12%)",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Cardiovascular: Hypotension (5%), palpitation (1%), syncope (1%), tachycardia (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Central nervous system: Confusion (7%), vertigo (5% to 7%), disorientation (4%), attention disturbance (3% to 4%), depression (3%), headache (3%), impaired balance (3%), insomnia (3%), panic attack (3%), euphoria (2% to 3%), hallucination (&le;3%), dissociation (2%), feeling abnormal (2%), lethargy (2%), amnesia (1%),  malaise (1%), memory impairment (1%), paranoia (1%), suicidal ideation (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Gastrointestinal: Vomiting (4% to 8%), diarrhea (6% to 7%), xerostomia (6%), glossodynia (3%), oral candidiasis (3%), taste abnormal (3%), anorexia (2%), constipation (2%), mouth ulceration (2%), oral mucosal disorder (2%), tooth discoloration (2%), abdominal pain (1%), appetite increased (1%), stomatitis (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Genitourinary: Urinary retention (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Hepatic: Hepatic function tests abnormal (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness (5% to 6%), dysarthria (2%), fall (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Ocular: Vision blurred (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Renal: Hematuria (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Respiratory: Throat irritation (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Miscellaneous: Drunken feeling (3%)",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     &lt;1% (Limited to important or life-threatening): Delusions, hypertension, illusion, urinary infection",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F608885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to cannabinoids or any component of the formulation; serious cardiovascular disease (including arrhythmias, severe heart failure, poorly controlled hypertension, and ischemic heart disease); history of psychotic disorders (including schizophrenia); women of childbearing potential who are not using a reliable form of contraception; males intending to start a family; children &lt;18 years of age; pregnancy; breast-feeding",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F608886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Buccal mucosa irritation: May be irritating to the buccal mucosa; avoid administration in an area of soreness or inflammation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular effects:",
"     <b>",
"      [Canadian Boxed Warning]: May be associated with adverse cardiovascular effects, including tachycardia and alterations in blood pressure (including orthostatic changes).",
"     </b>",
"     Dosage must be carefully titrated and monitored, with downward adjustment in patients with unacceptable adverse events. Use with caution in the perioperative setting. Use is contraindicated in ischemic heart disease, arrhythmias, poorly-controlled hypertension, and severe heart failure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects:",
"     <b>",
"      [Canadian Boxed Warning]: Use may be associated with dizziness, changes in mood, cognitive performance, memory, impulsivity, and coordination, as well as an altered perception of reality, particularly with respect to an awareness/sensation of time.",
"     </b>",
"     Adverse effects are dose-dependent and vary among patients. Dose reductions, greater intervals between doses, or interrupting therapy may resolve unwanted effects. May impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving). Concurrent use with other sedatives, psychotropics, hypnotics, opioids, or ethanol may potentiate adverse CNS effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Genitourinary effects: Increased risk for urinary retention and infection, especially in cancer patients; use caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug abuse:",
"     <b>",
"      [Canadian Boxed Warning]: Potential for drug dependency exists. Tolerance, psychological, and physical dependence may occur with prolonged use.",
"     </b>",
"     Use with caution in patients with a history of drug abuse or acute alcoholism.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic dysfunction: Use in patients with significant hepatic dysfunction has not been studied. Use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Psychosis: Avoid use in patients with personal or strong familial history of psychosis; suicidal ideation and depression have been reported with use. Discontinue use immediately in patients experiencing psychotic reactions, suicidal ideation, delusions, hallucinations, and/or confusion and monitor until complete resolution of symptoms.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal dysfunction: Use in patients with significant renal dysfunction has not been studied. Use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder:",
"     <b>",
"      [Canadian Boxed Warning]: Use with caution in patients with a history of seizure disorder.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Special populations:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly. Close monitoring of this patient population is required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ethanol: Formulation contains ethanol; use with caution in alcoholism or hepatic dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prescribing restrictions:",
"     <b>",
"      [Canadian Boxed Warning]: Prescriptions should be written for the minimal amount needed between clinic visits.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Toxicology screen: Cannabinoids may be detectable in the urine and serum for several weeks following drug discontinuation.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F608924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F608923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergic Agents: May enhance the tachycardic effect of Cannabinoids.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cocaine: May enhance the tachycardic effect of Cannabinoids.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: Cannabinoids may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F608926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F608882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cannabinoids have been associated with reproductive toxicity. Animal studies indicate possible effects on fetal development and spermatogenesis. Use in pregnancy is contraindicated. Women of childbearing potential and males who are capable of causing pregnancy should use a reliable form of contraception for the duration of treatment and for 3 months following discontinuation.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F608883\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/contraindicated",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F608944\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Mental status, response to pain; mucosal integrity and inflammation",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F2869443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Sativex (CZ, GB, NZ)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F608941\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stimulates cannabinoid receptors CB1 and CB2 in the CNS and dorsal root ganglia as well as other sites in the body. Cannabinoid receptors in the pain pathways of the brain and spinal cord mediate cannabinoid-induced analgesia. Peripheral CB2 receptors modulate immune function through cytokine release.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F608954\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Rapidly absorbed from the buccal mucosa",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: Widely distributed, particularly to fatty tissues",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Protein binding: Extensive",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Hepatic, via CYP isoenzymes (2C9, 2C19, 2D6 and 3A4) to THC metabolite 11-hydroxy-tetrahydrocannabinol (11-OH-THC, psycho-active) and CBD metabolite 7-hydroxy-cannabidiol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: Biphasic: Initial: 1-2 hours; Terminal: 24-36 hours (or longer) secondary to redistribution from fatty tissue",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Time to peak, plasma: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Excretion: As metabolites, urine and feces",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Berman JS, Symonds C, and Birch R, \"Efficacy of Two Cannabis Based Medicinal Extracts for Relief of Central Neuropathic Pain From Brachial Plexus Avulsion: Results of a Randomised Controlled Trial,\"",
"      <i>",
"       Pain",
"      </i>",
"      , 2004, 112(3):299-306.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/44/15046/abstract-text/15561385/pubmed\" id=\"15561385\" target=\"_blank\">",
"        15561385",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Djulus J, Moretti M, and Koren G, \"Marijuana Use and Breastfeeding,\"",
"      <i>",
"       Can Fam Physician",
"      </i>",
"      , 2005, 51:349-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/44/15046/abstract-text/15794018/pubmed\" id=\"15794018\" target=\"_blank\">",
"        15794018",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kozer E and Koren G, \"Effects of Prenatal Exposure to Marijuana,\"",
"      <i>",
"       Can Fam Physician",
"      </i>",
"      , 2001, 47:263-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/44/15046/abstract-text/11228023/pubmed\" id=\"11228023\" target=\"_blank\">",
"        11228023",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Smith, PF, \"GW-1000. GW Pharmaceuticals,\"",
"      <i>",
"       Curr Opin Investig Drugs",
"      </i>",
"      , 2004, 5(7):748-54.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/44/15046/abstract-text/15298072/pubmed\" id=\"15298072\" target=\"_blank\">",
"        15298072",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wade DT, Makela P, Robson P, et al, \"Do Cannabis-Cased Medicinal Extracts Have General or Specific Effects on Symptoms in Multiple Sclerosis? A Double-Blind, Randomized, Placebo-Controlled Study on 160 Patients,\"",
"      <i>",
"       Mult Scler",
"      </i>",
"      , 2004, 10(4):434-41.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/44/15046/abstract-text/15327042/pubmed\" id=\"15327042\" target=\"_blank\">",
"        15327042",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9457 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-5088ACF45B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15046=[""].join("\n");
var outline_f14_44_15046=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F596136\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F596139\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608937\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3062234\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608938\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608939\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10839907\">",
"      Dosing: Adjustment for Toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5951003\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11234346\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F596134\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608940\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F596140\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608919\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608885\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608886\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608924\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608923\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608926\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608882\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608883\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608944\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2869443\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608941\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F608954\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9457\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9457|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?13/26/13733?source=related_link\">",
"      Nabiximols: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_44_15047="Gastric erosion after gastric banding - Case 1";
var content_f14_44_15047=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F73420&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F73420&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Case 1: Gastric erosion after gastric banding",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 584px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Band erosion through the wall of the stomach is caused by an excessively tight band or injury to the gastric wall during placement. In panel A, the arrow points to the wall of the stomach outside the band in a case of gastric erosion. Panel B shows the endoscopic appearance of band erosion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15047=[""].join("\n");
var outline_f14_44_15047=null;
var title_f14_44_15048="Psychogenic purpura (Gardner-Diamond syndrome)";
var content_f14_44_15048=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Psychogenic purpura (Gardner-Diamond syndrome)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/44/15048/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/44/15048/contributors\">",
"     Benjamin P Geisler, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/44/15048/contributors\">",
"     Bruce J Dezube, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/44/15048/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/44/15048/contributors\">",
"     Lawrence LK Leung, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/44/15048/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/44/15048/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/44/15048/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychogenic purpura (Gardner-Diamond syndrome, autoerythrocyte sensitization, painful bruising syndrome) is a rare and poorly understood clinical presentation of unexplained painful ecchymotic lesions, mostly on the extremities",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the face. This disorder mainly occurs in Caucasian women with emotional stress or one or more concomitant mental illnesses. It has been speculated that this might be the disease entity responsible for reported episodes of \"hysterical\" bleeding or religious stigmata.",
"   </p>",
"   <p>",
"    The clinical, pathophysiologic, and diagnostic aspects of psychogenic purpura will be discussed here. The general approach to the patient with a bleeding diathesis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=see_link\">",
"     \"Approach to the adult patient with a bleeding diathesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/19/15674?source=see_link\">",
"     \"Approach to the adult patient with thrombocytopenia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/9/29850?source=see_link\">",
"     \"Congenital and acquired disorders of platelet function\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first publication concerning psychogenic purpura was by Gardner and Diamond in 1955 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/1\">",
"     1",
"    </a>",
"    ]. Since that time, a number of reviews [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/2-5\">",
"     2-5",
"    </a>",
"    ] and case reports have been published, the vast majority in adult Caucasian women [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/6-15\">",
"     6-15",
"    </a>",
"    ], although this disorder has also been described in children, adolescents, and adult men [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/16-21\">",
"     16-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Disease episodes are associated with painful bruises on the extremities",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    face; all systemic tests of the coagulation system are normal. Since psychogenic purpura occurs in the psychiatric patient population, factitious bleeding and deliberate self-induced mutilation or other trauma need to be ruled out.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Bleeding episodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;According to the patient, bruises occur either spontaneously or after trauma or surgery at other sites of the body. One patient, for example, had a wrist fracture and a subsequent carpal tunnel syndrome requiring intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/4\">",
"     4",
"    </a>",
"    ]. This was accompanied by severe emotional disturbance; spontaneous bruises began three weeks later on the same arm and hand.",
"   </p>",
"   <p>",
"    While some patients can describe the exact onset of purpura, others are unable to do so even after precise questioning. The patient usually has multiple small lesions that are purple in color, superficial in location, and may be associated with erythema and swelling.",
"   </p>",
"   <p>",
"    In one documented case, a large area of \"bruising\" was noted over the patient's chest when told of hospital discharge that she considered premature. After physicians relented and granted additional hospital time, the \"lesions\" retreated within hours to a small central discoloration (",
"    <a class=\"graphic graphic_picture graphicRef80842 \" href=\"UTD.htm?39/6/40046\">",
"     picture 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Concomitant psychiatric conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychiatric conditions that have been associated with psychogenic purpura include depression, anxiety disorder, dissociative disorder, and multiple personality disorder, as well as conversion, histrionic, dependent, or borderline personality disorder. Many patients have sadomasochistic relationships, a history of verbal, physical,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sexual abuse, and may have suffered one or more pregnancy losses or the loss of a child [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some patients, traits of a masochistic personality",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sleep disturbances and nightmares resembling the symptoms common in post-traumatic stress disorder may be observed. Most patients have been frequently hospitalized for various medical reasons and have had multiple surgeries. Malingering and factitious disorder, including Munchausen syndrome, need to be ruled out. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Psychiatric conditions and malingering'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Religious stigmata",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bleeding lesions in patients with psychogenic purpura have been likened to \"religious stigmata,\" a term that refers to bleeding",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sensations of pain in locations corresponding to the crucifixion wounds of Jesus Christ [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/25\">",
"     25",
"    </a>",
"    ]. These include wounds from nails in the hands and feet and from a lance in the side. Other reports include wounds to the forehead (\"crown of thorns\"), tears of blood or sweating blood [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/26\">",
"     26",
"    </a>",
"    ], wounds to the back as from whipping, or wounds to the shoulder as from bearing a cross.",
"   </p>",
"   <p>",
"    Most cases of religious stigmata appear to have occurred in individuals of the Roman Catholic faith. Many are members of Catholic religious orders, and 90 percent are female. Well-known historical cases demonstrating religious stigmata might include Saint Catherine of Siena and Saint Francis of Assisi.",
"   </p>",
"   <p>",
"    A striking similarity exists between religious stigmata cases in which bleeding occurred, and patients with psychogenic purpura. In both situations, the bleeding was otherwise unexplained, and the individuals were in a state of extreme emotional upset. In historical yet questionable reports of religious stigmata, the term \"religious ecstasy\" was used to describe the individual's condition, which some have regarded as an acute psychotic state. Other cases, however, are believed to be \"pious fraud\" [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/4,25,27,28\">",
"     4,25,27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiology of psychogenic purpura is not understood. Attempts to explain the phenomenon of psychogenic purpura include stress, an increase in local activity of tissue plasminogen activator (tPA) and a local autoimmune reaction to the patient's own erythrocytes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Response to stress",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is generally accepted that stress or \"distress\" (ie, an extreme response to one or more external stimuli causing a damaging pathophysiologic reaction in the host involving changes in behavior, physiology, and disease susceptibility) is associated with increased levels of endogenous glucocorticoids [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/25\">",
"     25",
"    </a>",
"    ]. Different types of stress (eg, fasting or heat shock) produce variable increases in glucocorticoids and catecholamines, and may alter hemostatic mechanisms, such as fibrinolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/25,29-31\">",
"     25,29-31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Increased fibrinolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alterations in the fibrinolytic pathway, leading to fibrin degradation, have been found in some cases of psychogenic purpura [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. There is credible research showing that local (cutaneous) activity of tPA may be increased in psychogenic purpura [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/32\">",
"     32",
"    </a>",
"    ], leading to substantial amounts of local plasmin activity, rapid degradation of fibrin clots, and resultant bleeding.",
"   </p>",
"   <p>",
"    In one report, for example, an increased intradermal tPA concentration could be shown in immunoassays of sites of psychogenic purpura; cutaneous fibrinolytic activity may be entirely inhibited by monoclonal antibodies directed against tPA [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/32\">",
"     32",
"    </a>",
"    ]. There is speculation that tPA release from endothelial cells is triggered by neuropeptides in the skin [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/25,32\">",
"     25,32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Autoerythrocyte sensitization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autoerythrocyte sensitization refers to the mechanism that Gardner and Diamond had originally ascribed to this clinical entity. Intradermal injection of autologous blood or washed red cells resulted in an ecchymotic lesion, whereas injection of control blood or saline did not [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/6,8,9\">",
"     6,8,9",
"    </a>",
"    ]. This finding has not been confirmed by others, and autoantibodies or cytotoxic T-lymphocytes directed against the individual's own erythrocytes have never been detected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Other mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other mechanisms and disorders have been postulated as underlying or exacerbating psychogenic purpura. However, because these have been reported infrequently, their relationship to psychogenic purpura may be completely fortuitous. These have included:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Exacerbation by a copper-containing intrauterine device [",
"      <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/35\">",
"       35",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Coexisting coagulation or bleeding disorders (eg, idiopathic thrombocytopenic purpura, platelet function disorder, thrombocytosis) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/20,36,37\">",
"       20,36,37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Presence of anticardiolipin antibodies or systemic lupus erythematosus [",
"      <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/38,39\">",
"       38,39",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial approach to any patient with a possible bleeding disorder consists of a complete bleeding history, including the use (or misuse) of medications that might be associated with bleeding (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , NSAIDs, and selective serotonin reuptake inhibitors [SSRIs]). It is also reasonable to determine whether the patient has access to medications with a high risk of bleeding (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , LMW heparins) prescribed for other patients such as relatives. An occupational history might determine whether the patient has or had such access (eg, as a nurse or pharmacist).",
"   </p>",
"   <p>",
"    A detailed psychiatric evaluation is of paramount importance if psychogenic purpura is suspected, with information concerning how the patient has responded to major stressful events in his or her life (eg, fetal losses, death in the family, divorce, loss of income).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Typical episode",
"    </span>",
"    &nbsp;&mdash;&nbsp;The typical history is that, often following trauma or surgery, an episode is heralded by a burning, stinging, or painful sensation in an extremity or the face, followed a few hours later by local warmth, puffiness, erythema, and itching [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/40\">",
"     40",
"    </a>",
"    ]. The pain usually subsides when ecchymotic lesions finally appear. Pain and swelling may be sufficiently severe to cause immobilization of the affected extremity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The locations of skin lesions, if present, need to be carefully noted, with attention to matching up the painful areas with the sites of actual skin bleeding. The patient must be examined thoroughly for scars and signs of other wounds, as well as for venipuncture sites, which may mean that the patient has drawn his or her own blood to be added to body fluids to simulate bleeding. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=see_link\">",
"     \"Approach to the adult patient with a bleeding diathesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some patients with psychogenic purpura report pain in the involved region that may not exactly match the location of the ecchymoses. All peripheral pulses are usually palpable and not diminished in amplitude.",
"   </p>",
"   <p>",
"    On occasion, the skin lesions and associated redness and swelling may be severe enough to mimic cellulitis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/41\">",
"     41",
"    </a>",
"    ] or an acute compartment syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/42\">",
"     42",
"    </a>",
"    ]. The rapid resolution of an involved area in one documented case suggests that some of these skin lesions may be vasoactive in nature, rather than being secondary to bleeding into the skin (",
"    <a class=\"graphic graphic_picture graphicRef80842 \" href=\"UTD.htm?39/6/40046\">",
"     picture 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;In all reported cases of psychogenic purpura, the systemic prothrombin time or international normalized ratio,",
"    <span class=\"nowrap\">",
"     (PT/INR),",
"    </span>",
"    activated partial thromboplastin time (aPTT), platelet count, and platelet morphology have been normal.",
"   </p>",
"   <p>",
"    Although a prolonged bleeding time has been observed in some patients with possible psychogenic purpura [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/6\">",
"     6",
"    </a>",
"    ], this may have been related to the ingestion of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    or other medications with antiplatelet activity. Thus, measuring the bleeding time will, most likely, not be diagnostically helpful. In addition, some clinical coagulation laboratories no longer perform the bleeding time test for any condition because of problems with test reproducibility as well as the inability to correlate test results with clinical bleeding tendencies.",
"   </p>",
"   <p>",
"    A more appropriate screening test in this setting would be platelet function testing via use of the Platelet Function Analyzer (PFA-100). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=see_link&amp;anchor=H13#H13\">",
"     \"Approach to the adult patient with a bleeding diathesis\", section on 'Bleeding time'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=see_link&amp;anchor=H14#H14\">",
"     \"Approach to the adult patient with a bleeding diathesis\", section on 'The Platelet Function Analyzer'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given that patients may present with a recent history of bleeding at sites other than the skin, samples of urine, vomitus, or stool should be evaluated to determine whether or not blood is actually present in the specimen. If present, it is helpful to determine the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Whether the blood is of human origin",
"     </li>",
"     <li>",
"      Whether the blood comes from the patient",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This may be established by testing for red cell antigens (eg, non-primate red cells do not carry the Rh antigen) or by direct microscopic examination for the presence of nucleated red cells, as might be the case if the blood arose from avian sources (ie, chicken blood).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Red cell sensitization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The autoerythrocyte sensitization test has never been critically analyzed or standardized and is not available in clinical laboratories [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, the sensitivity and specificity of this test for the diagnosis of psychogenic purpura are completely unknown. This test should not be attempted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Rare bleeding disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some of the more common causes for bleeding in a patient with normal",
"    <span class=\"nowrap\">",
"     PT/INR,",
"    </span>",
"    aPTT, and platelet counts are discussed below (see",
"    <a class=\"local\" href=\"#H18\">",
"     'Differential diagnosis'",
"    </a>",
"    below). We suggest that, in patients with bleeding confined to the skin, only the standard tests need to be performed (eg, prothrombin time, activated partial thromboplastin time, platelet",
"    <span class=\"nowrap\">",
"     count/complete",
"    </span>",
"    blood count, microscopy of a peripheral blood smear) plus evaluation for von Willebrand disease. Additional tests that might be considered include the PFA-100 test to rule out a platelet function disorder and a test to rule out presence of the antiphospholipid syndrome (see",
"    <a class=\"local\" href=\"#H23\">",
"     'Antiphospholipid syndrome'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Workup for",
"    <strong>",
"     all",
"    </strong>",
"    of the conditions which might be associated with skin bleeding in a patient with a normal",
"    <span class=\"nowrap\">",
"     PT/INR,",
"    </span>",
"    aPTT, and platelet count is time-consuming and expensive, and is",
"    <strong>",
"     not recommended",
"    </strong>",
"    . Such extensive testing is warranted only if recurring bleeding episodes have been carefully documented and the patient's history, family history, laboratory tests, and bleeding pattern are typical for one or more of these disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=see_link&amp;anchor=H23#H23\">",
"     \"Approach to the adult patient with a bleeding diathesis\", section on 'Normal PT and aPTT'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In all of the published case reports of psychogenic purpura, the prothrombin time",
"    <span class=\"nowrap\">",
"     (PT/INR),",
"    </span>",
"    activated partial thromboplastin time (aPTT), and platelet counts have been normal. Thus, the differential diagnosis includes conditions associated with bleeding and normal results for these three tests. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=see_link&amp;anchor=H23#H23\">",
"     \"Approach to the adult patient with a bleeding diathesis\", section on 'Normal PT and aPTT'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Inherited bleeding disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the inherited bleeding disorders, an acute onset in adulthood with the first hemorrhagic manifestation occurring at multiple cutaneous sites is extremely uncommon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     von Willebrand disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In von Willebrand disease (VWD), normal coagulation parameters and late onset during adolescence are frequently observed [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/43\">",
"     43",
"    </a>",
"    ]. In such patients, the intake of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    or nonsteroidal anti-inflammatory drugs (NSAIDs) can lead to bleeding which would not have occurred otherwise. The diagnosis of mild VWD may be difficult to make, and may require serial testing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24794?source=see_link\">",
"     \"Clinical presentation and diagnosis of von Willebrand disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Factor XIII deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital or acquired factor XIII deficiency is associated with normal PT and aPTT. The most commonly reported clinical symptoms include excessive bleeding after invasive procedures, umbilical cord, intracranial, muscle and joint bleeding, as well as recurrent miscarriages and impaired wound healing. Hence, this disorder is not likely to be confused with psychogenic purpura. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/21/16730?source=see_link&amp;anchor=H26#H26\">",
"     \"Rare (recessively inherited) coagulation disorders\", section on 'Factor XIII deficiency'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/4/24650?source=see_link&amp;anchor=H30#H30\">",
"     \"Acquired inhibitors of coagulation\", section on 'Factor XIII inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Vascular purpuras",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vascular purpuras include severe vitamin C deficiency, structural vascular abnormalities (eg, hereditary hemorrhagic telangiectasia), hereditary disorders of connective tissue (eg, Ehlers-Danlos syndrome, osteogenesis imperfecta), small vessel vasculitis, and purpura associated with the presence of paraproteins or amyloid involvement of cutaneous vessels.",
"   </p>",
"   <p>",
"    In most cases, routine history, physical examination, and laboratory testing will be sufficient to suspect these diagnoses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/62/28650?source=see_link&amp;anchor=H54#H54\">",
"     \"Overview of water-soluble vitamins\", section on 'Vitamin C (ascorbic acid)'",
"    </a>",
"    .) and (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31226?source=see_link\">",
"     \"Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/56/2953?source=see_link\">",
"     \"Clinical manifestations and treatment of the hypermobility syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38040?source=see_link\">",
"     \"Osteogenesis imperfecta: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1530?source=see_link&amp;anchor=H18#H18\">",
"     \"An overview of amyloidosis\", section on 'Skin manifestations'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    If a systemic vasculitis is suspected, an autoantibody screen including anti-nuclear antibodies (ANA) and anti-mitochondrial antibodies (AMA) as well as a skin biopsy may be useful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30614?source=see_link&amp;anchor=H3#H3\">",
"     \"Hypersensitivity vasculitis in adults\", section on 'Cutaneous vasculitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Antiphospholipid syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally, patients with the antiphospholipid syndrome may present with painful cutaneous lesions showing necrosis, infarctions,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ulcerations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/31/23034?source=see_link&amp;anchor=H30#H30\">",
"     \"Clinical manifestations of the antiphospholipid syndrome\", section on 'Cutaneous'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Drug intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of medications may be associated with bleeding, especially in patients with a prior psychiatric history (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , NSAIDs, other antiplatelet agents,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    prescribed for a family member) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     SSRIs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bleeding occurring during treatment with selective serotonin reuptake inhibitors (SSRIs) might be related to inhibition of platelet aggregation due to the effect of these agents on decreasing intraplatelet serotonin concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/45\">",
"     45",
"    </a>",
"    ]. As an example, the SSRI",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    inhibits platelet plug formation under shear stress and decreases platelet responsiveness to thrombin receptor-activating peptide [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/46\">",
"     46",
"    </a>",
"    ]. NSAID or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    intake may aggravate these SSRI-related adverse events [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/44,47-49\">",
"     44,47-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    SSRI-treated patients may present with ecchymoses or mucosal bleeding, including gastrointestinal and vaginal bleeding and epistaxis, often with a concomitant increase in bleeding time. When the SSRIs are discontinued, platelet function typically normalizes and hemorrhage ceases [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/46\">",
"     46",
"    </a>",
"    ]. In one documented case, ecchymoses appearing after SSRI treatment were successfully treated with Vitamin C&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=see_link&amp;anchor=H12543449#H12543449\">",
"     \"Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects\", section on 'Bleeding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Illicit drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subarachnoid hemorrhage after 3,4-MethyleneDioxyMethAmphetamine (MDMA, \"Ecstasy\") abuse has been reported in a single subject [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/51\">",
"     51",
"    </a>",
"    ]; little is otherwise known about bleeding complications following use of this drug.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Steroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some cases of suspected psychogenic purpura may be due to steroid-induced purpura which typically affects the sun exposed areas of the dorsum of the hand and forearm and is not accompanied by palpable swelling or pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link&amp;anchor=H6#H6\">",
"     \"Major side effects of systemic glucocorticoids\", section on 'Skin and soft tissues'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Psychiatric conditions and malingering",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some cases have been reported in which factitious purpura and psychogenic purpura were the main differential diagnoses [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. Self-induced mutilation can occur in impulse disorders, malingering, and factitious disorders, including Munchausen syndrome.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In impulse disorders, patients fail to resist impulses to scratch themselves.",
"     </li>",
"     <li>",
"      In malingering, illness is feigned or exaggerated for an external incentive",
"     </li>",
"     <li>",
"      In factitious disorder, the sufferer intentionally causes the abnormality in order to gain attention, sympathy, treatment, and comfort from medical personnel [",
"      <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The hemorrhagic presenting profile of patients with factitious bleeding has been termed \"hemorrhagica histrionica\" [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/55\">",
"     55",
"    </a>",
"    ], which reminds one of the histrionic personality disorder, one of the concomitant mental illnesses that may accompany psychogenic purpura.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Munchausen syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most extreme form of the factitious disorders is Munchausen syndrome, in which the patient travels extensively and seeks multiple invasive procedures. The disorder is named after Baron M&uuml;nchhausen, a real person who was portrayed in fiction as a famous teller of tall tales. The prevalence of Munchausen syndrome is relatively low; it is more frequent in men, health care professionals and their relatives, and in those suffering from bipolar disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/21/7512?source=see_link\">",
"     \"Factitious disorder and Munchausen syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In Munchausen syndrome by proxy, bleeding in a child may be induced by a parent or relative and is an insidious form of child abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36104?source=see_link\">",
"     \"Munchausen syndrome by proxy (medical child abuse)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychogenic purpura is a rare condition with a reasonably stereotyped clinical presentation (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Typical episode'",
"    </a>",
"    above). Routine coagulation tests are normal and, although the pathophysiology of the disorder is uncertain, an abnormal psychiatric history is virtually always present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that, in patients with a single episode of bleeding confined to the skin, only the standard tests need to be performed (eg, prothrombin time, activated partial thromboplastin time, complete blood count including platelet count, examination of the peripheral blood smear) plus evaluation for von Willebrand disease. Additional tests that might be considered include the PFA-100 test to rule out a platelet function disorder and a test to rule out presence of the antiphospholipid syndrome (see",
"    <a class=\"local\" href=\"#H11\">",
"     'Diagnosis'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Patients with psychogenic purpura may be difficult to deal with. In particular, they may give partly false or incomplete histories and be noncompliant. A multispecialty approach involving a hematologist, a psychiatrist, and, in the case of suspected vascular purpura, a rheumatologist may be required in order to rule out relevant underlying disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;If psychogenic purpura is the final diagnosis, we suggest referral for psychiatric treatment as the only reasonable therapeutic option (",
"    <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"     Grade 2C",
"    </a>",
"    ). Involvement of family members may also be advisable. Such treatment may result in a favorable outcome, especially in children, adolescents, and those with only a short personal history of this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15048/abstract/17-19,21\">",
"     17-19,21",
"    </a>",
"    ].",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/1\">",
"      GARDNER FH, DIAMOND LK. Autoerythrocyte sensitization; a form of purpura producing painful bruising following autosensitization to red blood cells in certain women. Blood 1955; 10:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/2\">",
"      Ratnoff OD. Psychogenic purpura (autoerythrocyte sensitization): an unsolved dilemma. Am J Med 1989; 87:16N.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/3\">",
"      Ratnoff OD, Agle DP. Psychogenic purpura: a re-evaluation of the syndrome of autoerythrocyte sensitization. Medicine (Baltimore) 1968; 47:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/4\">",
"      Ratnoff OD. The psychogenic purpuras: a review of autoerythrocyte sensitization, autosensitization to DNA, \"hysterical\" and factitial bleeding, and the religious stigmata. Semin Hematol 1980; 17:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/5\">",
"      Uthman IW, Moukarbel GV, Salman SM, et al. Autoerythrocyte sensitization (Gardner-Diamond) syndrome. Eur J Haematol 2000; 65:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/6\">",
"      Zhou L, Kardous A, Weitberg A. Psychogenic purpura. Med Health R I 2001; 84:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/7\">",
"      Klein RF, Gonen JY, Smith CM. Psychogenic purpura in a man. Psychosom Med 1975; 37:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/8\">",
"      Bartralot R, Gonz&aacute;lez-Castro U, Repiso T, Castells Rodellas A. [Autoerythrocyte sensitization syndrome (psychogenic purpura)]. Med Clin (Barc) 1995; 105:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/9\">",
"      Stocker WW, McIntyre OR, Clendenning WE. Psychogenic purpura. Arch Dermatol 1977; 113:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/10\">",
"      Koblenzer PJ, Koblenzer CS. Psychogenic purpura: a most distressing case. Cutis 1990; 45:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/11\">",
"      Lindahl MW. Psychogenic purpura: report of a case. Psychosom Med 1977; 39:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/12\">",
"      Lozano M, Avila JJ, Denia M, Mu&ntilde;oz E. Analysis of the family structure in a case of psychogenic purpura. Gen Hosp Psychiatry 1986; 8:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/13\">",
"      Archer-Dubon C, Orozco-Topete R, Reyes-Gutierrez E. Two cases of psychogenic purpura. Rev Invest Clin 1998; 50:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/14\">",
"      Boussault P, Doutre MS, Beylot-Barry M, et al. [Painful bruising syndrome: a psychogenic disease]. Rev Med Interne 2005; 26:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/15\">",
"      Behrendt C, Goos M, Thiel H, Hengge UR. [Painful bruising syndrome]. Hautarzt 2001; 52:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/16\">",
"      Alvin P. [Gardner-Diamond syndrome and psychogenic purpura. Case report of a 16-year-old adolescent]. Ann Pediatr (Paris) 1988; 35:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/17\">",
"      Anderson JE, DeGoff W, McNamara M. Autoerythrocyte sensitization (psychogenic purpura): a case report and review of the literature. Pediatr Emerg Care 1999; 15:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/18\">",
"      Sorensen RU, Newman AJ, Gordon EM. Psychogenic purpura in adolescent patients. Clin Pediatr (Phila) 1985; 24:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/19\">",
"      Campbell AN, Freedman MH, McClure PD. Autoerythrocyte sensitization. J Pediatr 1983; 103:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/20\">",
"      Puetz J, Fete T. Platelet function disorder in Gardner-Diamond syndrome: a case report and review of the literature. J Pediatr Hematol Oncol 2005; 27:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/21\">",
"      Meeder R, Bannister S. Gardner-Diamond syndrome: Difficulties in the management of patients with unexplained medical symptoms. Paediatr Child Health 2006; 11:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/22\">",
"      Bostwick JM, Imig MW. Gardner-Diamond Syndrome: bruising feeling. Mayo Clin Proc 2008; 83:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/23\">",
"      AGLE DP, RATNOFF OD. Purpura as a psychosomatic entity. A psychiatric study of autoerythrocyte sensitization. Arch Intern Med 1962; 109:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/24\">",
"      Gundogar D, Yuksel Basak P, Baysal Akkaya V, Akarsu O. Autoerythrocyte sensitization syndrome associated with grief complications. J Dermatol 2006; 33:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/25\">",
"      Panconesi E, Hautmann G. Stress, stigmatization and psychosomatic purpuras. Int Angiol 1995; 14:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/26\">",
"      Holoubek JE, Holoubek AB. Blood, sweat and fear. \"A classification of hematidrosis\". J Med 1996; 27:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/27\">",
"      Fisher JG, Kollar EJ. Investigation of a stigmatic. South Med J 1980; 73:1461.",
"     </a>",
"    </li>",
"    <li>",
"     Nickell J. Looking for a miracle: Weeping icons, relics, stigmata, visions and healing cures, Prometheus Books, Buffalo, NY 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/29\">",
"      Mason JW. The scope of psychoendocrine research. Psychosom Med 1968; 30:Suppl:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/30\">",
"      Takada Y, Urano T, Takahashi H, et al. Effects of electric footshock and water immersion restraint stresses on fibrinolytic parameters in the plasma of rats. Thromb Res 1998; 89:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/31\">",
"      Hata T, Kawabata A, Itoh E. Blood coagulation and fibrinolysis in SART-stressed (repeated cold-stressed) rats and drug effects on the altered hemostatic parameters. Jpn J Pharmacol 1991; 56:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/32\">",
"      Lotti T, Benci M, Sarti MG, et al. Psychogenic purpura with abnormally increased tPA dependent cutaneous fibrinolytic activity. Int J Dermatol 1993; 32:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/33\">",
"      Rowell NR. A painful bleeding syndrome associated with increased fibrinolytic activity. Br J Dermatol 1974; 91:591.",
"     </a>",
"    </li>",
"    <li>",
"     Withlock FA. Psychosocial Aspects of Skin Disease, WB Saunders, Philadelphia 1976.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/35\">",
"      Grossman RA. Autoerythrocyte sensitization worsened by a copper-containing IUD. Obstet Gynecol 1987; 70:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/36\">",
"      Gomi H, Miura T. Autoerythrocyte sensitization syndrome with thrombocytosis. Dermatology 1994; 188:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/37\">",
"      Fey MF, Beck EA. Psychogenic purpura, idiopathic thrombocytopenic purpura, and platelet dysfunction in the same patient. J Clin Psychiatry 1986; 47:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/38\">",
"      Sudy E, Urbina F, Vasquez P. Autoerythrocyte sensitization syndrome with positive anticardiolipin antibodies. Br J Dermatol 1998; 138:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/39\">",
"      Scott JP, Schiff DW, Githens JH. The autoerythrocyte sensitization syndrome as the primary manifestation of systemic lupus erythematosus. J Pediatr 1981; 99:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/40\">",
"      Verstraete M. [Psychogenic hemorrhages]. Verh K Acad Geneeskd Belg 1991; 53:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/41\">",
"      Ingen-Housz-Oro S, Viguier M, Guitera-Rovel P, et al. [Painful bruising syndrome mimicking cellulitis of the leg]. Ann Dermatol Venereol 2002; 129:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/42\">",
"      Karatosun V, Sato��lu S, G&uuml;nal I, Alptekin K. Autoerythrocyte sensitization (Gardner-Diamond) syndrome mimicking compartment syndrome. Arch Orthop Trauma Surg 2003; 123:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/43\">",
"      Kaufman RJ, Dorner AJ, Fass DN. von Willebrand factor elevates plasma factor VIII without induction of factor VIII messenger RNA in the liver. Blood 1999; 93:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/44\">",
"      Weinrieb RM, Auriacombe M, Lynch KG, Lewis JD. Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin Drug Saf 2005; 4:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/45\">",
"      Nelva A, Guy C, Tardy-Poncet B, et al. [Hemorrhagic syndromes related to selective serotonin reuptake inhibitor (SSRI) antidepressants. Seven case reports and review of the literature]. Rev Med Interne 2000; 21:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/46\">",
"      Ottervanger JP, Stricker BH, Huls J, Weeda JN. Bleeding attributed to the intake of paroxetine. Am J Psychiatry 1994; 151:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/47\">",
"      Dickinson T, Malhi S, Painter S, et al. Association between SSRIs and upper gastrointestinal bleeding. Self treatment with non-steroidal drugs may be confounding factor. BMJ 2000; 320:1406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/48\">",
"      Serebruany VL. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? Am J Med 2006; 119:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/49\">",
"      Schalekamp T, Klungel OH, Souverein PC, de Boer A. Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/50\">",
"      Tielens JA. Vitamin C for paroxetine- and fluvoxamine-associated bleeding. Am J Psychiatry 1997; 154:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/51\">",
"      Auer J, Berent R, Weber T, et al. Subarachnoid haemorrhage with \"Ecstasy\" abuse in a young adult. Neurol Sci 2002; 23:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/52\">",
"      DAVIDSON E. FACTITIOUS PURPURA PRESENTING AS AUTOERYTHROCYTE SENSITIZATION. Br Med J 1964; 1:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/53\">",
"      Levin RM, Chodosh R, Sherman JD. Factitious purpura simulating autoerythrocyte sensitization. Ann Intern Med 1969; 70:1201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/54\">",
"      Yates VM. Factitious purpura. Clin Exp Dermatol 1992; 17:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/55\">",
"      ASHER R. Munchausen's syndrome. Lancet 1951; 1:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15048/abstract/56\">",
"      Clark GD, Key JD, Rutherford P, Bithoney WG. Munchausen's syndrome by proxy (child abuse) presenting as apparent autoerythrocyte sensitization syndrome: an unusual presentation of Polle syndrome. Pediatrics 1984; 74:1100.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1343 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-7EC3A6EE76-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15048=[""].join("\n");
var outline_f14_44_15048=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Bleeding episodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Concomitant psychiatric conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Religious stigmata",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Response to stress",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Increased fibrinolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Autoerythrocyte sensitization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Other mechanisms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Typical episode",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Red cell sensitization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Rare bleeding disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Inherited bleeding disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - von Willebrand disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Factor XIII deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Vascular purpuras",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Drug intake",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - SSRIs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Illicit drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Steroids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Psychiatric conditions and malingering",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Munchausen syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/1343\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/1343|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/6/40046\" title=\"picture 1\">",
"      Gardner Diamond syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/4/24650?source=related_link\">",
"      Acquired inhibitors of coagulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1530?source=related_link\">",
"      An overview of amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=related_link\">",
"      Approach to the adult patient with a bleeding diathesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/19/15674?source=related_link\">",
"      Approach to the adult patient with thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/56/2953?source=related_link\">",
"      Clinical manifestations and treatment of the hypermobility syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/31/23034?source=related_link\">",
"      Clinical manifestations of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24794?source=related_link\">",
"      Clinical presentation and diagnosis of von Willebrand disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/9/29850?source=related_link\">",
"      Congenital and acquired disorders of platelet function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/21/7512?source=related_link\">",
"      Factitious disorder and Munchausen syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31226?source=related_link\">",
"      Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30614?source=related_link\">",
"      Hypersensitivity vasculitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36104?source=related_link\">",
"      Munchausen syndrome by proxy (medical child abuse)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38040?source=related_link\">",
"      Osteogenesis imperfecta: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/62/28650?source=related_link\">",
"      Overview of water-soluble vitamins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/21/16730?source=related_link\">",
"      Rare (recessively inherited) coagulation disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=related_link\">",
"      Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_44_15049="Intermittent explosive disorder in adults: Epidemiology, clinical features, assessment, and diagnosis";
var content_f14_44_15049=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Intermittent explosive disorder in adults: Epidemiology, clinical features, assessment, and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/44/15049/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/44/15049/contributors\">",
"     Emil Coccaro, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/44/15049/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/44/15049/contributors\">",
"     Susan McElroy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/44/15049/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/44/15049/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/44/15049/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H3220771\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with intermittent explosive disorder are periodically unable to restrain aggressive impulses and thus repeatedly assault others or destroy property [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The aggressive behavior is unplanned and grossly exceeds the response that is justified by the precipitant.",
"   </p>",
"   <p>",
"    This topic reviews the epidemiology, pathogenesis, clinical features, assessment, and diagnosis of intermittent explosive disorder. Treatment and prognosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26760?source=see_link\">",
"     \"Intermittent explosive disorder in adults: Treatment and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4226703\">",
"    <span class=\"h1\">",
"     AGGRESSIVE BEHAVIOR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aggression is defined as goal-directed motor behavior that is intended to harm or injure another person or object [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/4\">",
"     4",
"    </a>",
"    ]. Aggressive behavior can be classified by the [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Target &ndash; others, self, or property",
"     </li>",
"     <li>",
"      Mode &ndash; physical or verbal",
"     </li>",
"     <li>",
"      Degree of planning &ndash; impulsive (unplanned) or premeditated (predatory)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Impulsive aggression and premeditated aggression are both commonly pathologic, whereas defensive aggression, provoked by an immediate threat, is normal. Impulsive, aggressive behavior is the core feature of intermittent explosive disorder, but can also occur in psychotic, mood, personality, and general medical disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The differential diagnosis of impulsive aggression is discussed separately. (See",
"    <a class=\"local\" href=\"#H86451841\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Predicting future aggressive behavior is difficult; the best predictor may be past violence [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/6\">",
"     6",
"    </a>",
"    ]. Assessing prior aggressive behavior is discussed separately. (See",
"    <a class=\"local\" href=\"#H86453904\">",
"     'Assessment'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86453168\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimates of the lifetime prevalence of intermittent explosive disorder range from 1 to 7 percent, depending upon the study population [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86453175\">",
"    <span class=\"h2\">",
"     General population",
"    </span>",
"    &nbsp;&mdash;&nbsp;Large, nationally representative surveys of the general adult population in different countries estimate that the lifetime prevalence of intermittent explosive disorder is 1 to 5 percent (",
"    <a class=\"graphic graphic_table graphicRef67143 \" href=\"UTD.htm?25/51/26428\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/7,9-11\">",
"     7,9-11",
"    </a>",
"    ]. The estimated 12-month prevalence ranges from 1 to 3 percent, and the 1-month prevalence is approximately 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/7,9,10,12-14\">",
"     7,9,10,12-14",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4516567\">",
"    <span class=\"h3\">",
"     Sociodemographic correlates",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mean age of onset of intermittent explosive disorder is approximately 14 to 18 years [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/7,9-12\">",
"     7,9-12",
"    </a>",
"    ]. Epidemiologic studies show that the disorder occurs significantly more often in males and younger individuals (eg, age &lt;50 to 65 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/7,9-11,13\">",
"     7,9-11,13",
"    </a>",
"    ]. However, it is not clear if the disorder is associated with a specific marital or occupational status, or level of education or income. &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86453182\">",
"    <span class=\"h2\">",
"     Clinical settings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The estimated lifetime prevalence of intermittent explosive disorder in psychiatric patients is 6 to 7 percent, and the point (current) prevalence is 3 to 6 percent:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study of 1300 outpatients found that the lifetime prevalence of intermittent explosive disorder was 6 percent and the point prevalence was 3 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/15\">",
"       15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A study of 204 inpatients found that the lifetime prevalence of intermittent explosive disorder was 7 percent and the point prevalence was 6 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/8\">",
"       8",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86453196\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of intermittent explosive disorder is not known. Many authorities think that the etiology involves biologic, psychological, and social factors [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/5,16\">",
"     5,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4516858\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is probably a genetic component to intermittent explosive disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/17-21\">",
"     17-21",
"    </a>",
"    ]. A study using blinded raters found a positive family history of intermittent explosive disorder in significantly more first-degree relatives (parents, siblings, or offspring) of patients with the disorder (N = 32) than in relatives of nonaggressive controls (N = 32) (34 versus 10 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/22\">",
"     22",
"    </a>",
"    ]. In addition, twin and family studies suggest that 44 to 72 percent of the likelihood of developing impulsive aggressive behavior is genetic [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/5\">",
"     5",
"    </a>",
"    ]. This is consistent with a meta-analysis of 24 twin and adoption studies of aggression (number of subjects not specified), which found that genetic factors accounted for roughly 50 percent of the variance in aggression [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86453203\">",
"    <span class=\"h2\">",
"     Neurobiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impulsive aggressive behavior has been conceptualized as an imbalance between excessive, aggressive drives originating in limbic brain structures such as the amygdala, and insufficient control of these impulses by cortical structures such as the orbital frontal cortex and anterior cingulate cortex [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/5\">",
"     5",
"    </a>",
"    ]. Support for this hypothesis includes a functional magnetic resonance imaging study that presented photographs of angry faces to 10 patients with intermittent explosive disorder and 10 healthy controls [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/24\">",
"     24",
"    </a>",
"    ]. Compared with controls, patients exhibited increased activation of the amygdala and reduced activation of the orbitofrontal cortex.",
"   </p>",
"   <p>",
"    On a molecular level, studies suggest that serotonergic activity in patients with intermittent explosive disorder is reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/5,25,26\">",
"     5,25,26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A positron emission tomography study found significantly less serotonergic innervation in the anterior cingulate cortex in 10 patients with intermittent explosive disorder, compared with 10 healthy controls [",
"      <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/27\">",
"       27",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A study examined the number of platelet serotonin binding sites as a proxy for central nervous system serotonin activity, and found significantly fewer binding sites in 35 patients with intermittent explosive disorder compared with 65 controls [",
"      <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/28\">",
"       28",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A study found that response to a single dose of the serotonin releasing agent dexfenfluramine was significantly reduced in 62 patients with intermittent explosive disorder compared with 38 controls [",
"      <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/29\">",
"       29",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4516945\">",
"    <span class=\"h2\">",
"     Psychosocial factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Family environment and exposure to multiple traumas may be involved in the pathogenesis of intermittent explosive disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/5,23\">",
"     5,23",
"    </a>",
"    ]. A community survey found that intermittent explosive disorder was significantly associated with being a crime victim, exposure to six or more traumatic events, and trauma to a significant other [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3220792\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intermittent explosive disorder is one of several impulse control disorders that are marked by an inability to resist a drive or temptation that is harmful to the patient or others [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/2,30\">",
"     2,30",
"    </a>",
"    ]. Patients with intermittent explosive disorder are periodically unable to restrain aggressive impulses and thus repeatedly assault others or destroy property [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The aggressive behavior is unplanned and grossly exceeds the response that is justified by the precipitant.",
"   </p>",
"   <p>",
"    The violent outbursts that characterize intermittent explosive disorder are generally preceded by a brief prodrome. The initial impulse to strike out typically occurs in response to a minor provocation by someone close to the patient [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/17,31\">",
"     17,31",
"    </a>",
"    ]. The impulse is usually accompanied by an increasing sense of tension or arousal that progresses quickly [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/2,17,31,32\">",
"     2,17,31,32",
"    </a>",
"    ]. Irritability, rage, increased energy, racing thoughts, poor communication, and inefficient information processing can occur, along with somatic symptoms such as paresthesias, tremor, palpitations, and chest tightness [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/33\">",
"     33",
"    </a>",
"    ]. Little or no thought is given to the consequences of the violent behavior, which occurs &ldquo;all of a sudden.&rdquo;",
"   </p>",
"   <p>",
"    The impulsive aggressive behavior consists of one or more of the following [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physically striking others &ndash; Ranges from low intensity (eg, shove or slap) to high intensity (eg, fistfights or using a weapon against someone)",
"     </li>",
"     <li>",
"      Verbal outbursts, arguments, and threats to physically assault others &ndash; Generally occurs during temper tantrums or heated arguments that are marked by shouting and loss of control",
"     </li>",
"     <li>",
"      Destruction of property &ndash; Breaking objects or injuring an animal",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The explosive outbursts typically last less than 30 minutes and immediately afterwards, patients may feel a sense of relief [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/17\">",
"     17",
"    </a>",
"    ]. Ensuing feelings commonly include fatigue, dysphoria, regret, and embarrassment. &nbsp;",
"   </p>",
"   <p>",
"    An epidemiologic study found that among 463 individuals with intermittent explosive disorder, 68 percent had physically struck someone during some of their anger attacks, 21 percent had threatened but not perpetrated interpersonal violence during some of their explosive outbursts, and 11 percent had broken objects but never physically harmed anyone or threatened interpersonal violence [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequency of impulsive, aggressive episodes may depend upon their specific nature. Aggressive behavior that consists of physically assaulting others or destroying property may be isolated and occur as few as three times per year [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1,9\">",
"     1,9",
"    </a>",
"    ]. However, verbal aggression and threats against others that occurs twice weekly on average for at least one month also qualifies for a diagnosis of IED [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1\">",
"     1",
"    </a>",
"    ]. An epidemiologic study found that among 463 patients with intermittent explosive disorder, the mean number of physical and verbal outbursts at the height of the illness was 28 per year [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Signs of generalized aggressiveness may occur in between explosive episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/9,17,32\">",
"     9,17,32",
"    </a>",
"    ]. Patients with intermittent explosive disorder may experience chronic anger as well as subthreshold incidents in which patients either resist aggressive impulses or behave less aggressively than usual (eg, briefly scream or punch a wall without damaging it or harming themselves).",
"   </p>",
"   <p>",
"    Cognitive deficits may occur in intermittent explosive disorder. One study found that impulsive, aggressive male prisoners scored significantly lower on tests of attention, concentration, memory, and intelligence compared with non-aggressive, non-inmate controls matched for age, race, and education [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intermittent explosive disorder is usually associated with psychosocial impairment, including interpersonal difficulties, divorce, school suspension, job loss, and financial problems [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/9,12,17,35\">",
"     9,12,17,35",
"    </a>",
"    ]. Other adverse consequences include hospitalization because of injuries suffered in fights, legal charges, and incarceration. In an epidemiologic study of 230 patients, 40 percent reported severe functional impairment in the prior 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5267627\">",
"    <span class=\"h2\">",
"     Suicidal and self-injurious behavior",
"    </span>",
"    &nbsp;&mdash;&nbsp;Self-directed aggression such as suicide attempts and nonsuicidal self-injurious behavior (eg, superficial cutting with razor blades or burning with cigarettes) can occur in patients with intermittent explosive disorder. An observational study found that a history of attempted suicide was reported by significantly more patients (N = 76) than controls (N = 112) (21 versus 7 percent), as was a history of self-injurious behavior (9 versus 2 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/36\">",
"     36",
"    </a>",
"    ]. A second study of 376 patients found a history of attempted suicide in 13 percent and self-injurious behavior in 7 percent; self-directed aggression was significantly more common in females and patients with a lifetime history of unipolar major depressive disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/37\">",
"     37",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H93016713\">",
"    <span class=\"h1\">",
"     COMORBIDITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comorbidity is common in intermittent explosive disorder. However, intermittent explosive disorder is not diagnosed if the impulsive, aggressive behavior occurs only in the context of a different, active psychiatric disorder or an active general medical disorder; the exception is that intermittent explosive disorder is diagnosed if the aggressive behavior occurs in the context of a personality disorder (eg, borderline personality disorder or antisocial personality disorder) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H93016750\">",
"    <span class=\"h2\">",
"     Psychiatric disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with intermittent explosive disorder generally have a lifetime history of other psychiatric disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/15,17\">",
"     15,17",
"    </a>",
"    ]. Onset of intermittent explosive disorder usually precedes onset of the comorbid psychopathology [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/9,12,15\">",
"     9,12,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An epidemiologic study of 162 patients with a lifetime diagnosis of intermittent explosive disorder found that at least one other lifetime psychiatric disorder occurred in 82 percent of the patients, and that three or more other lifetime psychiatric disorders occurred in 48 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/9\">",
"     9",
"    </a>",
"    ]. Comorbidities included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Unipolar major depressive disorder &ndash; 37 percent of patients with intermittent explosive disorder",
"     </li>",
"     <li>",
"      Alcohol abuse &ndash; 33 percent",
"     </li>",
"     <li>",
"      Drug abuse &ndash; 22 percent",
"     </li>",
"     <li>",
"      Social phobia &ndash; 28 percent",
"     </li>",
"     <li>",
"      Specific phobia &ndash; 24 percent",
"     </li>",
"     <li>",
"      Generalized anxiety disorder &ndash; 19 percent",
"     </li>",
"     <li>",
"      Posttraumatic stress disorder &ndash; 15 percent",
"     </li>",
"     <li>",
"      Oppositional defiant disorder &ndash; 25 percent",
"     </li>",
"     <li>",
"      Conduct disorder &ndash; 24 percent",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Attention-deficit/hyperactivity",
"      </span>",
"      disorder &ndash; 20 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The prevalence of these comorbid disorders among individuals with intermittent explosive disorder is significantly greater than the overall rates that are found in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/9\">",
"     9",
"    </a>",
"    ]. As an example, the estimated lifetime prevalence of unipolar major depression in the general population is 23 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many patients with intermittent explosive disorder may also have bipolar disorder. As an example, a study of 27 patients with intermittent explosive disorder found that 52 percent had a lifetime diagnosis of bipolar disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/17\">",
"     17",
"    </a>",
"    ]. The co-occurrence of intermittent explosive disorder and bipolar disorder has been obscured in many epidemiologic studies because patients with bipolar disorder were not permitted to receive a diagnosis of intermittent explosive disorder, due to the symptomatic overlap between the two conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/9,12\">",
"     9,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with intermittent explosive disorder who are treated in clinical settings may have higher rates of comorbid psychopathology than individuals with intermittent explosive disorder who are identified in the general population. An observational study of 82 clinic patients with a lifetime diagnosis of intermittent explosive disorder found that a lifetime comorbid substance use disorder occurred in 60 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/15\">",
"     15",
"    </a>",
"    ]. By contrast, an epidemiologic study identified 162 individuals with a lifetime diagnosis of intermittent explosive disorder, and found that a lifetime comorbid substance use disorder occurred in 35 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H93016757\">",
"    <span class=\"h2\">",
"     General medical disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intermittent explosive disorder appears to be associated with physical health problems. In an epidemiologic study, several general medical disorders were significantly more prevalent in 929 individuals with a lifetime history of intermittent explosive disorder than in 9437 individuals without intermittent explosive disorder, including [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/39\">",
"     39",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hypertension",
"     </li>",
"     <li>",
"      Diabetes",
"     </li>",
"     <li>",
"      Coronary heart disease",
"     </li>",
"     <li>",
"      Stroke",
"     </li>",
"     <li>",
"      Arthritis",
"     </li>",
"     <li>",
"      Peptic ulcers",
"     </li>",
"     <li>",
"      Headaches",
"     </li>",
"     <li>",
"      Chronic pain",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86453904\">",
"    <span class=\"h1\">",
"     ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial assessment for intermittent explosive disorder includes a psychiatric history and mental status examination, with emphasis upon aggressive impulses and behavior. In addition, the evaluation includes a general medical history, physical examination, and focused laboratory tests [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. The clinician should be alert for psychiatric and general medical disorders that may entirely account for any impulsive aggressive behavior and thus exclude the diagnosis of intermittent explosive disorder, as well as disorders that are often comorbid with intermittent explosive disorder. The differential diagnosis and comorbidity of intermittent explosive disorder are discussed separately. (See",
"    <a class=\"local\" href=\"#H86451841\">",
"     'Differential diagnosis'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H93016713\">",
"     'Comorbidity'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The psychiatric history taken from the patient and available informants (especially family members) should address the following [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1,42,43\">",
"     1,42,43",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Episodes of aggressive behavior, including the specific behavior and its frequency and severity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Physically assaulting others (eg, threatening gestures or striking someone)",
"     </li>",
"     <li>",
"      Verbal aggression (verbal outbursts, arguments, and threatening to physically assault others)",
"     </li>",
"     <li>",
"      Destroying property (breaking things or injuring an animal)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antecedents to aggressive behavior",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Situations, behaviors, emotions, and cognitions that triggered the aggressive behavior",
"     </li>",
"     <li>",
"      Whether the provocation justifies the impulsive aggression (ie, was the explosive outburst grossly out of proportion to the precipitant)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Planning for behavior",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Whether the aggression was impulsive (unplanned and without regard to consequences) or premeditated",
"     </li>",
"     <li>",
"      Whether the aggression was intended to achieve an objective (eg, sex, money, or power)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Consequences of aggressive behavior, including job loss, disruption of interpersonal relationships, hospitalization for injuries, legal charges, and incarceration",
"     </li>",
"     <li>",
"      Lifetime chronology of impulsive aggressive behavior",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Age of onset",
"     </li>",
"     <li>",
"      Periods of remission",
"     </li>",
"     <li>",
"      Prior efforts to control aggression",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intensity and duration of generalized aggressiveness (eg, externally directed anger) between explosive outbursts",
"     </li>",
"     <li>",
"      Subjective distress",
"     </li>",
"     <li>",
"      Psychosocial impairment (eg, occupational and interpersonal functioning)",
"     </li>",
"     <li>",
"      Suicidal thoughts, suicide attempts, and nonsuicidal self injurious behavior such as head banging, superficial cutting, or burning",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    No self-report instrument is available to screen for intermittent explosive disorder or to assess response to treatment. Although there are two clinician-administered instruments (The Module for the Diagnosis of Intermittent Explosive Disorder and a module of the Minnesota Impulse Disorders Interview), these are typically used in research settings rather than routine clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/8,29,42\">",
"     8,29,42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86451820\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend that clinicians diagnose intermittent explosive disorder using research criteria (",
"    <a class=\"graphic graphic_table graphicRef65924 \" href=\"UTD.htm?42/28/43467\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. These criteria reliably identify patients with recurrent, clinically meaningful impulsive aggression and are widely used [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1,7,9,12,13,36\">",
"     1,7,9,12,13,36",
"    </a>",
"    ]. One review found that lifetime history of aggression, impulsivity, family history of the disorder, and several biologic markers were greater in patients with research criteria intermittent explosive disorder, compared to individuals without the disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/3\">",
"     3",
"    </a>",
"    ]. The essential criteria are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Recurrent episodes of physically assaulting others, verbally threatening to assault others, verbal outbursts, arguments, and destroying property",
"     </li>",
"     <li>",
"      Aggressive behavior is impulsive (unplanned)",
"     </li>",
"     <li>",
"      Aggressive behavior is grossly out of proportion to the provocation",
"     </li>",
"     <li>",
"      Marked subjective distress or psychosocial impairment",
"     </li>",
"     <li>",
"      Aggression is not accounted for by another disorder",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Intermittent explosive disorder is not diagnosed if the impulsive, aggressive behavior occurs only in the context of a different, active psychiatric disorder (eg, schizophrenia, schizoaffective disorder, unipolar major depressive disorder, bipolar disorder, substance intoxication, or autistic disorder) or a general medical disorder (eg, dementia, delirium, or temporal lobe epilepsy) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1\">",
"     1",
"    </a>",
"    ]. The exception is that intermittent explosive disorder is diagnosed if the impulsive aggressive behavior occurs in the context of personality disorders (eg, borderline personality disorder or antisocial personality disorder).",
"   </p>",
"   <p>",
"    The research criteria for intermittent explosive disorder are more reliable and valid than other criteria sets, including the criteria specified in the American Psychiatric Association&rsquo;s Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSM-IV-TR) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1-3,35,36,44\">",
"     1-3,35,36,44",
"    </a>",
"    ]. Among other problems, the DSM-IV-TR criteria lack specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/2\">",
"     2",
"    </a>",
"    ]. As an example, one DSM-IV-TR criterion is: &ldquo;Several discrete episodes of failure to resist aggressive impulses that result in serious assaultive acts or destruction of property.&rdquo; It is not clear what constitutes &ldquo;several,&rdquo; nor does the criterion specify a time frame or frequency for the episodes.",
"   </p>",
"   <p>",
"    The World Health Organization&rsquo;s International Classification of Diseases &ndash; 10",
"    <sup>",
"     th",
"    </sup>",
"    Revision (ICD-10) does not specify diagnostic criteria for intermittent explosive disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/45\">",
"     45",
"    </a>",
"    ]. Rather, ICD-10 simply mentions the disorder as an example of &ldquo;Other Habit and Impulse Disorders;&rdquo; these are marked by repeated failure to resist impulses to carry out maladaptive behavior that is not secondary to another psychiatric syndrome, as well as a prodromal period of tension and a feeling of release at the time of the behavior.",
"   </p>",
"   <p>",
"    The psychopathology encompassed by intermittent explosive disorder has previously been labelled episodic dyscontrol [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/46\">",
"     46",
"    </a>",
"    ], explosive personality [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/47\">",
"     47",
"    </a>",
"    ], and passive-aggressive personality, aggressive type [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86451841\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent, impulsive aggressive behavior can occur in psychiatric and general medical disorders other than intermittent explosive disorder. Intermittent explosive disorder is not diagnosed if the impulsive, aggressive behavior occurs only in the context of a different, active psychiatric disorder or general medical disorder, with the exception that intermittent explosive disorder is diagnosed if the aggressive behavior occurs in the context of a personality disorder (eg, borderline personality disorder or antisocial personality disorder) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, some psychiatric disorders that resemble intermittent explosive disorder may be comorbid with intermittent explosive disorder. (See",
"    <a class=\"local\" href=\"#H93016750\">",
"     'Psychiatric disorders'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Other disorders that can give rise to impulsive aggressive behavior are differentiated from intermittent explosive disorder as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Schizophrenia and schizoaffective disorder",
"      </strong>",
"      &ndash; Schizophrenia and schizoaffective disorder may cause paranoid delusions and command auditory hallucinations that can lead to aggressive behavior. By contrast, intermittent explosive disorder does not present with delusions and hallucinations, nor other signs of psychosis (eg, disorganized speech and behavior and affective flattening). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/47/34552?source=see_link&amp;anchor=H17284630#H17284630\">",
"       \"Schizophrenia: Clinical manifestations, course, assessment, and diagnosis\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Unipolar major depressive disorder",
"      </strong>",
"      &ndash; Unipolar major depressive disorder and intermittent explosive disorder may both present with dysphoria (including irritability), guilt, and suicidal ideation and behavior. However, major depression usually includes anergia, anhedonia, sleep disturbance, and psychomotor retardation, which are generally not observed in intermittent explosive disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link\">",
"       \"Clinical manifestations and diagnosis of depression\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Bipolar disorder",
"      </strong>",
"      &ndash; Irritability, increased energy, and racing thoughts may be seen in both bipolar disorder and intermittent explosive disorder; in particular, the rage episodes of intermittent explosive disorder often resemble hypomania. However, mania and hypomania can be distinguished by the presence of increased goal directed activity, euphoria, inflated self-esteem, decreased need for sleep, and pressured speech, which are generally not observed in intermittent explosive disorder. In addition, the aggressive episodes of intermittent explosive disorder generally last minutes to hours, whereas hypomanic and manic episodes generally last days to months. Bipolar major depression is distinguished by anergia, anhedonia, sleep disturbance, and psychomotor retardation; these symptoms usually do not occur in intermittent explosive disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link&amp;anchor=H5#H5\">",
"       \"Bipolar disorder in adults: Epidemiology and diagnosis\", section on 'Mania'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link&amp;anchor=H7#H7\">",
"       \"Bipolar disorder in adults: Epidemiology and diagnosis\", section on 'Depression'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Substance intoxication",
"      </strong>",
"      &ndash; Alcohol and phencyclidine intoxication can present with nystagmus and amphetamine and cocaine intoxication can present with pupillary dilation; these ocular signs are not generally seen in intermittent explosive disorder. More so, drug tests can detect each of these substances. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=see_link&amp;anchor=H17#H17\">",
"       \"Substance use disorders: Principles for recognition and assessment in general medical care\", section on 'Drug testing'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       <strong>",
"        Attention-deficit/hyperactivity",
"       </strong>",
"      </span>",
"      disorder",
"      &ndash;",
"      <span class=\"nowrap\">",
"       Attention-deficit/hyperactivity",
"      </span>",
"      disorder (ADHD) in adults is distinguished by the presence of hyperactivity, poor attention, inability to complete tasks, and disorganization, which are generally not observed in intermittent explosive disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32761?source=see_link&amp;anchor=H4#H4\">",
"       \"Adult attention deficit hyperactivity disorder\", section on 'Clinical features and diagnostic criteria'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Autistic disorder",
"      </strong>",
"      &ndash; Autistic disorder is characterized by impairments in social interaction (eg, failure to develop peer relationships and lack of social or emotional reciprocity), communication (eg, stereotyped or idiosyncratic language), and behavior (eg, stereotyped and repetitive motor mannerisms), which are generally not observed in intermittent explosive disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38969?source=see_link&amp;anchor=H11#H11\">",
"       \"Diagnosis of autism spectrum disorders\", section on 'Autistic disorder'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      <strong>",
"       Antisocial personality disorder",
"      </strong>",
"      &ndash; Intermittent explosive disorder and antisocial personality disorder are both more prevalent in males than females. However, antisocial personality disorder is distinguished by the presence of a pervasive pattern of breaking laws (eg, stealing), deceiving others (lying, using aliases, or conning others for profit), chronic irresponsibility (eg, not honoring financial obligations), and lack of remorse; these traits are not characteristic of intermittent explosive disorder. In addition, the aggressive behavior in antisocial personality disorder is often premeditated, which is not the case in intermittent explosive disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/26/42409?source=see_link\">",
"       \"Antisocial personality disorder: Epidemiology, clinical manifestations, course and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Borderline personality disorder",
"      </strong>",
"      &ndash; Suicide attempts and nonsuicidal self-injurious behavior can occur in both borderline personality disorder and intermittent explosive disorder. However, borderline personality disorder is more prevalent in females in clinical settings, whereas intermittent explosive disorder is more prevalent in males. In addition, borderline personality disorder is marked by a pervasive pattern of chronic feelings of emptiness, frantic efforts to avoid abandonment, and unstable interpersonal relationships that alternate between extremes of idealization and devaluation; these features are not characteristic of intermittent explosive disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/19/10553?source=see_link&amp;anchor=H16#H16\">",
"       \"Borderline personality disorder: Epidemiology, clinical features, diagnosis, and differential diagnosis\", section on 'Diagnosis'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      <strong>",
"       General medical disorders",
"      </strong>",
"      &ndash; Aggressive behavior can occur in general medical disorders, which are differentiated from intermittent explosive disorder as follows:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <strong>",
"       Dementia",
"      </strong>",
"      impairs memory and other cognitive functions and interferes with occupational and social functioning to a degree that generally exceeds what is found in patients with intermittent explosive disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/25/28057?source=see_link&amp;anchor=H2#H2\">",
"       \"Evaluation of cognitive impairment and dementia\", section on 'Definition of dementia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Delirium",
"      </strong>",
"      is characterized by a disturbance of consciousness and attention that usually develops over hours to days and tends to fluctuate during the course of the day; a change in cognition or the development of a perceptual disturbance that is not better accounted for by dementia; and evidence from the history, physical examination, or laboratory findings that the disturbance is caused by a medical condition, substance intoxication, or medication side effect. These features are not characteristic of intermittent explosive disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39081?source=see_link&amp;anchor=H2#H2\">",
"       \"Diagnosis of delirium and confusional states\", section on 'Definition and terminology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Temporal lobe epilepsy",
"      </strong>",
"      is marked by a seizure aura or a simple partial seizure with sensory symptoms, behavioral arrest and staring, automatisms (ie, repetitive, stereotyped, and purposeless movements), and temporal sharp waves on the electroencephalogram (EEG); these findings are not characteristic of intermittent explosive disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/1/23578?source=see_link&amp;anchor=H8#H8\">",
"       \"Localization-related (partial) epilepsy: Causes and clinical features\", section on 'Mesial temporal lobe epilepsy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, intermittent explosive disorder is distinguished from purposeful, premeditated aggressive behavior that is intended to achieve an objective (eg, sex, money, or power) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/44/15049/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3220848\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intermittent explosive disorder is characterized by recurrent, impulsive aggressive behavior that is distinguished from both premeditated aggression as well as defensive aggression provoked by an immediate threat. (See",
"      <a class=\"local\" href=\"#H4226703\">",
"       'Aggressive behavior'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Epidemiologic surveys of the general adult population estimate that the lifetime prevalence of intermittent explosive disorder is 1 to 5 percent (",
"      <a class=\"graphic graphic_table graphicRef67143 \" href=\"UTD.htm?25/51/26428\">",
"       table 1",
"      </a>",
"      ); the prevalence in psychiatric patients is 6 to 7 percent. The mean age of onset is approximately 14 to 18 years, and the disorder occurs more often in males and individuals aged less than 50 to 65 years. (See",
"      <a class=\"local\" href=\"#H86453168\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although the pathogenesis of intermittent explosive disorder is not known, there appears to be a genetic component. (See",
"      <a class=\"local\" href=\"#H86453196\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with intermittent explosive disorder are periodically unable to restrain aggressive impulses and thus repeatedly assault others or destroy property. The explosive outbursts are unplanned and grossly exceed the response that is justified by the precipitant. Physical assaults of others or destruction of property may occur as few as three times per year, whereas aggressive behavior that includes verbal threats to assault others occurs twice weekly on average for at least one month. Suicide attempts and nonsuicidal self-injurious behavior can also occur. (See",
"      <a class=\"local\" href=\"#H3220792\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with intermittent explosive disorder generally have a lifetime history of other psychiatric disorders; the most common are unipolar major depressive disorder, alcohol abuse, drug abuse, social phobia, specific phobia, generalized anxiety disorder, posttraumatic stress disorder, oppositional defiant disorder, conduct disorder, and",
"      <span class=\"nowrap\">",
"       attention-deficit/hyperactivity",
"      </span>",
"      disorder. Comorbid bipolar disorder may occur as well. (See",
"      <a class=\"local\" href=\"#H93016750\">",
"       'Psychiatric disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intermittent explosive disorder may be associated with general medical disorders, including hypertension, diabetes, coronary heart disease, stroke, arthritis, peptic ulcers, headaches, and chronic pain. (See",
"      <a class=\"local\" href=\"#H93016757\">",
"       'General medical disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The evaluation for intermittent explosive disorder includes a psychiatric and general medical history, mental status and physical examination, and focused laboratory tests. The assessment should address episodes of impulsive aggressive behavior, whether the aggression was unplanned and grossly out of proportion to the provocation, consequences of aggressive behavior, signs of generalized aggressiveness between explosive episodes, psychosocial functioning, and suicidal thoughts and history of suicide attempts. (See",
"      <a class=\"local\" href=\"#H86453904\">",
"       'Assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of intermittent explosive disorder is summarized in the table (",
"      <a class=\"graphic graphic_table graphicRef65924 \" href=\"UTD.htm?42/28/43467\">",
"       table 2",
"      </a>",
"      ). Intermittent explosive disorder is not diagnosed if the impulsive, aggressive behavior occurs only in the context of a different, active psychiatric or general medical disorder, with the exception that intermittent explosive disorder is diagnosed if the aggressive behavior occurs in the context of a personality disorder. (See",
"      <a class=\"local\" href=\"#H86451820\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Recurrent impulsive, aggressive behavior can occur in many disorders. The differential diagnosis of intermittent explosive disorder includes schizophrenia, schizoaffective disorder, unipolar major depressive disorder, bipolar disorder, substance intoxication, attention",
"      <span class=\"nowrap\">",
"       deficit/hyperactivity",
"      </span>",
"      disorder, autistic disorder, antisocial personality disorder, borderline personality disorder, and general medical disorders such as dementia, delirium, and temporal lobe epilepsy. (See",
"      <a class=\"local\" href=\"#H86451841\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/1\">",
"      Coccaro EF. Intermittent explosive disorder: development of integrated research criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Compr Psychiatry 2011; 52:119.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, American Psychiatric Association, Washington, DC, 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/3\">",
"      Coccaro EF. Intermittent Explosive Disorder as a Disorder of Impulsive Aggression for DSM-5. Am J Psychiatry 2012; 169:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/4\">",
"      Jones RM, Arlidge J, Gillham R, et al. Efficacy of mood stabilisers in the treatment of impulsive or repetitive aggression: systematic review and meta-analysis. Br J Psychiatry 2011; 198:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/5\">",
"      Siever LJ. Neurobiology of aggression and violence. Am J Psychiatry 2008; 165:429.",
"     </a>",
"    </li>",
"    <li>",
"     Suris A, Coccaro E. Aggression measures. In: Handbook of Psychiatric Measures, Second Edition, Rush Jr AJ, First MB, Blacker D.  (Eds), American Psychiatric Publishing, Inc, Washington, DC 2008. p.731.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/7\">",
"      Yoshimasu K, Kawakami N, WMH-J 2002-2006 Survey Group. Epidemiological aspects of intermittent explosive disorder in Japan; prevalence and psychosocial comorbidity: findings from the World Mental Health Japan Survey 2002-2006. Psychiatry Res 2011; 186:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/8\">",
"      Grant JE, Levine L, Kim D, Potenza MN. Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 2005; 162:2184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/9\">",
"      Kessler RC, Coccaro EF, Fava M, et al. The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006; 63:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/10\">",
"      Bromet EJ, Gluzman SF, Paniotto VI, et al. Epidemiology of psychiatric and alcohol disorders in Ukraine: findings from the Ukraine World Mental Health survey. Soc Psychiatry Psychiatr Epidemiol 2005; 40:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/11\">",
"      Lee S, Tsang A, Zhang MY, et al. Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China. Psychol Med 2007; 37:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/12\">",
"      Coccaro EF, Schmidt CA, Samuels JF, Nestadt G. Lifetime and 1-month prevalence rates of intermittent explosive disorder in a community sample. J Clin Psychiatry 2004; 65:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/13\">",
"      Fincham D, Grimsrud A, Corrigall J, et al. Intermittent explosive disorder in South Africa: prevalence, correlates and the role of traumatic exposures. Psychopathology 2009; 42:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/14\">",
"      Shen YC, Zhang MY, Huang YQ, et al. Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China. Psychol Med 2006; 36:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/15\">",
"      Coccaro EF, Posternak MA, Zimmerman M. Prevalence and features of intermittent explosive disorder in a clinical setting. J Clin Psychiatry 2005; 66:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/16\">",
"      Linnoila M, Virkkunen M, Scheinin M, et al. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 1983; 33:2609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/17\">",
"      McElroy SL, Soutullo CA, Beckman DA, et al. DSM-IV intermittent explosive disorder: a report of 27 cases. J Clin Psychiatry 1998; 59:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/18\">",
"      Bach-y-Rita G, Lion JR, Climent CE, Ervin FR. Episodic dyscontrol: a study of 130 violent patients. Am J Psychiatry 1971; 127:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/19\">",
"      Maletzky BM. The episodic dyscontrol syndrome. Dis Nerv Syst 1973; 34:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/20\">",
"      Mattes JA, Fink M. A family study of patients with temper outbursts. J Psychiatr Res 1987; 21:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/21\">",
"      Mattes JA, Fink M. A controlled family study of adopted patients with temper outbursts. J Nerv Ment Dis 1990; 178:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/22\">",
"      Coccaro EF. A family history study of intermittent explosive disorder. J Psychiatr Res 2010; 44:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/23\">",
"      Miles DR, Carey G. Genetic and environmental architecture of human aggression. J Pers Soc Psychol 1997; 72:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/24\">",
"      Coccaro EF, McCloskey MS, Fitzgerald DA, Phan KL. Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression. Biol Psychiatry 2007; 62:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/25\">",
"      Siever LJ, Buchsbaum MS, New AS, et al. d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology 1999; 20:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/26\">",
"      Berman ME, McCloskey MS, Fanning JR, et al. Serotonin augmentation reduces response to attack in aggressive individuals. Psychol Sci 2009; 20:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/27\">",
"      Frankle WG, Lombardo I, New AS, et al. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry 2005; 162:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/28\">",
"      Coccaro EF, Lee R, Kavoussi RJ. Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder. J Psychiatr Res 2010; 44:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/29\">",
"      Coccaro EF, Lee R, Kavoussi RJ. Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects. Neuropsychopharmacology 2010; 35:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/30\">",
"      Dell'Osso B, Altamura AC, Allen A, et al. Epidemiologic and clinical updates on impulse control disorders: a critical review. Eur Arch Psychiatry Clin Neurosci 2006; 256:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/31\">",
"      Felthous AR, Bryant SG, Wingerter CB, Barratt E. The diagnosis of intermittent explosive disorder in violent men. Bull Am Acad Psychiatry Law 1991; 19:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/32\">",
"      Mattes JA. Comparative effectiveness of carbamazepine and propranolol for rage outbursts. J Neuropsychiatry Clin Neurosci 1990; 2:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/33\">",
"      Stanford MS, Helfritz LE, Conklin SM, et al. A comparison of anticonvulsants in the treatment of impulsive aggression. Exp Clin Psychopharmacol 2005; 13:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/34\">",
"      Barratt ES, Stanford MS, Kent TA, Felthous A. Neuropsychological and cognitive psychophysiological substrates of impulsive aggression. Biol Psychiatry 1997; 41:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/35\">",
"      McCloskey MS, Berman ME, Noblett KL, Coccaro EF. Intermittent explosive disorder-integrated research diagnostic criteria: convergent and discriminant validity. J Psychiatr Res 2006; 40:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/36\">",
"      Coccaro EF, Kavoussi RJ, Berman ME, Lish JD. Intermittent explosive disorder-revised: development, reliability, and validity of research criteria. Compr Psychiatry 1998; 39:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/37\">",
"      McCloskey MS, Ben-Zeev D, Lee R, Coccaro EF. Prevalence of suicidal and self-injurious behavior among subjects with intermittent explosive disorder. Psychiatry Res 2008; 158:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/38\">",
"      Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/39\">",
"      McCloskey MS, Kleabir K, Berman ME, et al. Unhealthy aggression: intermittent explosive disorder and adverse physical health outcomes. Health Psychol 2010; 29:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/40\">",
"      Work Group on Psychiatric Evaluation, American Psychiatric Association Steering Committee on Practice Guidlines. Psychiatric evaluation of adults. Second edition. American Psychiatric Association. Am J Psychiatry 2006; 163:3.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association Practice Guideline for the Psychiatric Evaluation of Adults, Second Edition, 2006. file://www.psych.org/MainMenu/PsychiatricPractice/PracticeGuidelines_1.aspx (Accessed on July 18, 2011).",
"    </li>",
"    <li>",
"     Grant JE. The Minnesota Disorders Interview. In: Impulse Control Disorders: A Clinician's Guide to Understanding and Treating Behavioral Addictions, W. W. Norton &amp; Company, New York 2008. p.187.",
"    </li>",
"    <li>",
"     Suris A, Coccaro EF. Aggression measures. In: Handbook of Psychiatric Measures, second edition, Rush Jr AJ, First MB, Blacker D.  (Eds), American Psychiatric Publishing, Washington, DC 2008. p.731.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/44\">",
"      McCloskey MS, Lee R, Berman ME, et al. The relationship between impulsive verbal aggression and intermittent explosive disorder. Aggress Behav 2008; 34:51.",
"     </a>",
"    </li>",
"    <li>",
"     The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. file://www.who.int/classifications/icd/en/bluebook.pdf (Accessed on September 08, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/44/15049/abstract/46\">",
"      Lewin J, Sumners D. Successful treatment of episodic dyscontrol with carbamazepine. Br J Psychiatry 1992; 161:261.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Second Edition (DSM-II), 1968 file://www.psychiatryonline.com/DSMPDF/dsm-ii.pdf (Accessed on September 08, 2011).",
"    </li>",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual: Mental Disorders, 1952. file://www.psychiatryonline.com/DSMPDF/dsm-i.pdf (Accessed on September 08, 2011).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14750 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-210.101.131.232-2A3F076F4F-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15049=[""].join("\n");
var outline_f14_44_15049=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3220848\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3220771\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4226703\">",
"      AGGRESSIVE BEHAVIOR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86453168\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86453175\">",
"      General population",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4516567\">",
"      - Sociodemographic correlates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86453182\">",
"      Clinical settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86453196\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4516858\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86453203\">",
"      Neurobiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4516945\">",
"      Psychosocial factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3220792\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5267627\">",
"      Suicidal and self-injurious behavior",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H93016713\">",
"      COMORBIDITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H93016750\">",
"      Psychiatric disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H93016757\">",
"      General medical disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86453904\">",
"      ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86451820\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86451841\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3220848\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/14750\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/14750|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/51/26428\" title=\"table 1\">",
"      Estimated prevalence rates of intermittent explosive disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/28/43467\" title=\"table 2\">",
"      Research criteria for intermittent explosive disorder",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32761?source=related_link\">",
"      Adult attention deficit hyperactivity disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/26/42409?source=related_link\">",
"      Antisocial personality disorder: Epidemiology, clinical manifestations, course and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=related_link\">",
"      Bipolar disorder in adults: Epidemiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/19/10553?source=related_link\">",
"      Borderline personality disorder: Epidemiology, clinical features, diagnosis, and differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38969?source=related_link\">",
"      Diagnosis of autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39081?source=related_link\">",
"      Diagnosis of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/25/28057?source=related_link\">",
"      Evaluation of cognitive impairment and dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26760?source=related_link\">",
"      Intermittent explosive disorder in adults: Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/1/23578?source=related_link\">",
"      Localization-related (partial) epilepsy: Causes and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/47/34552?source=related_link\">",
"      Schizophrenia: Clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=related_link\">",
"      Substance use disorders: Principles for recognition and assessment in general medical care",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_44_15050="Progression of human coronary atherosclerosis I";
var content_f14_44_15050=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71847&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71847&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 597px\">",
"   <div class=\"ttl\">",
"    Progression of human coronary atherosclerosis I",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 577px; height: 619px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histopathology of human coronary plaque progression, part 1 of 2.",
"    <br>",
"     (A) Intimal thickening is normal in all age groups and is characterized by smooth muscle cell accumulation within the intima.",
"     <br>",
"      (B) Intimal xanthoma or so-called fatty streak corresponds to the accumulation of predominantly macrophages within the intima; these lesions have been shown to regress in later adult life.",
"      <br>",
"       (C) Pathologic intimal thickening marks the first of the progressive lesions and denotes the accumulation of extracellular lipid in the absence of apparent necrosis.",
"       <br>",
"        (D) Fibrous cap atheroma indicates the presence of an encapsulated necrotic core.",
"        <br>",
"         (E) The core may eventually become thinned (thin-cap fibroatheroma).",
"         <br>",
"          (F) This lesion may rupture, allowing contact of the contents of the necrotic core, causing a luminal thrombosis.",
"          <div class=\"footnotes\">",
"           EL: extracellular lipid; NC: necrotic core; FC: fibrous cap; Th: thrombus.",
"          </div>",
"          <div class=\"reference\">",
"           Reproduced with permission from: Virmani R, Kolodgie FD, Burke AP. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20:1262. Copyright &copy; 2000 Lippincott Williams &amp; Wilkins.",
"          </div>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15050=[""].join("\n");
var outline_f14_44_15050=null;
var title_f14_44_15051="Differential dx fibromyalgia";
var content_f14_44_15051=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F50712&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F50712&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of fibromyalgia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Helpful features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rheumatoid arthritis or lupus",
"       </td>",
"       <td>",
"        Symmetrical polyarthritis, systemic features (dermatitis,",
"nephritis), elevated erythrocyte sedimentation rate, serologic",
"abnormalities (rheumatoid factor, anti-DNA antibodies)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Polymyalgia rheumatica",
"       </td>",
"       <td>",
"        Elderly, elevated erythrocyte sedimentation rate, stiffness&gt;pain, responds well and quickly to steroids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myositis",
"       </td>",
"       <td>",
"        Muscle weakness, elevated muscle enzymes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypothyroidism",
"       </td>",
"       <td>",
"        Abnormal thyroid function tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperparathyroidism",
"       </td>",
"       <td>",
"        Hypercalcemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neuropathies",
"       </td>",
"       <td>",
"        Clinical and electrical evidence of neuropathy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15051=[""].join("\n");
var outline_f14_44_15051=null;
var title_f14_44_15052="Ingredient label terms for soy";
var content_f14_44_15052=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F77407&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F77407&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    How to read an ingredient label for a soy-free diet",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Avoid foods that contain soy or any of these ingredients:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Edamame",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Miso",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Natto",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shoyu",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Soy (soy albumin, soy cheese, soy fiber, soy flour, soy grits, soy ice cream, soy milk, soy nuts, soy sprouts, soy yogurt)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Soya",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Soybean (curd, granules)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Soy protein (concentrate, hydrolyzed, isolate)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Soy sauce",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tamari",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tempeh",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Textured vegetable protein (TVP)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tofu",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Soy is sometimes found in the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asian cuisine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vegetable broth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vegetable gum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vegetable starch",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Keep the following in mind:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;",
"        <strong>",
"         The FDA exempts highly refined soybean oil from being labeled as an allergen.",
"        </strong>",
"        Studies show most allergic individuals can safely eat soy oil that has been highly refined (",
"        <em>",
"         not",
"        </em>",
"        cold pressed, expeller pressed, or extruded soybean oil).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Most individuals allergic to soy can safely eat soy lecithin.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Follow your doctor's advice regarding these ingredients.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    All FDA-regulated manufactured food products that contain soy as an ingredient are required by US law to list the word \"soy\" on the product label.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; 2010 The Food Allergy &amp; Anaphylaxis Network. Used with permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15052=[""].join("\n");
var outline_f14_44_15052=null;
var title_f14_44_15053="Discharge checklist";
var content_f14_44_15053=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Ideal discharge of the elderly patient: A hospitalist checklist",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Data elements",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Processes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Discharge summary",
"       </td>",
"       <td class=\"subtitle2\">",
"        Patient instructions",
"       </td>",
"       <td class=\"subtitle2\">",
"        Communication to follow-up clinician on day of discharge",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Presenting problem that precipitated hospitalization",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        x",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Key findings and test results",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        x",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Final primary and secondary diagnoses",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        x",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Brief hospital course",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        x",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Condition at discharge, including functional status and cognitive status if relevant",
"       </td>",
"       <td>",
"        <p>",
"         x - functional status",
"        </p>",
"        <p>",
"         o - cognitive status",
"        </p>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Discharge destination (and rationale if not obvious)",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        x",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        Discharge medications:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Written schedule",
"       </td>",
"       <td class=\"sublist_other\">",
"        x",
"       </td>",
"       <td class=\"sublist_other\">",
"        x",
"       </td>",
"       <td class=\"sublist_other\">",
"        x",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Include purpose and cautions (if appropriate) for each",
"       </td>",
"       <td class=\"sublist_other\">",
"        o",
"       </td>",
"       <td class=\"sublist_other\">",
"        x",
"       </td>",
"       <td class=\"sublist_other\">",
"        o",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Comparison with pre-admission medications (new, changes in dose/freq, unchanged, meds should no longer take)",
"       </td>",
"       <td class=\"sublist_other\">",
"        x",
"       </td>",
"       <td class=\"sublist_other\">",
"        x",
"       </td>",
"       <td class=\"sublist_other\">",
"        x",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Follow-up appointments with name of provider, date, address, phone number, visit purpose, suggested management plan",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        x",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        All pending labs or tests, responsible person to whom results will be sent",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        x",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recommendations of any sub-specialty consultants",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        o",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Documentation of patient education and understanding",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any anticipated problems and suggested interventions",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        x",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        24/7 call-back number",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Identify referring and receiving providers",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        x",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Resuscitation status and any other pertinent end-of-life issues",
"       </td>",
"       <td>",
"        o",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     x: required element; o: optional element.",
"    </div>",
"    <div class=\"reference\">",
"     Derived and expanded from: Halasyamani L, Kripalani S, Coleman E, et al. Transition of care for hospitalized elderly patients: Development of a discharge checklist for hospitalists. J Hosp Med 2006; 1:354.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15053=[""].join("\n");
var outline_f14_44_15053=null;
var title_f14_44_15054="Bartholin gland excision";
var content_f14_44_15054=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1070px;\">",
"  <div class=\"videoplayer\" h264=\"./images/OBGYN/74807/Barth_gland_excision_movie.mp4?title=Bartholin+gland+excision\" style=\"width:480px;height:352px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bartholin gland excision video",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 265px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Gerald Harkins, MD and Kristin Riley, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15054=[""].join("\n");
var outline_f14_44_15054=null;
var title_f14_44_15055="Cervico-vaginal agenesis";
var content_f14_44_15055=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80263&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80263&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vaginal agenesis with agenesis of the cervix",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 406px; height: 318px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      Reproduced with permission from: Laufer MR. Structural abnormalities of the female reproductive tract. In: Pediatric and adolescent gynecology, 6th ed, Emans SJ, Laufer MR, Goldstein DP (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"     </p>",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_44_15055=[""].join("\n");
var outline_f14_44_15055=null;
